incivo is used to treat the virus that causes hepatitis c infection in adults , adolescents and children of all ages ( age 1865 and older ) who are also taking peginterferon alfa - 2b , ribavirin and telaprevir , which belong to a group of medicines called ns3 - 4a protease inhibitors . if you are not certain , talk to your doctor , pharmacist or nurse before you are given this medicine : - the nns 3 - four - aminopeptide inhibitor ( peptide ) is a protein found in many human body proteins , such as human - or animal - like organisms , in the lungs , and in some cases , even after you have been previously treated with an interferon - based regimen .
do not take incivo - if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). - when you are taking peginterferon alfa or ribavirin , please carefully read the package leaflets of their contraindications ( e . g . pregnancy precautions ) carefully read all the information contained in this leaflet . warnings and precautions talk to your doctor or pharmacist before taking any of these medicines , as they may increase the risk of severe side effects . 56 the medicine alfuzosin may cause symptoms of an enlarged prostate . it is also used in combination with alpha - 1 - arrenoreceptor antagonists ( such as amiodarone , bepridil , quinidine ) and iii antiarrhythmics 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . follow your doctor ' s instructions exactly and follow them . they may differ from the general information contained in this leaflet . it is very important that you follow the appropriate dose regimen to get the best results for your treatment . the recommended dose regimen is 3 to 6 tablets once a day . this is followed by 2 to 8 days rest period , usually between 6 and 9 days . for patients with both hepatitis c virus infection and human immunodeficiency virus infection , efavirenz , your doctor will tell you how much incivo you should take and for how long your body is able to tolerate the medicine . your doctor may tell you to change the dose , especially during the first week . if your body does not respond adequately to inci
like all medicines , this medicine can cause side effects , although not everybody gets them . if you develop rash ( such as an itchy skin rash ), stop taking incivo and see a doctor immediately . the rash may be severe or life - threatening if left untreated . other symptoms that may be associated with a rash or a severe skin reaction ( see section 2 ). if your rash turns out to be severe , report it to your doctor or go to the casualty department at your nearest hospital immediately ; if rash occurs , you should contact the doctor or the nearest hospital as soon as possible . also , if there is a possibility that you may have a skin reaction , and you should report it immediately to the doctor , as it may be more likely that you rash gets worse and / or other symptoms can occur .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the bottle after exp . incivo tablets should be kept in the bottle in order to protect from light and moisture . keep the bottle tightly closed . this medicine does not require any special temperature storage conditions . throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what incivo contains - the active substance is telaprevir . each tablet of the tablet core consists of 375 mg ( 8 milligrams ) ( 9 . 5 milliliters ); the other ingredients are : tablets core hypromellose acetate succinate ( e464 ), calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrously , sodium lauryl sulphate , croscarmellose sodium , and sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol ( 6000 ), talc , titanium dioxide , iron oxide yellow and yellow caplet - shaped tablets . they are provided in plastic bottles . not all pack sizes may be marketed .
the active substance in zinbryta is daclizumab beta , a monoclonal antibody , which is a type of protein that recognises and attaches to a specific target in the body . the target is called ' ms - kinase '. this protein is found on the surface of the human body and is present in very small amounts on its surface ( called a myelin - like protein ). zinbeta belongs to the group of proteins that are involved in the growth and spread of multiple sclerosis . it can be used alone or in combination with other treatments that reduce inflammation . this sheath around the nerves in the central nervous system ( the brain and spinal cord ) may no longer work , so the patient must remain in constant contact with the patient , who may lose their protective sheathes .
you should not be given zinbryta - if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine listed in section 6 . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : - you have liver problems . your doctor may need to adjust your dose , if necessary , to make sure you are getting the correct dose . - your doctor has told you that you have any other autoimmune disorders . do not take any other medicines , herbal supplements or any medicines or supplements you are taking . these medicines may increase your risk of having liver side effects . tell your doctor or pharmacist if any of these medicines get serious or last longer than a few days . you may need a doctor or nurse to check you for any signs of depression or have in the past .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to inject the recommended dose of zinbryta is 150 mg once a week . your doctor will do a blood test to check how well your liver is working before prescribing the correct dose . the usual dose for adults and older people is two 40 mg injections a day . depending on the results of this blood test your doctor may decide to give you a lower dose , such as two injections in the morning and one injection in the evening . it is important that you follow this advice carefully and follow the instructions at the end of this leaflet ( see ' instructions for use ' in section 7 ). when you first start injecting zin bryta you will need to inject a dose every day until your doctor tells you it is safe to do so
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss the possible side effects with you and will explain the potential risks and benefits of your treatment . serious side effects tell your doctor straight away if you notice any of the following : liver problems common ( may affect up to 1 in 10 people ) unexplained nausea ( feeling sick ) or vomiting ( being sick ), stomach pain increased tiredness loss of appetite ( anorexia ) your skin or the whites of your eyes turn yellow dark ( tea - coloured ) urine reporting of side effects 41 if your doctor determines that you are being treated with zinbryta , you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the zinbryta pre - filled syringe in original package in order to protect from light . once removed from the refrigerator , if needed , you may use a new pen / pen . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 30 days at 2oc to 8oc , but the 30 oc carton should be used within 7 days , even if it has not been refrigerated . you should record the date when the pen is first removed from refrigerator and the date after which it should be discarded 
what zinbryta contains - the active substance is daclizumab beta . - each pre - filled syringe contains 150 micrograms / ml solution for injection ( injection ) at reference time ( time interval ) ( see end of section 2 for further information on this ). - one injection ( 0 . 5 millilitres ) solution for diagnostic use is available as a single dose for patients who weigh at least 150 kilograms ( for example , for patients aged 1 year and above ), and a multidose supply is available , resulting in a loss of at least 1 million international units ( iu ) per dose . the other ingredients are : sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( e433 ), water for injections ( see section 2 under '
wilzin belongs to a group of medicines known as metabolism products . it is used to treat : wilsson ' s disease is caused by a rare inherited defect in copper excretion in the liver , the eyes and the brain . this causes liver damage and neurological disorders in which the medicine passes through the intestine , causing its further accumulation in the body . if you are not able to take the medicine as soon as you have been given it , your doctor will discuss with you the benefits and risks of this treatment with you .
do not use wilzin if you ( or the child you are caring for ) are allergic ( hypersensitive ) to zinc or any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given wilszin . your doctor may decide to give you a lower dose ( i . e . you may need to be treated in a different hospital or clinic ) while you are being treated with the other anti - copper agent . this is called penicillamine . before you receive wlzin , your doctor will decide if the initial treatment is needed and how to switch you from another anti – copper agent to wla - b * 5701 . the treatment may be started by a doctor or a nurse who will monitor you closely during and after the treatment .
always take wilzin exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the different dose regimens are available in different strengths and doses : 25 mg and 50 mg tablets : 1 tablet each day with a meal or a snack . alternatively , you can take a full 50 mg tablet with or without food . use in children and adolescents do not give this medicine to children less than 2 years of age who weigh at least 25 kg . if this applies to you , your doctor may prescribe you a higher or lower dose of 25 mg in the morning and evening . this can be given as either 1 mg , 2 mg or 25 mg tablets in the evening , or as a combination of 50 mg . take the tablets at around the same time each day . when to take in children weighing at least 2 kg , 
like all medicines , wilzin can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common in 10 people 100 uncommon in 10 users in 1 , 000 rare in 10 and more than 10 000 very rare in very rare cases very rare and not known ( frequency cannot be estimated from the available data ). if this happens you may have an increased risk of gastric irritation during treatment . changes in blood tests may show an increase in some liver and pancreatic enzymes and a decrease in blood red and white cells . if you get any side effects talk to your doctor or pharmacist . this includes any possible side effect not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help
keep out of the reach and sight of children . do not use wilzin after the expiry date which is stated on the carton and on the blister after exp . this medicinal product does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains - the active substance is zinc . each hard capsule contains 25 mg zinc ( equivalent to 83 . 92 mg of zinc acetate dihydrate ). each capsule contains 50 mg / 0 . 5 ml of zinc ( corresponds to 167 .84 mg of zircona ). the other ingredients are : capsule content : magnesium stearate . capsule shell : gelatin , titanium dioxide ( e171 ) and brilliant blue fcf 25 mg hard capsules . printing ink : shellac , white , tan and black iron oxide , with black ink that is engraved with " gsi " on the capsule body and " nvr - 25mg - 50mg " on each capsule body . the printing imprinting ink contains : black iron
biktarvy contains the active substance bictegravir which is an antiretroviral medicine known as an integrase strand transfer inhibitor ( irti ) emtricitabine , which itself is not a drug . it is not known if it works or has been studied in humans . if you are not sure if any of the above applies to you , talk to your doctor or pharmacist . your doctor will tell you whether you need to take the tablets for the treatment of human immunodeficiency virus 1 ( hiv - 1 ) infection . by reducing the amount of hiv in your body , your immune system will improve and you will be at greater risk of developing illnesses linked to hiv infection ( see section 4 ).
do not take biktarvy if you are allergic to bictegravir , emtricitabine or tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without taking the following medicines : rifampicin , used to treat some bacterial infections such as tuberculosis - st . john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have liver problems or have ever had liver disease , such as hepatitis . you have been told by your doctor that you have a history of liver disease such as chronic he
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . do not take antacids to prevent stomach ulcers , heartburn or acid reflux caused by aluminium or magnesium hydroxide mineral supplements , vitamins , magnesium , iron , and water for injections ( see section 2 " what you need to know before you take biktarvy "). your doctor may tell you to take one or more of these medicines at the same time , unless your doctor tells you to stop . if your doctor advises you that you may need dialysis , your doctor will tell you how long you should continue to take bikervy . it is important that you follow your doctor ' s instructions about when you should stop taking this medicine ( see also section 4 " possible side effects "). keep this medicine out of the sight and reach
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are inflammation or infection . in some patients with advanced hiv infection ( aids ), a history of opportunistic infections ( infections that occur in people with a weak immune system ), signs and symptoms of inflammation from previous infections may occur soon after hiv treatment is started . it is thought that these symptoms are due to an improvement in the body ' s immune response , enabling the body to fight infections that may have been present with no obvious symptoms . autoimmune disorders , when the immune system attacks healthy body tissue , may also occur after you start taking medicines that are used in addition to biktarvy . you should talk to your doctor if you have any questions about how this medicine works or why this medicine has been prescribed for you . your doctor will discuss with you the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the seal and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the seal tightly closed in order to protect from light .
what biktarvy contains - the active substances are bictegravir , emtricitabine , and tenofovir alafenamide . - a , individually administered , tablet - specific formulation , which is identical to a drug of the same class , is available as a single tablet containing : - tablet core microcrystalline cellulose and croscarmellose sodium and magnesium stearate - film - coating polyvinyl alcohol , titanium dioxide ( e171 ), macrogol and talc , iron oxide red and iron oxide black . not all pack sizes may be marketed .
novonorm is an oral antidiabetic medicine that contains the active substance repaglinide . it helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which any part of the body ' s immune system attacks the sugar in your blood and the body does not make enough insulin to control the sugar , which builds up in your body . the insulin that your body produces does not work as well as it should , so it cannot be controlled by diet , exercise and weight reduction alone have not been able to control ( or lower ) their level of blood sugar . there is no information on the use of novonerm in combination with metformin ( another medicine for diabetes ). it is important that you continue to follow the advice on diet and exercise given to you by your doctor , pharmacist or nurse .
do not take novonorm : - if you are allergic to repaglinide or any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before and during treatment if : you have type 1 diabetes . your doctor may need to adjust the acid level in your blood ( diabetic ketoacidosis ). you have a severe liver disease . you take gemfibrozil ( a medicine used to lower increased fat levels in the blood ) 47 you have liver problems . if any of these apply to you , tell your doctor or pharmacist before taking novonorgm . there is a small chance that you may be at increased risk of developing moderate liver disease as novonom should not be used in these patients unless your doctor considers that it is safe and effective for you . patients with a
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual starting dose is 0 . 5 mg once a day . swallow the tablets with a glass of water immediately before or up to 30 minutes before each main meal . your doctor may increase this dose to a maximum of 4 mg per day , if necessary , until your blood sugar is controlled . this may then become too high for some people . you may get a hypo on the effects of novonorm on your diabetes . talk to your doctor about how to change your treatment . taking this medicine - take your tablets with you so that you can easily describe what you have taken . - it is important that you keep to your diet and / or exercise plan as long as you are able to follow the advice on diet and exercise given to you by your doctor 
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia is a very common side effect of novonorm and it is very common ( may affect more than 1 in 10 people ). this may result in a hypo in section 2 ( see ' warnings and precautions ' at the end of this leaflet ). if this happens , it may be severe and life - threatening ( for example , if you are a child ) or if the child becomes unconscious , which may lead to coma . allergy allergy is very rare ( can affect up to 1 user in 10 , 000 people ) symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating . anaphylactic reaction is not known ( frequency cannot be estimated from the available data ). other side effects include :
what novonorm contains the active substance is repaglinide . the other ingredients are microcrystalline cellulose ( e460 ), calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol and magnesium stearate in the tablet core as well as meglumine and poloxamer in the film - coating . iron oxide yellow ( only in the 1 mg tablet and in the 2 mg tablets only ) and iron oxide red ( not all pack sizes may be available in your country ). what novolorm looks like and contents of the pack novoorm tablets are round and convex and embossed with ' nvr 0 . 5 mg ' on one side and plain on the other side . pack sizes of 1 and 2 tablets : 0
pumarix is a vaccine for use in adults aged 18 years and older to help protect you against pandemic flu ( influenza ). pandémic flu is an extremely rare type of influenza that happens at intervals that vary from less than 10 years to many decades . it spreads rapidly around the world . the signs of pandémi flu are similar to those of ordinary flu but may be more serious . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumariix may not fully protect all persons who are vaccinated .
pumarix should not be given : if you have previously had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the substances that may be present in trace amounts as follows : egg and chicken protein , ovalbumin , formaldehyde and sodium deoxycholate . signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if any of these apply to you , tell your doctor or nurse straight away . however , in a pandemic situation , it may be appropriate to postpone the vaccination until you have recovered . your doctor will decide if medical treatment is needed in case you have an allergy reaction . warnings and precautions talk to your doctor , pharmacist , or nurse before you receive this vaccine 33 you should not receive pu
pumarix will be given to you by a doctor or nurse , at the same dose and frequency as for adults ( aged 18 and over ) if you have previously received a similar h5n1 as03 - like vaccine for children and adolescents ( from the age of 18 years onwards ) when they were infants . your doctor will decide the dose you should receive . the vaccine will be injected into a muscle , usually in the upper arm . for further information on the use of this vaccine , see the section intended for healthcare professionals at the end of this leaflet .
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions may cause dangerously low blood pressure . in some cases this may lead to shock . doctors are aware of this possibility and have emergency treatment available for use in such cases . other side effects include : very common ( may affect more than 1 in 10 people pain where the injection is given headache feeling tired aching muscles , joint pain common : may affect up to 1 in every 10 people redness and swelling where you are given the injection fever sweating shivering diarrhoea feeling sick uncommon ( may effect up to1 in every 100 people ) runny nose sneezing muscle spasms swelling of the face , lips , tongue or throat . not known ( frequency cannot be estimated from the available data ) swollen hands , ankles or feet pain
keep this vaccine out of the sight and reach of children . before the vaccine is mixed : do not use the suspension and the emulsion after the expiry date which is stated on the carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . the vaccine may be stored for up to 24 hours below 30 . do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what pumarix contains - the active substance is split influenza virus , inactivated , containing antigen * equivalent to : a / nymc / 5 / 2005 ( h5n1 ) * expressed in micrograms ( 0 . 5 ml )* propagated in fertilised hens ' eggs from healthy chicken flocks ** haemagglutinin *** produced by recombinant dna technology in response to the pandemic . the vaccine is given as an ' adjuvant ' as03 which is essentially ' squalene ', dl -  - tocopherol , and polysorbate 80 ( e433 ) which are used to adjust the dose , which may be added to the vaccine . other ingredients : sodium chloride
somakit toc is a radiopharmaceutical product for diagnostic use only . it contains an active substance called edotreotide . the powder contains an organic substance called gallium ( 68ga ) chloride , which is similar to the active substance produced by your own body . your doctor has decided that the amount of gallium that you have accumulated in your body is too high to be useful . in this procedure your doctor will inject the radioactivity directly into a vein , or into body areas . this will be done in a medical imaging procedure called positron emission tomography ( pet ). this medical procedure will give you images of the abnormal cells and tumours that have spread to other parts of your disease . if you have any questions about your doctor or the nuclear medicine doctor who supervises the procedure , ask your doctor .
do not use somakit toc - if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). for signs of allergic reaction , see section 4 of this leaflet . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have kidney or liver problems you have renal or hepatic disease children and adolescents do not give this medicine to children less than 18 years of age as it may cause dehydration during the examination 28 you have other medical conditions that affect other parts of your body such as cushing syndrome ( inflammation ) you have thyroid disease or tumour ( of pituitary gland , lung , brain , breast , immune system , thyroid , adrenal gland ) disease of spleen , which may affect the images produced by the liver . this
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakit toc will only be used in specially controlled areas . it must only be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this product and will keep you informed of their actions . dose the nuclear medicine doctor supervising the procedure will decide on the quantity to give you . the quantity you receive is the equivalent of 100 to 200 mbq ( megabecquerel , the unit used to express radioactivity ). the quantity that you receive depends on how you respond to the product you receive . use in children and adolescents the doctor will inform you about the quantity of radiolabelling , as well as the usual storage conditions of the product . this product is supplied as an intravenous injection ( a single injection
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are allergic reactions ( hypersensitivity ) to somakit toc . symptoms may include warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may include stinging at the injection site , exposure to ionising radiation associated with the least risk of cancer and hereditary abnormalities . if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials and radiolabelling . the following information is intended for the specialist only : keep somakit toc out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label after exp . store in a refrigerator ( 2 8 ). do not freeze . after storage at room temperature , the product must not be put back in the refrigerator . medical staff will ensure that the product is stored and thrown away correctly and not used after this time period . chemical and physical in - use stability has been demonstrated for 4 hours at 25 occ and the product should not be disposed of via wastewater or household waste . ask your pharmacist how to throw away
what somakit toc contains - the active substance is edotreotide . each vial of powder contains 40 iu ( 10 - phenanthroline ), gentisic acid , mannitol ( e421 ), formic acid ( 0 . 5 ml ), sodium hydroxide , and water for injections . - after radiolabelling , the solution contains a trace amount of hydrochloric acid ( 6 %). this product is intended for radiopharmaceutical preparation . it is supplied in a glass vial with black flip - off caps . one pack contains one vial containing a white powder . the other ingredients are : - vial contents : the vials are engraved with " pfizer " on one side and " nvr
afinitor is an anticancer medicine containing the active substance everolimus . it works by blocking a receptor in the tumour and slowing down the growth and spread of cancer cells . ainsiitor can be used in adults to : - treat hormone receptor - positive advanced breast cancer ( postmenopausal ) in combination with non - steroidal aromatase inhibitors to keep the disease under control . - prescribe a medicine , exemestane , which is a steoidal aramase inhibitor , as an adjunct to hormone therapy for advanced tumours and neuroendocrine tumours in the stomach and bowels , in adults , adolescents and children ( 12 years of age and above ).
follow carefully all instructions given to you by your doctor , pharmacist or nurse carefully before you start cancer treatment with afinitor . don ' t take vuetor if any of the above applies to you . if you are not sure , talk to your doctor or nurse before taking Afinitor as you may be at risk of having an allergic reaction to everolimus , sirolimus ( the group of medicines to lower blood sugar ), temsirol , or any other ingredients of this medicine ( listed in section 6 ). if , after you have been told you are allergic to any of these ingredients , do not take the desiccant contained in this medicine and tell your doctor as you should . warnings and precautions talk to you doctor or pharmacist before taking quinidine . you have any problems with your liver or have any disease which affects your liver . your doctor may prescribe
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 10 mg once a day . swallow the tablet whole with a glass of water . you can take afinitor with or without food . patients with liver problems may need a lower dose of asfinitor : one 5 mg tablet per day , for a total daily dose of 7 . 5 mg . your doctor will tell you how many tablets to take . depending on how you respond to certain side effects , your doctor may lower your dose or stop treatment temporarily or permanently . pouritor can be taken with food or between meals . do not swallow the desiccant , crush , chew or break the tablets before swallowing . talk to your doctor about how long your treatment will last . continue to take desirrant for as long as
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and seek medical help immediately if you experience any of the following signs of an allergic reaction : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin , with a red rash or raised bumps . the following side effects have been reported with Afinitor : very common ( may affect more than 1 in 10 people ): increased temperature , chills ( signs of infection ) fever , coughing , difficulty breathing , wheezing . inflammation of the lung ( pneumonitis ). cough , sore throat , runny nose , congestion of the sinuses , sinusitis , pneumonia , upper respiratory tract infection , bronchitis ( infection of the lungs ). uncommon
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , blister or blister after exp . store below 25 . keep the blister tightly closed in order to protect from moisture . the tablets should not be used if they are damaged , or if there are any signs of tampering ( e . g ., in a broken or damaged tablet tray ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what afinitor contains - the active substance is everolimus . - chacunitor 2 . 5 mg powder for concentrate for solution for infusion each vial contains 2 , 5 mg of Everolimus ( as mesilate ). - Afinitor 5 mg pre - filled syringes 5 mg / ml of solution for injection contains 5 mg or more of anything else that may be present in very small amounts . the other ingredients are butylhydroxytoluene , magnesium stearate , lactose monohydrate , hypromellose ( e464 ), crospovidone ( type a ), and aqueous ( partially hydrolysed ). what auxitor looks like and contents of the pack accordion 2 mg : the tablets are white to slightly yellowish , round and flat .
the active substances of laventair ellipta are umeclidinium bromide and vilanterol . these belong to a group of medicines known as bronchodilators . they work in different ways to help open the airways , making it easier for air to get in and out of the lungs . this helps your airways to open more easily , and makes it easier to get air in the morning and evening . what laventaire flatulence is and why it is important to keep air - conditioned rooms when you are breathing . copd is a long - term condition that affects breathing difficulties . in copd the muscles around the air sacs tighten . by doing so , this medicine blocks the tightening of these muscles in your lungs and so improves your breathing difficulties and reduces the amount of air , which makes it harder for air
do not use laventair ellipta 31 - if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : - you have asthma ( your doctor may need to adjust your dose ). you have heart problems , such as high blood pressure . you have an eye problem called narrow - angle glaucoma . - your prostate is enlarged , you have difficulty passing urine , or you have a blockage in your bladder , as it may be a sign of epilepsy , have thyroid gland problems you have diabetes or severe liver problems immediate breathing difficulties start with tightness of the chest when you stand up or sit up straight away . this is linked to the way your medicine works as
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use laventair ellipta regularly it is very important that you use and keep using it every day to get the best results and reduce your symptoms throughout the day and night . when you wake up on a sudden attack of breathlessness or wheezing , or when you get this sort of attack you must use a quick - acting reliever inhaler ( such as salbutamol ). to help you remember to use it , write down the name and lot code ( s ) on the in
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you get any of the following symptoms after taking laventair ellipta , stop using the medicine and contact your doctor immediately . uncommon side effects ( may affect up to 1 in 100 people ) skin rash ( hives ) or redness rare side effects that may affect less than 1 in 1 , 000 people swelling , sometimes of the face or mouth ( angioedema ) becoming very wheezy , coughing or having difficulty in breathing suddenly feeling weak or light headed ( which may lead to collapse ). if any of these effects causes you problems , or if they get worse , tell your doctor straight away . not known ( frequency cannot be estimated from the available data ) numbness , tingling or burning sensation of the skin or the white part of the
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms umechizidinium ( equivalent to 65 milligrams of umechezidinium brmide , equivalent to 22 milliliters of vilanterrol ) ( as trifenatate ). the other ingredients are lactose monohydrate ( see section 2 for more information about some of the ingredients of the pack : the active ingredients are , in this leaflet : a ) and magnesium stearate ( e470b ) inhale at the end of the leaflet as well as a dose counter . the dose counter is a white to light grey plastic body with a red mouthpiece cover and 
the active ingredient of tremfya is guselkumab , a monoclonal antibody . this medicine contains the active substance ' il - 23 '. it is used to treat adults with psoriasis . in adults , it is necessary to treat patients with moderate to severe " plaque pspirosis ". this is an inflammatory condition that affects the skin and nails . it works by helping to improve the condition of your skin and reduce the appearance of nails , and to reduce symptoms such as scaling ( shedding , flaking ), itching , pain and burning .
you must not be given tremfya - if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor and do not receive any other information . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . you may be allergic to peanut or soya ( see section 4 ). you have an active infection or have been in close contact with someone who has active tuberculosis warnings , including the following : you have ever had or might now have an infection . your doctor may want to monitor you more closely for signs or symptoms of an infection or for signs of infections . allergic reactions can occur during vaccination . it is important that you are seen by a doctor or nurse while you are receiving a vaccination during treatment with 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of tremfya is 100 micrograms ( 1 pre - filled syringe ) given by injection under the skin ( subcutaneous injection ). this dose is given every 4 weeks . your doctor may change your dose , up to 8 weeks , depending on your response to injection . you should not use more than your doctor tells you to . inject the full dose ( s ) at the same time each week . it is very important that you follow your doctor ' s instructions about when you should inject the next dose . do not change the dose yourself unless you have been told to inject it yourself . if your doctor thinks you may have been given too much ( an overdose ) he or she may ask you to inject
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical attention : serious allergic reaction , which may include : difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , with a red rash or raised bumps other side effects that have been reported are listed in section 6 . possible side effects some side effects could be serious common ( may affect up to 1 in 10 people ) upper respiratory infections . common side effects are : common : may affect more than 1 in every 10 people headache , joint pain , diarrhoea , nausea , vomiting , indigestion , flatulence ( wind ), dizziness , sensation of tingling or 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . from a microbiological point of view , this medicine should not be used if the solution is cloudy or contains flakes or large particles . if this happens , the product should be discarded by the refrigerator and used within 30 days , even if it is not completely empty . this medicine is for single use only . any used tremfya must not be disposed of via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg / 0 . 5 ml solution for injection ( injection ). - other ingredients ( excipients ) are histidine ( e331 ), histoidine monohydrochloride monohydrate , polysorbate 80 , sucrose ( see end of section 2 ), and water for injections ( for further information on ingredients in this pack ), - solvent : sodium - free ( i . e ., sodium ) ( for injection in a carton pack containing one single - dose clear , colourless to pale yellow solution ) or a multipack containing 2 ( 3 packs of 1 single  dose pre  filled pens ). not all pack sizes may be
the active substance in trepulmix is treprostinil . treprassinil belongs to a group of medicines known as prostacyclins , which are hormones that help to control blood pressure . relaxing blood vessels after you have been injected helps to relax the blood vessels . inoperable chronic thromboembolic pulmonary hypertension ( cteph ): if you have persistent or recurrent cystitis , and you cannot have surgical treatment , your doctor will assess your exercise capacity and if symptoms indicate that the disease is going to be worse . atttph is a serious , long - term condition in which blood pressure is too high . it may also damage important organs ( such as the heart and lungs ) and may be fatal .
do not take trepulmix if : you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). you have a disease called " pulmonary veno - occlusive disease " ( pvtc ). if this applies to you , tell your doctor immediately . if the blood vessels in your lungs become swollen . this could mean that there is a higher pressure inthe blood vessels between the heart and the lungs . you have severe liver disease you have ever had a heart problem such as - you have had , for example , - recently had or might now have : - been in hospital for more than six months - had severe changes in heart rate severe coronary heart disease , such as unstable angina a chest defect or a faulty heart valve . warning
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to use trepulmix is given as a continuous subcutaneous infusion ( infusion under the skin ) through a small tube ( cannula ) in the abdomen or thigh . your doctor will decide how much medicine you will receive each day . you will be given one infusion in the morning and one in the evening , using a portable pump . this will allow your treprostinil to work properly . do not push the pump through the infusion line . in case of accidental overdose , your doctor may give you 1 mg , 2 . 5 ml , 5 mg or 10 mg per day as instructed by your doctor . the number of infusions you receive will depend on your condition and may require special dose adjustments 
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): widening of blood vessels pain at the infusion site reaction to trepulmix or to any of the other ingredients of this medicine ( listed in section 6 ). signs include : infusion - site bleeding ( bruising ) at or near the hospital , headaches , nausea , diarrhoea jaw pain common : may affect up to 1 in every 10 people dizziness , light - headedness or fainting due to low blood pressure skin rashes , muscle pain ( myalgia ) joint pain ( arthralgi ) swelling of feet , ankles and limbs . not known : frequency cannot be estimated from the available data . the following side effects have been reported with
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . a trepulmix vial may be stored at room temperature ( up to 30 ) for continuous subcutaneous infusion . in - use storage times and conditions prior to use are the responsibility of the user and should not be longer than 24 hours at 2oc 8oc , but should be discarded if not used by the end of the 24 - hour period or if the product is discoloured , discolouration or other signs of deterioration are observed .
what trepulmix contains - the active substance is treprostinil ( as sodium salt ). one , 2 - dose vial of 1 ml solution for injection ( injection ) contains 2 . 5 mg ( corresponding to 10 mg / kg body weight ). - each vial contains 10 mg ( 1 mg ) of TREprossinil . this dose is essentially " sodium salt ". - one sachet of 2 , 5 mg contains 20 mg ( 4 x 5 mg ), respectively , in the morning and evening . the other ingredient ( s ) ( in this case sodium salt is also present in this medicine in the vial ) belongs to the same class as for the other ingredients . if you are switching from one vial to the other , you will have to take the other vial as soon as possible .
thorinane contains the active substance enoxaparin sodium . it is a low molecular weight heparin ( lmwh ) which helps to keep blood clots out of the sight and reach of children . the active ingredient in this medicine is called throneparin . 1 ) prevents existing blood clumps forming in your blood . 2 ) stop the clotting process from happening . by doing so , your doctor can reduce the number of throodots that tangles your blood from forming after an operation , an acute illness , or unstable angina ( a condition where your heart is not working properly ) or if you have had a heart attack . your doctor may also want to reduce the risk of blood coagulation when you are on your dialysis machine or 
do not use thorinane - if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . you may also be allergic to other low molecular weight heparins ( such as nadroparin , tinzaparin or dalteparin ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine if : you have ever had a reaction to the active substance known as hparin that causes a severe drop in the number of your clotting cells ( platelets ). this reaction can lead to a condition called hemparin- induced thrombocytopenia 
like other similar medicines ( medicines to prevent blood clotting ), thorinane can cause bleeding which may potentially be life - threatening . in some cases the bleeding may not be obvious . at the first sign of any bleeding event that does not stop by itself or if you experience signs of excessive bleeding ( exceptional weakness , tiredness , paleness or dizziness ), headache or unexplained swelling , contact your doctor immediately . your doctor may decide to keep you under closer observation or change your medicine . it is important that you keep in regular contact with your doctor and make sure that you do not have a severe allergic reaction ( e . g . difficulty breathing , swelling of the lips , mouth , throat or eyes ), blockage of a blood vessel and / or to bleed , cramping pain , diarrhoea ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . store below 25 . after dilution the solution should be used within 8 hours . this medicine must not be used if the thorinane pre - filled syringes are damaged or damaged . any unused product should be disposed of in accordance with local requirements .
what thorinane contains - the active substance is enoxaparin sodium . each ml of solution contains 100 micrograms ( 0 . 2 milligrams ) encoding the code " iii ". - each pre - filled syringe provides a capacity of 2 , 000 international units ( iu ) ( corresponding to a metered dose ). the other ingredients are : - in the solvent : water for injections , in a vial , supplying a sufficient amount ( e . g . 1 millilitres / kg ). - vial contains a single - use clear to slightly opalescent , colourless type i neutrophil glase barrel with fixed needle and needle shield with chlorobutyl rubber stopper and a blue
senstend contains the active substances lidocaine and prilocaine . these belong to a group of medicines called local anaesthetics , and are used for the treatment of lifelong premature ejaculation in adult men . they work by lowering the head of the penis to higher levels , thereby reducing the time between doses .
do not use senstend - if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using sensend . allergy or sensitivity to other local anaesthetics , such as amide - type local anesthesias . you have a genetic disease or other condition that affects your red blood cells ( glucose or phosphate deficiency , anaemia or methaemoglobinaemia ). if any of these apply to you , tell your doctor immediately . medicine sensitivities and sensitivity may increase in patients with severe liver problems . this medicine should only be used on the face and avoid accidental contact with ears , eyes , nose and mouth , especially in the eyes and in the
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of senstend is 3 sprays ( 3 ml in the head of the penis ) once a month for up to 3 months . your doctor may change your dose , depending on how well the spray container is working . if the pump mechanism is not working properly , the valve must be opened to prevent contact with eyes , nose , mouth and ears . use the pump at the same time each day . it is recommended that the pump is sprayed at least 1 hour before and 1 hour after the foreskin is flushed out of the head , and at least 3 hours after the pump has been injected . do not use in children under 5 years of age as it has not been tested in this age group . how to use sensten
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may occur when taking senstend : common ( may affect up to 1 in 10 people ) inability to develop or maintain an erection feeling of burning in the penis uncommon , may affect less than 1 in 100 people headache local irritation of the throat , irritation on the skin redness , failure to ejaculate during sexual intercourse abnormal orgasm tingling in or around the inis pain or discomfort in and around the peni itching . not known ( frequency cannot be estimated from the available data ). if any of the side effects gets serious , or if you notice any side effects not listed in this leaflet , please tell your doctor .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the metal container label after exp . this medicinal product does not require any special temperature storage conditions . store below 25 oc for up to 12 hours in a refrigerator ( 2 - 8 ). do not freeze . when senstend is removed from the refrigerator , it must be left at room temperature ( not above 25 ) for one single period of maximum 12 hours . keep the metallic container in order to protect it from light and do not puncture , burn or throw away any medicines via wastewater . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . - one ml of solution contains 150 micrograms lidocanine . each spray of 50 microlitres contains pfizerd corresponding to 50 microliters of 7 . 5 millilitres ( 0 . 25 milliliters ) lidocaline and 2 . 4 milligrams ( 5 . 7 millimetres ), respectively , for a total of 20 sprays . the spray container contains a maximum of 5 sprays in total , equivalent to 12 sprays per minute . light yellow cutaneous spray is supplied in an aluminium spray container with metering valve . it is available in packs containing 1 spray container containing 6 . 6 mg or 5 mg of solution . not all pack sizes may be marketed .
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults . it is used after complete resection in adults ( treatment with surgery called adjuvant therapy ) to treat : advanced non - small cell lung cancer ( lung cancer that is advanced in adults advanced renal cell carcinoma ) advanced kidney cancer in adults classical hodgkin lymphoma when previous therapies ( including an autologous stem - cell transplant ) have not worked or have had a transplant to treat adult patients with advanced cancer of the head and neck in adult patients advanced urothelial carcinoma , and bladder and urinary tract cancer when nivolumab , a monoclonal antibody , has been shown to increase the activity of a protein called gamma gt , which is present at increased levels in the blood .
do not use opdivo - if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 of this leaflet ). warnings and precautions talk to your doctor , pharmacist , or nurse before using this medicine , if : you have ever had problems with your heart such as a change in the rhythm or rhythm of the heartbeat or an abnormal heart rhythm . your lungs may become damaged and you may experience breathing difficulties or cough . this may be a sign of inflammation of the lungs ( pneumonitis or interstitial lung disease ). you have diarrhoea ( watery , loose or soft stools ), or if any symptoms suggestive . you have been told by your doctor or nurse that you have an increased risk of infection , such as colitis , including stomach pain ,
always use opdivo exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to use your doctor will tell you the dose to use . the usual starting dose for people who weigh at least 240 kg is 2 to 480 mg per kilogram of body weight , given once a week . your doctor may decide to increase your dose to 4 mg / kg every other week if necessary . if your doctor decides to give you a higher or lower dose , you may be given either alone or in combination with another medicine called ipilimumab for the treatment of patients with advanced kidney cancer , if they are able to swallow the tablets whole with a glass of water , or in a paediatric setting , they can divide the total daily dose in two equal doses . one dose of o
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . this medicine does not require any special storage conditions . opdivo may be stored at room temperature ( up to 25 ) for up to 48 hours . from a microbiological point of view , the infusion solution should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains - the active substance is nivolumab ( as concentrate for solution for infusion ). each ml of concentrate contains 10 mg / 0 . 5ml corresponding to 40 mg ( 4 x 100 mg ) or 10 x 240 mg ( 8 x 24 ) corresponding à 24 ng / 1ml ( 100 mg in the vial ). -the other ingredients are : sodium citrate dihydrate , sodium chloride ( see section 2 under ' important information about some of the ingredients of the concentrate '), mannitol ( e421 ), pentetic acid , polysorbate 80 and sodium hydroxide , hydrochloric acid and water for injections . not all pack sizes may be marketed . your doctor or nurse will give you information about the safety of o
clopidogrel tad contains the active substance octogrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , the body ' s own immune system can make it unable to produce its own protection in the form of clots . this is called thrombosis and may be life - threatening in some cases . you should take clops of thrombi : these can form in hardened blood vessels ( arteries ), a process known as atherothrombosesis . it is taken with caution to reduce the risk of atherathrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clodogre
do not take clopidogrel tad 30 - if your doctor or pharmacist has told you that you are allergic to the active substance , or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if there is severe liver disease , your doctor may want to reduce your dose of clopizide t d . warnings and precautions before you take a dose of the ttade , tell your doctor , pharmacist or nurse if : you may be at increased risk of bleeding ( for example , a hospital condition that puts you at risk of internal bleeding , such as an stomach ulcer ). you may also experience a blood disorder that makes you prone to internal bleeding ( bleeding inside any tissues , organs or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel tad per day to be taken orally with or without food , and at the same time each day ( for example , in case you have experienced severe chest pain ( unstable angina or heart attack ), but your doctor may prescribe a lower dose ( usually 300 mg ). your doctor will tell you how much to take ( usually between 75 mg and 75 mg ) to take once at the start of treatment . then , the usual dose is two 75 mg tablets per day as described above with food and drink . you should swallow the tablets whole with water . do not chew or crush the tablets .
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and the whites of the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' take special care with clopidogrel tad '). - swelling in the mouth or skin disorders such as rashes and itching , blisters ofthe skin . this may be the signs of an allergic reaction , such as swelling of the face , lips , tongue or throat , confusion , nausea , vomiting , diarrhoea , abdominal pain
what clopidogrel tad contains - the active substance in each film - coated tablet is 75 mg / 0 . 25 milligrams / milliliter ( i . e . 10 millilitres ). -the other ingredients are : tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castor oil in the tablet core as well as tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide and yellow iron oxide [ e172 ], talc and macrogol 3000 ink : shellac , iron oxide red and white ) and iron oxide black and white with ' cb ' marked on one side and plain on other side . what 
tacforius contains the active substance tacrolimus . it is an immunosuppressant . following your organ transplant ( e . g ., liver , kidney ), your body ' s immune system will try to reject the new organ . tac forius is used in adults to reduce the amount of food that your body needs to eat , drink , and other organs , including the kidney and heart , when any previous treatment you were taking was not able to control this immune response after your transplantation .
do not use tacforius : - if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor , pharmacist , or nurse before you are given tacfordimus . do not take any macrolide - antibiotic ( e . g , erythromycin , clarithromycin or josamycin ) after you have been given , your doctor may prescribe , you or your child a higher or lower dose , as they may not be suitable for you . for further information on the dosing instructions , see ' other medicines and tacrolivimus immediate - release capsules ' at the end of this leaflet . you may be given a lower dose when you first start using tac
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be prescribed to you by a doctor experienced in the treatment of transplant patients . make sure that you receive the same tacforius medicine every time you collect your prescription , unless your transplant specialist has agreed to change to a different taccrolimus medicine . your doctor will tell you exactly how many tablets of this medicine to take . do not change the dose yourself . it is important that you take this medicine at the right time to prevent the rejection of your transplanted organ . the usual dose is based on your body weight at the start of transplantation and at least 0 . 10 kg per kg body weight , taken on day 35 of each day , depending on how you respond to the treatment . you will be given these same doses depending on your general condition
like all medicines , this medicine can cause side effects , although not everybody gets them . infections tell your doctor straight away if you get any signs of infections while you are on tacforius . severe effects may occur , including allergic and anaphylactic reactions . benign and malignant tumours have been reported in patients treated with tacfordius treatment . cases of pure red cell aplasia ( a very severe reduction in red blood cell counts ) have also been reported . these patients are also known as agranulocytosis ( which is a severely lowered number of white blood cells ), haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown ) and febrile neutropenia ( an increase in the level of a type of whiteblood cells that help fight infection ). these patients have experienced the following reactions : very common side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . all the prolonged - release hard capsules should be used within 1 year of opening the aluminium wrapping . store in the original package in order to protect from light and moisture .
what tacforius contains - the active substance is tacrolimus ( as monohydrate ). - each capsule of tac forius 0 . 5 mg contains : - one vial of 5 mg , or - two vials of 10 mg : each vial contains , if not used , at least a third time ( at least one third ) after the first dose . - tacoimus 1 mg each capsule contains 1 mg ( approximately one third of the recommended dose ), if used as a single dose , it may contain , in some cases , up to a maximum of three doses . the other ingredients are : capsule content hypromellose 2910 ( ethylcellulose , lactose , magnesium stearate , water for injections ( see section 2 ). hard capsule shell tacfor
clopidogrel zentiva contains the active substance triazolam . it belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , a process that clumps together during blood clotting . by preventing this clumpeding the body ' s own platelet ( thrombocyte ) from forming ( forming in blood vessels ) with a weakened immune response , which in turn reduces its ability to obstruct the blood supply ; this process is known as thrombosis . octrosis is a condition that can occur in patients who have tried their hands on one side of their blood and who have a reduced ability to use clots (" thrombi ") and hardened blood vessels ( arteries ), which can lead to athero
you should not be given clopidogrel zentiva : if you are allergic ( hypersensitive ) to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if the medicine has been prescribed for you by your doctor , as you should be informed of any signs of severe liver disease . warnings and precautions if any of these apply to you , or the child you are caring for , please tell your doctor before you are given octocog alfalfide . your doctor may need to change your dose or stop your treatment temporarily or permanently . you should tell your dentist that you are bleeding , including those described below . for the sake of clarity and appropriate measures , you should
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food and drink , and at the same time each day . in case of severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg . your doctor will prescribe you the 300 mg tablet . you should take 4 tablets of 75 mg once at the start of treatment . then , you should continue with the 75 mg / m2 of body surface area ( i . e . up to 75 days ) until your next scheduled dose . contact your doctor , pharmacist or your nearest hospital emergency
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and the whites of the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters ofthe skin . this may be the signs of an allergic reaction . the signs may include reddening , unusually intense pain when applying clopidogrel zentiva to your eyes , lips , tongue or throat , as well as nausea and vomiting 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 8 ). do not freeze . clopidogrel zentiva can be stored in aluminium blisters for a single period of up to 30 days at room temperature ( not above 30 ). if you cannot keep the blister tightly closed in order to protect it from light , you should return it to the refrigerator and use it within this period or it should be disposed of as advised by your pharmacist . for reconstituted and diluted solutions , see ' handling instructions ' at the end of this leaflet . when storing in the original blister , keep away from direct heat and direct light ( for example direct sunlight or direct sunlight ). it is strongly recommended that you dispose of this medicine in all aluminium
what clopidogrel zentiva contains - the active substance in this medicine is called cbs . - each tablet contains 75 mg / 0 . 5 milligram ( 8 . 6 milliliter ) of clopdogrell ( as hydrogen sulphate ). ( see section 2 under ' cd ' and ' do not use ').  the other ingredients are :  tablet core : lactose ' or ' colloidal '; mannitol ( e421 )  hydrogenated castor oil  microcrystalline cellulose ; macrogol 6000  low - substituted hydroxypropylcellulose ,  pregelatinised starch ( derived from maize starch );  skimmed milk sugar ;  hyprome
yttriga is a radioactive medicine that does not contain radioactivity . it is used in combination with another medicine that is used to deliver tiny radiation doses . your doctor will decide on the dose you receive . the treatment will be supervised by a doctor who is experienced in the use of this type of radiolabelled medicinal product .
do not use yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you are pregnant or think you may be pregnant . you are breast - feeding . your doctor may decide that you should not use the active substance at the same time , if at any time during your pregnancy , or if it is the same as for any other medicinal product . radiopharmaceuticals are the responsibility of the user and would not normally be disposed of via wastewater or household waste . the following information is intended for the specialist only for the storage of radioactive material . for radioactive medicinal products , see ' handling instructions ' at the end of this leaflet . children and adolescents do not give this medicine
your doctor will determine the appropriateness of the treatment . method of administration yttriga should only be used under the supervision of a physician experienced in radiolabelling of medicinal products . the doctor will decide on the most appropriate dosage for you . use in children and adolescents there is no experience with the use of this product in children . specific diseases should be considered when deciding on the appropriate dosage . if you are given more than the recommended dose , you should contact your doctor immediately . in case of overdose , your doctor may decide that appropriate treatment is appropriate .
like all medicines , yttriga can cause side effects , although not everybody gets them . if any of the side effects get serious , or if you notice any side effects not listed in this leaflet , please tell your doctor or pharmacist . reporting of side effects you can help provide more information on the safety of this medicine .
yttriga will be stored under the responsibility of the specialist in appropriate premises . storage of radioactive substances will be in accordance with national regulations . the following information is intended for the specialist only : keep this medicine out of the sight and reach of children . do not use after the expiry date which is stated on the label and carton after exp . store in the original package . any unused product or waste material should be thrown away correctly .
what yttriga contains - the active substance is chloride . 1 ml sterile solution for injection contains 1 mg of hydrochloric acid . the other ingredient is water for injections ( see section 3 under ' sodium content ' for further information on the contents of this leaflet ). - has a v - shaped bottom and a colourless type i glass vial . - each vial contains 10ml of solution , which is supplied in a flat bottom sealed with a silicon stopper and an aluminium seal .
ciambra is a medicine used in the treatment of cancer . it is used in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , in adults , adolescents and children who have not received prior chemotherapy , to be treated in this capacity . in this situation , it may be prescribed to you by your doctor as the initial treatment for patients with advanced stage of lung cancer whose disease has responded to treatment or it remains largely unchanged after other initial chemotherapy has been used .
do not use ciambra : - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before receiving and while receiving breast - feeding . your doctor may decide that you should discontinue breast and feeding after your first dose , and will monitor you during treatment . you should also receive a vaccine against yellow fever ( see section 4 ). if any of these apply to you , tell your doctor as you may not be able to receive the correct dose . do not have a chance of having problems with your kidneys . before each infusion you will have your blood checked by your doctor to check that you have sufficient kidney and liver function and to make sure you have enough blood cells , before and after each dose is given . if
the dose of ciambra is 500 mg for every square metre of your body ' s surface area . this dose is calculated from your height and weight . your doctor will use this body surface area to work out the right dose for you . the dose may be adjusted , or treatment may be delayed depending on your blood cell counts and on your general condition . a hospital pharmacist , nurse or doctor will have mixed the citambra powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution for injection before it is given to you ( see section 2 ). you will only be given one infusion of the medicine into one of your veins ( intravenous use ). the infusion will last approximately 10 minutes . you may also be given another medicine called cisplatin the doctor or hospital pharmacist will work out your dose you need based on your height  and weight
like all medicines , this medicine can cause side effects , although not everybody gets them . you must contact your doctor immediately if you notice any of the following : 52 fever or infection ( common ): at a temperature of 38oc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . tell your doctor as soon as possible if : you get chest pain ( uncommon ) or a fast heart rate you get pain , redness , swelling or sores in your mouth not known ( frequency cannot be estimated from the available data ). allergic reaction : signs may include skin rash ( commonly known as burning or prickling sensation ) and fever . these can be signs of skin reactions . they can be severe or life - 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . this medicine does not require any special storage conditions . the infusion solution of pemetrexed may be stored for up to 24 hours at 2 - 8 , at a concentration not above 15 or 25 . from a microbiological point of view , the reconstituted solution should be used immediately after reconstitution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours between 2 and 8 and 15 , unless dilution has taken place in controlled and validated aseptic conditions , and must not be disposed of . any unused solution must be discarded .
what ciambra contains - the active substance is pemetrexed . - one vial / 100 ml solution for injection or infusion : each vial contains 100 milligrams ( millilitres ) delamanid sodium hemipentahydrate , - two vials / 500 milliliters ( 0 . 5 mg / 50ml ), and two ampoules / 5ml ( 2 - 8 ). - after reconstitution , one ampoule of the solution contains 25 mg ( 8 gbq ) per millimetrex dl . further dilution by a healthcare provider is required prior to administration . the other ingredients are mannitol ( e421 ), hydrochloric acid ( for ph adjustment ) and sodium hydroxide
immunogam belongs to a group of medicines known as immunoglobulins ( antibodies ) that are used to prevent certain infections from coming back in your blood . immunogam can help to increase levels of human hepatitis b immunisation . it can also be given to individuals who have been previously treated for the following diseases : igg - 1 , ig - 2 , and immunoglobuin g ( img ) in the blood or blood plasma of screened individuals . how immunogam works immunogam reduces the amount of virus in your body and makes it less likely that you will be given immunogam in a short time . this is because immunogam has been shown to reduce the risk of being able to infect other people . if you are not sure about this , talk to your doctor , pharmacist or nurse . the use of immunogam is
you must not be given immunogam : - if you have ever had an allergic reaction to human immunoglobulins or other blood products , or to any of the other ingredients of immunogam ( listed in section 6 ). you have an iga deficiency . warnings and precautions talk to your doctor , pharmacist or nurse before receiving immunogam and during treatment , if : you have been told by your doctor that you have a possible allergy to iga containing products . children and adolescents ( below 18 years of age ) who have been treated with immunogam before , they could have adverse reactions such as chills , headache , fever , vomiting , allergic reactions including nausea and arthralgia . you have joint pain , low blood pressure , and moderate low back pain . your doctor will make sure you have antibodies against hepatitis b immuno
immunogam is intended for vaccination against hepatitis b virus only . as the first vaccine dose will be administered by a qualified healthcare professional , experienced in the use of humans ' s immune system , it is important to follow the instructions from the doctor or nurse that are given to you by your doctor , pharmacist or nurse . the recommended dose is one dose ( 0 . 5 ml ), preferably in the morning , at about the same time each day . if necessary , your doctor may prescribe a higher or lower dose , depending on the dose prescribed for you . dose adjustment after administration prevention and control of the following doses in adults , adolescents and children ( 6 years of age and above ) will be prescribed a dose ( 500 mg ) to be administered every 24 - 72 hours . in adult patients , the dose may be increased to 500 mg every 2
like all medicines , immunogam can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common : affects 1 to 10 users in 100 % uncommon : effect 1 to10 users in 1 , 000 not known : frequency cannot be estimated from the available data very common undesirable effects observed during clinical trials with immunogam , particularly in regard to the muscle activity reported . very commonly reported reactions were nausea , fatigue , induration , swelling and bruising more easily than in normal clinical trials . if you get any of these effects or if they occur , stop taking immunogam and talk to your doctor immediately . children and adolescents the following undesirable effects have been reported in clinical trials where immunogam has been injected into the muscle . uncommonly reported reactions have been observed
keep immunogam out of the sight and reach of children . do not use immunogam after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . from a microbiological point of view , immunogam should not be used if the solution is cloudy or contains flakes or deposits . if you have any further questions on the use of immunogam , ask your pharmacist or nurse . these measures will help to protect the environment .
what immunogam contains - the active substance is human hepatitis b immunoglobulin . immunogam 1 mg / ml solution for injection in a vial is a colourless to pale yellow liquid . each vial contains 1 mg immunogam .
remicade contains the active substance infliximab , which is a monoclonal antibody a type of protein that recognises and attaches to a specific target in the body called tnf ( tumour necrosis factor ) alpha . rericade is one of a family of medicines known as ' nf blockers '. it is used to treat the following inflammatory diseases in adults : rheumatoid arthritis psoriatic arthritis ankylosing spondylitis ( bechterew - s disease ) and in children and adolescents opportunistic use in adults and children , adolescents and children aged 6 years and older who are at high risk of developing crohn 's disease or ulcerative colitis in both of these diseases . by attaching to the target protein , 
you must not be given remicade : - if you are allergic to infliximab or any of the other ingredients in this medicine ( listed in section 6 ). if your doctor thinks you may be allergic ( hypersensitive ) to proteins like soya , or to proteins that come from mice . warnings and precautions tuberculosis ( tb ) or another serious infection such as pneumonia or sepsis have heart failure . if any of these apply to you or your child , tell your doctor before you are given , if they are not sure . your doctor may want to monitor you more closely . talk to your doctor , pharmacist or nurse before your next dose if : you are breast - feeding . you are unsure about the benefits and risks of breast enlargement . there is no experience with the use of 
rheumatoid arthritis the usual dose is 3 milligrams for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), p soriasis , ulcerative colitis and crohn 's disease the normal dose is 5 milliliters for each kg , and body weight is calculated from the available data . how remicade is given the doctor or nurse will prepare the medicine for infusion . the medicine will be given as an infusion ( drip ) ( over 2 hours ) into one of your veins , usually in your arm . after the third treatment , your doctor may decide to give you a lower dose . you will be monitored while you are given rericade . it is not known how well it works in each
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however some patients may experience serious side effects and may require treatment . side effects may also occur after your treatment with remicade has stopped . tell your doctor straight away if you notice any of the following : signs of an allergic reaction such as swelling of your face , lips , mouth or throat which may cause difficulty in swallowing or breathing , skin rash ( hives ), swelling of the hands , feet or ankles . many of these reactions may be serious or life - threatening . you should seek immediate medical advice from your doctor , pharmacist or nurse if any of these occur . the doctor may decide to keep you under closer observation or change the dose or stop the administration . for more information , see section 2 " allergic side effects ". children
remicade will be stored by the health professionals at the hospital or clinic . the storage details should you need them are as follows : keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the original carton in order to protect from light . from a microbiological point of view , the product should be used immediately after infusion . however , if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 3 hours at 2 8 for up to 28 days and an additional 24 hours at 25 after removal from the refrigerator . if you have any further questions on the use of this medicine , ask your doctor or
what remicade contains - the active substance is infliximab . each single - use vial contains either : - one vial containing 100 mg ( 100 mg at refrigerated temperature ) or - two vials containing 10 mg ( 200 mg at frost ). - other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate ( mppm ) and dibasic salt ( e331 ). what retinade looks like and contents of the pack rericade is supplied as a glass vial with a powder for concentrate for solution for infusion . the powder is white to off - white and the solvent is a clear colourless liquid supplied in a pack of 1 , 2 , 3 , 4 , or 5 ml . not all pack sizes
rasagiline mylan is used to treat parkinson ' s disease in adults , adolescents and children . it can be used together with or without levodopa ( another medicine that is used in this disease ). it can also be used for other conditions in adults and children at the same time , for example if you are a child who is at high risk of experiencing parkinsons 's disease . if any of the above applies to your child , it is important that you discuss with your doctor whether or not you should continue to take it . when you are younger than one year of age , there is a loss of cells that produce dopamine in the brain which is important in helping the brain to play a key role in movement control . rasagide mylan has been shown to reduce the amount and timing of action that is needed for you , and to improve movement control
you must not be given rasagiline mylan : - if your doctor or pharmacist is unsure of the active substance , or of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions severe liver problems talk to your doctor before you are given any of the following medicines . rasagaline mylan belongs to a group of medicines called monoamine oxidase ( mao ) inhibitors ( e . g . for treatment of depression or parkinson ' s disease ). it is also used in combination with medicinal or natural products , such as tsh . please also read the " do not take " section of this leaflet . it is important that you tell your doctor if you are taking , have recently taken or might take any other medicines , including those obtained without a prescription . you should not be treated with rasag
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 tablet of 1 mg taken by mouth once daily . rasagiline mylan can be taken with or without food ; however , you should swallow the tablet whole with water and do not chew , crush or split the tablet before it is swallowed with some water or other non - alcoholic drink ( e . g . apple puree or grapefruit juice ). do not crush or chew the tablet until it is ready to take it , as it may have a detrimental effect on your condition . your doctor will tell you how long your treatment will last . do not change the dose yourself unless you have been instructed by your doctor , pharmacist , or nurse . you should take rasagile mylan every day until your doctor tells you otherwise 
like all medicines , this medicine can cause side effects , although not everybody gets them . some of these side effects may be similar to those seen with placebo . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common in children and adolescents ( 1 to 10 users in 100 ) uncommon in children  1 , 000 not known ( frequency cannot be estimated from the available data ) very common abnormal movements ( dyskinesia ) headache common abdominal pain fall allergy fever flu ( influenza ) general feeling of being unwell neck pain chest pain ( angina pectoris ) if you experience any of these , talk to your doctor or pharmacist as soon as possible . side effects that may occur with rasagiline mylan are listed below . they are usually mild to moderate and usually disappear after a few days or weeks . very
what rasagiline mylan contains - the active substance is rasagisline tartrate . - each tablet contains 1 mg rasageline . the other ingredients are microcrystalline cellulose , tartric acid ( e330 ), maize starch , pregelatinized maize meal starch ( maize ), talc , stearic acid , all in the tablet core and in the film - coating . see section 2 for important information about some of the ingredients in this medicine before you take it , and then take the rest of the day , at about the same time each day ; in addition , the tablet may be divided into equal doses : - tablets are 11 . 5 mg tablets ( 6 mm in diameter ), round , biconvex tablets , debossed with " 1 " on one side and plain on the other side 
do not use hulio if : you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). you have a severe infection including tuberculosis ( see " warnings and precautions "). it is important that you tell your doctor if you have symptoms of infections , e . g . fever , wounds , feeling tired , dental problems . you have moderate or severe heart failure . this is because it may be a serious heart condition that requires immediate medical attention . allergic reaction allergic reactions can be life - threatening . symptoms can include chest tightness , wheezing , dizziness and swelling or a rash . your doctor will advise you how to recognise and treat these reactions . infections can be serious and include an infection , including localised infection or 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . polyarticular juvenile idiopathic arthritis in adults , adolescents and children from 2 to 17 years old : use in children and adolescents from 10 to 30 kg : hulio 20 mg / kg body weight : 17 kg to be taken orally with or without food . if your child is older than 2 years old and weighs 30 kg or more , your doctor may prescribe a higher or lower dose . for enthesitis ( a type of arthritis ) in adults from 6 to 17 year of age : take the tablets daily as prescribed by your doctor . this will usually be given as early as possible and at least 15 minutes before or 30 minutes after taking the tablets . your doctor will prescribe the most appropriate dose based on your child ' 
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require urgent medical treatment . side effects may occur at least up to 4 months after the last hulio injection . seek medical attention urgently , if you notice any of the following signs of allergic reaction or heart failure : severe rash or hives swollen face , hands or feet trouble breathing or swallowing ; pale complexion ; dizziness ; persistent fever ; bruising or bleeding ; signs and symptoms of infection such as fever , feeling sick , diarrhoea , vomiting , stomach discomfort ; nausea and vomiting ; joint pain , back pain ; pain in joints or muscles ; muscle pain . uncommon : may affect up to 1 in 100 people
what hulio contains the active substance is adalimumab . the other ingredients are monosodium glutumate , sorbitol ( e420 ), methionine , polysorbate 80 , hydrochloric acid , and water for injections ( see ' important information about some of the ingredients in this medicine ' later in this section ). what helio 40 mg / ml solution for injection in vial is provided as a sterile solution . each vial contains 40 mg in 0 . 8ml of solution , which is colourless to slightly opalescent and is provided in a clear glass vial with a rubber stopper . hULio is available in packs containing 1 or 2 vials . pack sizes : 1 vial , 1 
yellox contains the active substance bromfenac . it belongs to a group of medicines called non - steroidal anti - inflammation drugs ( nsaids ), which help reduce inflammation . Yellox is used to reduce eye inflammation after cataract surgery in adults .
do not use yellox - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using yellowx if : you have asthma , skin allergy , or intense inflammation in your nose you are taking other nsaids . you should not be given this medicine : acetylsalicylic acid , ibuprofen , ketoprofened , diclofen you must not use this medicine together with topical steroids ( such as cortisone ) because it may increase the risk of unwanted side effects . this is because of the increased risk of bleeding problems in patients with haemophilia who have used in the past or have used other medicines that reduce bleeding time ( e . g . war
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one drop of yellox in your eye ( s ) once a day in the morning . your doctor will tell you how many drops to use . do not use more than 2 drops each day . you may need to use the drops again the next day , depending on the size of your cataract surgery . method of administration yellowx should only be used if your hands are sensitive to the effects of the eye drops . remove the bottle cap . hold the bottle , pointing down , between your thumb and fingers . tilt your head back . pull down your lower eyelid with a finger . keep the bottle tip close to the eye . if it is a long - lasting , colourless liquid , it should be used immediately 
what yellox contains - the active substance is bromfenac ( as sodium sesquihydrate ). each ml of solution contains 33 milligrams ( 0 . 25 millilitre ) of bromfedenac . the other ingredients are boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride ( e1510 ), tyloxapol , povidone ( k30 ), disodium edetate , and sodium hydroxide ( to adjust acidity levels ) in the blood . what Yellox looks like and contents of the pack the solution is a clear yellow liquid ( solution ) supplied in a pack of 5 glass vials with a screw cap . each pack contains one vial .
dzuveo contains the active substance sufentanil . it belongs to a group of strong painkillers ( opioids ) that are used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo if : you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). you have a serious lung or breathing problem . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . your doctor may need to adjust your dose . you are not sure if any condition affects your breathing ( e . g . asthma , wheezing , or shortness of breath ) after taking the medicine , your doctor will check your breathing at regular intervals , and may decide to stop treatment if necessary ( see also section 4 ); you have or have had a head injury or brain tumour affecting your heart and circulation , slow heart rate , irregular heartbeat , low blood volume or low blood pressure ; you have moderate to severe liver problems or severe kidney problems
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the single - dose administration device should only be used to administer this medicine . dzuveo must not be used in combination with strong painkillers such as sufentanil . how much to take the sublingual tablet should be swallowed whole with a drink of water . do not crush , dissolve or chew the tablet before swallowing . your doctor will tell you how many tablets to take , when to take them , and how often to use them . instructions for use the applicator provided in the package for use : - an adapter for application into the tongue . once the tablets dissolve under the tongue for a short period of time , you will feel pain relief when you swallow the tablet ( see figure 10 ). the maximum daily dose is 720 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need medical attention : - severe breathing problems with slow and shallow breathing ( see section 2 ). if any of these side effects occur , contact your doctor immediately . very common side effects ( may affect more than 1 in 10 people ): nausea ( feeling sick ), vomiting ( being sick ) and feeling hot ( seeing or sensing things that are not there ). common side effect ( may effect up to 1 in10 people ), inability or difficulty sleeping ( seeing flashes of light ). not known ( frequency cannot be estimated from the available data ). your doctor will tell you what you can take to prevent these effects . if they happen , they are usually mild and will usually disappear after a few weeks . nausea (
dzuveo will be stored by the health professionals at the hospital or clinic . keep this medicine out of the sight and reach of children . store in a refrigerator ( 2 - 8 ). do not use this medicine after the expiry date which is stated on the label and carton after exp . this medicine does not require any special temperature storage conditions . if you notice any visible sign of deterioration , please tell your pharmacist . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg of sufenil ( as citrate ).  the other ingredients are mannitol , dicalcium phosphate , hypromellose ( e464 ), croscarmellose sodium , indigo carmine [ e132 ], stearic acid , magnesium steerate . the tablets are round edges , marked with " 3 " on one side and " nvr " on the other side . pack sizes : one single - dose applicator ( labelled [ sublingual tablet ]. not all pack sizes may be available in your country . your doctor or pharmacist will provide you with instructions for use . this information is intended for healthcare professionals only . it is important that you also read the " do not use
erleada is a cancer medicine that contains the active substance apalutamide . it is used to treat adult men with prostate cancer that has come back or has spread to other parts of the body or cannot be removed by surgical treatments . this is for the treatment of sensitive prostate cancer in adult men who cannot be treated with conventional or surgical treatment that reduces testosterone ( also called castration - resistant prostate cancer ). erleda works by blocking the activity of androgens in the body , allowing the cancer to grow and divide . by blocking their action , apalutaMIDe stops prostate cancer cells from growing and growing .
do not take erleada if : you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). you are pregnant or think you may be pregnant ( see pregnancy and contraception section ). if you are breast - feeding . warnings and precautions talk to your doctor or pharmacist before taking this medicine . this medicine is not intended for the treatment of seizures . take special care with this medicine tell your doctor straight away if: you have ever taken any medicines to prevent blood clots ( e . g . warfarin or acenocoumarol ) you have or have ever had any heart or blood vessel conditions or heart rhythm problems ( arrhythmia ) or falls . your doctor may want to monitor you closely if any of these apply to you . children and adolescents do not give this medicine to children and
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is 240 mg twice a day for up to 60 days . your doctor will tell you how many tablets of erleada to take . this medicine is taken by mouth . swallow the tablets with a glass of water . do not crush , dissolve or chew the tablets . if necessary , your doctor may tell you to take more tablets than needed . you can take the tablets either alone or in combination with other medicines , or with food to lower your chance of getting the desired effect . try to take it at the same time each day . it does not matter whether you take it with or without food . always take the tablet with food , preferably one hour before or one hour after a meal . take your tablet at least half a
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and tell your doctor straight away if you develop any of the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk , with central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may also be preceded by fever and flu- like symptoms ( toxic epidermal necrolysis ). serious side effects possible side effects may be a sign of fit , seizure or fits ( uncommon : may affect up to 1 in 100 people ). if these side effects become severe , you should contact your doctor immediately . fits ( convulsions ) may occur at any time during treatment with er
what erleada contains the active substance in each film - coated tablet is 60 mg of apalutamide . the other ingredients are : tablet core : colloidal anhydrous silica , croscarmellose sodium ( e468 ), hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose , and silicified microscopic cellulose in the core of the tablet . film coating : iron oxide black , iron oxide yellow , macrogol ( 6000 ), polyvinyl alcohol ( pvt ) talc, and titanium dioxide , all in the tablet coating is engraved with ' e171 ' on one side and plain on the other side , with the number " 60 " on the score line on the tablet and on the blister on the opposite side . what 
this medicine is a radiopharmaceutical product for diagnostic use only . axumin contains the active ingredient fluciclovine . it is used to carry out a type of scan ( called a pet scan ) in adults who have not previously responded to treatment for prostate cancer . other tests may also show that the presence of prostate specific antigen ( psa ) has been detected in patients who have had an initial diagnosis of the cancer before , and during an additional dose , the doctor may decide to perform an additional scan if the cancer has spread to other parts of the body . your doctor will discuss the results of the test with you and tell you if you need to have the scan . you should not have an appointment with the nuclear medicine doctor who supervises this procedure , as the use of this product will be in accordance with national regulations on radioactivity .
do not use axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . your doctor may decide to give you a lower dose . talk to a doctor if this applies to you . children and adolescents do not give this medicine to children under the age of 18 years . this is because it is not recommended for use in children or adolescents under 18 years of age , because it has not been studied in this age group . other medicines or other medicines are not known to affect the interpretation of the images . pregnancy and breast - feeding there is no information on the use of machines in pregnant women . however , it is possible that a small number of people who are pregnant or breastfeeding could be more likely to get pregnant .
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only ever be used in specially controlled areas . this medicine will only be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . dose the nuclear medicine doctor supervising the procedure will decide on the quantity of megabecquerel to give to you . the quantity to give you depends on your age , weight , size and location of the product to be administered . use in children and adolescents the doctor will calculate the appropriate dose for your child based on the child ' s body surface area ( mbq ) you will be given and will tell you how often you will have the injection . administration in children the surgeon will arrange for the procedure .
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies and post - marketing experience , side effects were uncommon ( may affect up to 1 in 100 people ) with exposure to the medicine . the following side effects have been reported in patients treated with axumin : very common : may affect more than 1 in 10 people pain , rash , altered taste in the mouth , and altered sense of smell . this radiopharmaceutical will deliver low amounts of ionising radiation associated with the least risk of cancer and hereditary abnormalities . reporting of side effects 9 . 5 people : if you get any side effects talk to your nuclear medicine doctor . these are listed under " rare " and " not known ". you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : axumin will be stored in the healthcare facility where it is used .
what axumin contains - the active substance is fluciclovine . each milliliter contains 16000 international units ( iu ) ( corresponding to 1600 micrograms ). - each ml of solution contains 1600 milligrams ( 0 . 5 millilitres ) if you are not able to swallow the tablets whole , you can crush and mix them with water for example , water for injections , or grapefruit juice ( see section 2 under ' sodium content '). the other ingredients are : sodium citrate , concentrated hydrochloric acid , and sodium hydroxide ( see end of section 2 for further information on the contents of the pack ). the tablets are white to off - white , oblong - shaped with " gsi " on one side and " nvr " on the other
the active substance of azopt is brinzolamide , which belongs to a group of medicines called carbonic anhydrase inhibitors . they work by reducing pressure within the eye . their effect is to improve the function of the eye and to reduce their wear and tear . the active ingredient in the medicine works by lowering the amount of water in the e . g . water , in the urine and in the sweat glands of people with high pressure in the eye which can lead to an illness called glaucoma . when this happens , the pressure inside the eye builds up and can damage your sight .
do not take azopt if you have severe kidney problems . you are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). you may also be allergic to medicines called sulphonamides ( also known as medicines used to treat diabetes , infections or diuretics ( water tablets ). warnings and precautions talk to your doctor or pharmacist before taking the medicine if : you have the same allergy or you have too much acidity in your blood ( hyperchloraemic acidosis ). if any of these apply to you , tell your doctor before you take the medicine as you may need to be monitored more carefully while you are taking it . kidney or liver problems you may be at risk of dry eyes ( cornea problems ) when taking other sulphphonamide medicines to treat glaucoma . your doctor may want to monitor you more closely
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . azopt should only be used in the eyes . use in adults the recommended dose is 1 drop in the affected eye or eyes once a day at the same time each day . do not use more than your doctor tells you to use . you should rinse your eyes with water after each use , even if there is no medicine left in the bottle . how much to use adults , adolescents and children ( aged 1 year and above ) and adolescents ( aged 2 to 3 years ) before you start using the Azopt bottle , see instructions at the end of this leaflet for more information . wash your hands . twist off the cap on the bottle to release it . pull the cap off and snap collar off the bottle and pull it back . hold the bottle
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision , eye irritation and eye pain . eye discharge . itchy eye , dry eye and abnormal eye sensation . redness of the eye some patients have experienced these side effects before . bad taste was also reported . uncommon side effects are thought to be related to the occurrence of these effects in patients less than 1 in 100 people ). not known ( frequency cannot be estimated from the available data ). eye effects that have been observed during clinical trials are : eye pain and eye irritation . if any of the side effects gets serious , or if you notice any side effects not listed in this leaflet , please tell your doctor or pharmacist .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle label and the carton after exp . this medicine does not require any special temperature storage conditions . azopt is for single use only . after opening a pack containing a single bottle , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what azopt contains - the active substance is brinzolamide . each ml of solution contains 10 milligrams of brinzolam .  the other ingredients are benzalkonium chloride , carbomer 974p , edetate disodium ( see end of section 2 ), mannitol ( e421 ), purified water , sodium chloride and tyloxapol . hydrochloric acid and sodium hydroxide are added to keep acidity levels ( ph levels ) normal and keep the tablets at a normal level . keep the tablet container tightly closed in order to protect from moisture and keep it at room temperature ( 20 - 30 ) for as long as the user is satisfied with the result of the treatment , the product is a liquid ( a suspension ) that comes in a 5 m
the active substance in forxiga is dapagliflozin . this belongs to a group of medicines called " oral anti - diabetics ". it is taken by mouth to treat diabetes . it works by lowering the amount of sugar ( glucose ) in your blood . in adults ( 18 years of age and older ), it can be used : on its own if you have diabetes called " type 1 diabetes ", which occurs when your body is not able to use any insulin it produces . your doctor will tell you exactly how many tablets you need to take , when to take them . there are different types of diabetes in which overweight people ( obese people ) and type 2 diabetes where the body does not make enough insulin , and the insulin that your body produces does not work as well as it should . the insulin you make can also be a target for diabetes by monitoring the level of sugar in
do not take forxiga : - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before and during treatment . feeling sick or being sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , especially if it has a fruity or metallic taste in your mouth or a different odour to your urine , sweat , rapid weight loss . if any of these symptoms occur , contact your doctor immediately . these may be a sign of " diabetic ketoacidosis " a rare but serious , sometimes life threatening problem you can get with diabetes because of increased levels of " ketone bodies " in your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . for type 2 diabetes the usual dose is 10 mg once a day . your doctor may prescribe you a lower dose ( 5 mg ) if your liver problem is not well controlled . how much to take the recommended dose of forxiga for type 1 diabetes is 5 mg twice daily . taking this medicine swallow the tablet whole with a glass of water . you can take the tablet with or without food . it is best to take your tablet at the same time each day , but your doctor will tell you exactly how many tablets you need to take . the amount of sugar in your blood will be checked at regular intervals . to help control your blood sugar , you will need to follow a diet and exercise program recommended by your doctor . show the doctor your pack of tablets . if
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are angioedema ( very rare : may affect up to 1 in 10 , 000 people ): these can be severe and can be life - threatening if not treated early . signs of angiodema include swelling of the face , tongue or throat , difficulties swallowing , hives and breathing problems . they can also be caused by diabetic ketoacidosis ( see also section 2 ). these can occur in patients with type 1 diabetes ( rare ) or in patients 10 years of age and older . in type 2 diabetes , cases have been reported , but may rarely be fatal , sometimes leading to an increased risk of becoming fatal . there have been rare reports of " ketone bodies " in your urine . these may be signs of diabetic
what forxiga contains - the active substance is dapagliflozin . - each , individually packaged , film - coated tablet ( tablet ) contains : one tablet containing a total of 5 mg / 0 . 7 ml of solution for injection , corresponding to 5 mg diasalicylic acid . the other ingredients are : tablet core : microcrystalline cellulose ( e460 ( i )), lactose ( see section 2 under ' for more information on the contents of the tablet '), crospovidone ( type a ), silicon dioxide , magnesium stearate in the tablet coating : polyvinyl alcohol ( partially hydrolysed ), titanium dioxide [ e171 ], macrogol 3350 and talc in the printing ink : shellac , yellow iron oxide (
mepact contains the active substance mifamurtide that can kill certain bacteria that are part of the immune system ( the body ' s natural defences ). it can be used to treat adults with osteosarcoma ( bone cancer ) that has spread to other parts of the world between 2 and 30 years after they have had surgery to remove the tumour . it can also be used in combination with chemotherapy to kill cancer cells and prevent cancer from coming back .
do not use mepact if : you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). you are taking medicines containing ciclosporin and other calcineurin inhibitors ( nsaids ) if you have or have had problems with your heart or blood vessels such as blood clottes ( thrombosis ) or bleeding ( haemorrhage ) because of inflammation of the veins ( vasculitis ) warnings and precautions talk to your doctor or pharmacist before using Mepact and during treatment . you may experience long - lasting or worsening symptoms after discontinuation of mypact treatment in some patients with asthma or other breathing disorders . if your asthma is not well controlled by inflammatory or autoimmune disease , you may be given corticosteroids or other medicines that
treatment mepact will be started by a doctor who is experienced in the use of this medicine . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one vial ( 2 mg mifamurtide ) once a day , for at least 12 to 24 hours . your doctor will tell you the dose you need to take . do not change your dose unless your chemotherapy schedule has been adjusted by your doctor . if your chemotherapy is going to be postponed for more than 36 weeks , your doctor may decide to continue to monitor you and decide how to treat youpact to avoid an interruption in the manufacturing process . once the freeze - dried powder is mixed with a liquid suspension before it is given to you , the filter will be opened and a new one will be added . mepac
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue have been reported very commonly in patients receiving mypact ( transient ) in combination with paracetamol . they usually develop in the first few days of treatment and can be severe . if you experience fever during or after your first dose , tell your doctor as soon as possible . your doctor may decide to reduce your dose . stomach problems ( such as nausea , vomiting , or loss of appetite due to chemotherapy ) contact your doctor immediately . continuing fever and chills have also been reported in patients treated for 8 months after they have been treated . warnings and precautions talk to your doctor , pharmacist or nurse straight away . you may be at increased risk of getting an infection such as rash or any problems breathing or wheezing . these may be signs of a
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in outer carton in order to protect from light . from a microbiological point of view , reconstituted suspension should be used immediately after reconstitution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 9 hours at 2 - 8 ( but not above 25 ). if refrigerated for use within 6 hours , this medicine should not be used if there is visible signs of deterioration .
what mepact contains - the active substance is mifamurtide . each ml of concentrate contains 4 million international units ( iu ) ( 6 , 000 international units ). - after reconstitution with suspension , each millilitre of suspension contains 0 . 08 milligrams ( g ) of mfamurdide as a single - use syringe . the other ingredients are : 1 - palmitoyl - 2 - dioleoyn - sn- glycero - 3- phosphocholine ( 1 , 2 , 4 , 5 , 8 , 9 , 12 , 13 , 14 , 20 , 30 , 40 , 60 , 84 , 90 and 98 , see section 2 " mepac
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . it is used to treat redness in the face caused by rosacea ( which causes redness of the face ). it is also used in adults to reduce the amount of redness at the start of treatment , in adults , and in children and adolescents ( 6 months to 17 years of age ) who have either : - a condition that causes high levels of blood flow in the facial skin as well as enlargement ( dilation ) of the small blood vessels of the skin . Mirvaso acts by reducing the number of blood vessels that are blocked by the excess blood flow , resulting in redness .
do not take mirvaso : - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 , end of section 2 , possible side effects ). the medicine must not be injected under the skin . warnings and precautions certain medicines used to treat depression or parkinson ' s disease such as monoamine oxidase ( mao ) inhibitors ( e . g . selegiline , moclobemide ), tricyclic antidepressants ( imipramine ), tetracyclic antagonistidepressants such as maprotiline ( mianserin ) or mirtazapin . please also read the package leaflet for these medicines . do not give this medicine to children under the age of 18 years because they have not been studied in this age group . other medicines and
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use mirvaso is usually given by injection under the skin or on the face . your doctor will tell you how many pea sized amounts of this medicine to use . do not use on other parts of your body , or on other body surfaces , such as your eyes , mouth , nose or vagina . if your doctor tells you to : - wash your face with mild soap and water - rinse the area you are using for the treatment with a small amount of gel ( a peach - sized amount ) once a day , preferably in the morning and evening . depending on your symptoms , your doctor may tell you to increase the dose or stop the treatment . it may also be used up to a maximum daily dose of
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects are : severe skin irritation or inflammation , skin rash ( which may cause skin pain or discomfort ), dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects include : worsening of rosacea . the treatment should be stopped immediately and symptoms should be seen immediately . see section 2 " warnings and precautions ". contact allergy / allergic reaction including rash , rare angioedema ( a serious allergic reaction which may be life - threatening ). if you get any of these effects or if they occur , stop the treatment immediately and contact your doctor . allergic reaction with rash is very common in patients treated with mirvaso . it is not known how often these reactions occur . skin
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the tube and pump after exp . store in the original package in order to protect from light and moisture . this medicine does not require any special temperature storage conditions . once opened , mirvaso should be used immediately .
what mirvaso contains - the active substance is brimonidine . each gram of gel contains 3 . 3 mg of brimoniidine , followed by 5 mg / 0 . 5 ml sulphonyl alcohol , - methylparahydroxybenzoate ( as phenoxyethanol ), glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water ( see end of section 2 for further information ). each millilitre contains 2 milligrams ( mg ) for each kilogram ( kg ) of gel . the other ingredients are : - acrylic , opaque gel , supplied in 2 , 10 or 30 grams of gel in airless pump system . not all pack sizes may be marketed .
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that recognises and attaches to a specific target in the immune system , the body ' s natural defences ). it is used to help fight infection and cancer in adults , adolescents and children of all ages who are able to carry out certain activities in their body , such as blocking a protein called human vascular endothelial growth factor ( vegf ), which is found on the lining of blood vessels and lymph vessels , helping them to grow and provide the body with nutrients and oxygen . by attaching to the VEgf protein , tumour growth is prevented by blocking their growth , allowing the blood vessels to supply the nutritional and oxygen to be delivered to the tumour . this medicine is used as a medicine to
you must not be given this medicine - if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor thinks you may be allergic or hypersensitive to chinese hamster ovary ( cho ) cell products or to other recombinant human or humanised mvasi . if this applies to you , tell your doctor . warnings and precautions talk to your doctor or nurse before you are given the medicine if : you are pregnant or breast - feeding . you are a woman who is able to become pregnant because of the lack of data in your blood . your doctor may want to monitor you more closely while you are being treated with the medicine and may decide to change your dose , if necessary . do not use mvai if any
dose and frequency of administration the dose of mvasi you receive is based on your body weight and the kind of cancer to be treated . the recommended dose is 5 mg , 7 . 5 mg, 10 mg or 15 mg / kg body weight given once every week . your doctor will work out the right dose for you . do not change the dose yourself unless you are specifically told to do so by your doctor . use in children and adolescents do not give this medicine after the expiry date which is stated on the carton and the vial after ' exp '. if you are being treated for cancer , the dose may be changed every 2 or 3 weeks . for instance , your doctor may decide to give infusions once a week , depending on how you respond to treatment . you should continue to receive this medicine until you have stopped your tumour growing . how and when to prepare and administer 
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . the side effects listed below were seen when mvasi was given together with chemotherapy . you should be aware of the possibility of experiencing these side effects whilst being treated with mvai . allergic reactions - in rare cases you may experience an allergic reaction . these may include difficulty in breathing , chest pain , redness or flushing of the skin or a rash . chills or shivering , feeling sick ( nausea ) or being sick ( vomiting ). if any of the above occur , tell your doctor or nurse straight away . other side effects include severe side effects that may be serious , include : very common ( may affect more
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton . store in a refrigerator ( 2 8 ). do not freeze . keep vial in the outer carton in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user . however , the chemical and physical stability of mvasi has been demonstrated for up to 24 hours at 2 to 8 , protected from light prior to infusion . when diluted , a sterile environment is the preferred storage conditions are the product , which is stable for a maximum of 35 hours when stored at 2 , 8 or 48 hours at room temperature ( below 30 ). if you notice any particulate matter
what mvasi contains - the active substance is bevacizumab . each ml of concentrate contains 25 mg ( 8 . 4 mg ) or 16 . 5 mg ( 6 . 6 mg ). - each 4ml vial contains 100 mg ( 9 . 8 mg ), corresponding to 16 % of the recommended dose for adults . this is equivalent to a 400 mg dose for patients who weigh at least 40 kg . the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 ( e433 ) and water for injections ( see end of section 2 for further information on some of the ingredients in this pack ) the concentrate for solution for infusion is a clear to slightly opalescent , colourless to slightly yellow liquid in a glass vial with a rubber stopper containing 100 mg bevac
tecartus is a type of medicine known as a gene therapy medicine . it is used to treat mantle cell lymphoma that has come back or has not responded to other medicines . if you have relapsed or are now at an advanced stage of life , your own white blood cells ( called autologous anti - cd19 - transduced ccd3 + cells ), you may be at risk of losing your own immune system ( the body ' s natural defences ). it can affect the number of b - lymphocytes in your body , resulting in a reversible , potentially life - long , effect on these cells . this results in an uncontrolled way in which cells ( lymph tissue , bone marrow and blood ) become active again , leading to a decrease in the number and quality of
do not use tecartus - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor , pharmacist or nurse before using the medicine if : - you have a reduced number of white blood cells in your blood ( lymphodepleting chemotherapy ) ( see section 3 for more information ). your doctor will keep you informed of this . - the medicine is made specially for you by a biotechnology process called autologous use . tests and checks will be carried out before and after use to count the number of your lungs , heart , kidney and blood pressure . your doctor may also check for signs of infection and inflammation of your cancer ( graft - against - host disease ). after a transplant of your body
tecartus will be given to you by a doctor or nurse who is experienced in the use of your own white blood cells . they will take some of your cells from your own blood and will donate them to you through a catheter placed in your vein ( a procedure call leukapheresis ). if you do not have enough of your red blood cells in your blood , your blood will be infused into your vein , over a period of 3 to 6 hours . if this is the case you will have less than 1 hour to make up for a missed dose . your doctor will tell you how long you will need to be treated . medicines that you may be given during Tecartus treatment , such as lymphodepleting chemotherapy , will be collected from you in a hospital or clinic . this will take about 30 to 60 minutes . you may also be given other medicines
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if your side effects get worse or if you notice any of the following serious side effects you may need urgent medical attention . the following side effects have been reported during the tecartus infusion : very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure , symptoms such as dizziness or lightheadedness , fluid in the lungs . all symptoms may be due to a condition called cytokine release syndrome . loss of consciousness , decreased level of consciousness and confusion , memory loss , difficulty in thinking , feeling or being aware of one or more of these effects . if any of these side effects causes you problems , you should contact a doctor or the nearest hospital straight away . other side effects may include :
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and infusion bag . store in a refrigerator ( 2 8 ). do not freeze . liquid nitrogen should be used within 150 minutes after dilution . this medicine contains genetically modified human blood cells . any unused medicine or human - derived material should be disposed of in accordance with local requirements 36
what tecartus contains - the active substance is autologous anti - cd19 - transduced incd3 + cells . each patient - specific single infusion bag contains a dispersion of anti  - cad19 car t cells in approximately 68 ml of solution ( corresponding to 2 x 106 anti ).  the other ingredients are : sodium chloride , human albumin ( see section 2 ) and water for injections ( see end of section 2 for further information about some of the ingredients in this medicine ). what Tecartus looks like and contents of the pack this medicine is a clear to slightly opalescent , colourless to yellow solution for infusion , supplied in a hospital or clinic . it is supplied in an infusion bags packed in an aluminium cassette . the hospital staff have placed a single
januvia contains the active substance sitagliptin which is a member of a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase -4 inhibitors ) that lowers blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your type2 diabetes . you should continue to follow your food and exercise plan while taking this medicine . it is used in combination with certain other medicines ( insulin , metformin , sulphonylureas , or glitazones ), to lower blood sugar and lower the level of sugar in your blood when you are still taking it in addition to diet and
do not take januvia - if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before and during treatment if : - you have inflammation of the pancreas , which can lead to pancreaticitis . if this applies to you , tell your doctor and take the tablets with you ( see section 4 ). - there may be blistering of the skin . this may be a sign of a condition called bullous pemphigoid . your doctor may want to monitor you more closely . take special care with the tablets if any of these apply to you ( or you are not sure ), ask your doctor or pharmacist for advice . before you take your tablets , make sure that you have a disease of the
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 100 mg film - coated tablet 63 once a day by mouth . patients with kidney problems your doctor may prescribe lower doses ( such as 25 mg or 50 mg ). your doctor will tell you the dose to take . taking this medicine with food and drink this medicine can be taken with certain other medicines that lower blood sugar . diet and exercise can help your body use its blood sugar better . it is important to stay on the diet and activity of your food and exercise recommended by your doctor while taking januvia . you should keep following the recommendations of your doctor , pharmacist or nurse so that you are able to take the medicine at the right times of day , unless your doctor tells you to stop taking it . if your doctor prescribes this medicine for you
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact your doctor immediately if you notice any of the following serious side effects you may need medical attention : severe and persistent pain in the abdomen ( stomach area ) which might reach through to your back with or without nausea and vomiting , as these could be signs of an inflamed pancreas ( pancreatictitis ). a serious allergic reaction ( frequency not known , cannot be estimated from the available data ): rash , hives , blisters on the skin / peeling skin , swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or swallowing . if any of these side effects causes you problems , you should stop taking this medicine and contact a doctor or the nearest hospital straight away . other side
what januvia contains - the active substance is sitagliptin which is present in each film - coated tablet ( tablet ) in a vial . - each millilitre ( 0 . 25 ml ) of tablet contains sitaglitin phosphate monohydrate , equivalent to 25 milligrams / milliliters . the other ingredients are : - tablet core : microcrystalline cellulose ( e460 ), calcium hydrogen phosphat e553b , croscarmellose sodium , magnesium stearate and sodium stearyl fumarate ( see end of section 2 ). the tablet film coating contains : poly ( vinyl alcohol ), macrogol 3350, talc , titanium dioxide , red iron oxide , and yellow iron oxide ( indigo carmine iron oxide [ e132 ]).
xultophy contains the active substance insulin degludec . it is used to lower blood glucose in adults with type 2 diabetes mellitus . diabetes is a type of diabetes that occurs when your body does not make enough insulin to control the level of blood sugar . in this case , your body will make a higher amount of insulin when the insulin is not working as well as it should . your doctor will tell you what to do . for example , if you are on a long - acting basal insulin , which helps lower your blood sugar levels . you may also be given liraglutide ( also known as glp - 1 ) to help you stay on the diet and exercise plan while you are taking it . when to take it with food , it is important that you take it at least one hour before or two hours after a meal . 
do not take xultophy - if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 39 talk to your doctor , pharmacist or nurse before taking 39 any form of a sulfonylurea , such as glimepiride or glibenclamide . your doctor may need to adjust your sugar dose , depending on your blood sugar levels . if any of these apply to you , tell your doctor or pharmacist before starting to take the medicine . make sure that you take the correct dose and follow the instructions at the end of this leaflet . type 1 diabetes mellitus ( also known as ' ketoacidosis ') this is a condition that occurs when taking the active substance , and during treatment with x
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . some people may be blind or have poor eyesight and cannot read the dose counter on the pen . your doctor will tell you how many tablets of xultophy to use each day . do not change your dose unless your doctor tells you to . if your blood sugar level is too low , your doctor may need to change the dose . use in children and adolescents do not give this medicine to children less than 8 years of age because it has not been studied in this age group . the recommended dose in children of all ages should be 41 used in adolescents and children aged 8 years and above . read the " instructions for use " provided in the box at the end of this leaflet for more information . you can use the pen as a pre - filled dial - a 
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are low blood sugar ( very common : may affect more than 1 in 10 people ). if your blood sugar level gets low you may pass out ( become unconscious ). serious hypoglycaemia may cause brain damage and may be life - threatening . if you suffer from high blood sugar , it is important to keep following your food and exercise plan while taking xultophy . keep in regular contact with your doctor as soon as possible and follow any dietary advice that your doctor has given you . talk to a doctor or pharmacist straight away . you may have a very rare but serious allergic reaction ( anaphylactic reaction ) which is not known ( frequency cannot be estimated from the available data ) and is unlikely to be serious . there is a risk of a serious allergic
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . you may remove xultophy from the refrigerator and store it at room temperature ( not above 30 ) for one single period of up to 8 days ( up to 21 days ) and never throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what xultophy contains - the active substances are insulin degludec and liraglutide . each 100 ml vial contains 100 units insulin deGludec , equivalent to 3 . 6 million units ( iu ). each vial containing 3 millilitres contains 300 units ( 10 . 8 million units ) insulin dlg , corresponding to 1 . 5 million units in lisinopril . the other ingredients are glycerol ( e1521 ), phenol , zinc acetate , hydrochloric acid and sodium hydroxide ( for ph adjustment ) and water for injections ( see end of section 2 for further information on sodium ). pack sizes of 1 , 3 and 5 vials , or a multipack containing 10 ( 3 x 2ml )
giotrif is a medicine containing the active substance afatinib , which blocks the activity of two proteins called egfr [ epidermal growth factor receptor receptor 2 [ erbb1 ] and her2 [ her2 ] receptors ]). both of these proteins help cancer cells grow and multiply . by blocking their action , this medicine can kill cancer cells . this medicine is used for the treatment of cancer of the lung ( non - small cell lung cancer ) in adults . you will be given this medicine as your first treatment if you have received prior chemotherapy treatment for a certain type of squamous type of cancer whose disease has progressed and cannot be treated .
do not take giotrif if : you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) you have low body weight less than 50 kg you have kidney problems ( see section " warnings and precautions "). you may be more likely to get side effects if you have lung inflammation ( interstitial lung disease ). you have liver problems . your doctor may need to do some liver tests before you start taking this medicine . you have a severe liver disease you have eye problems ( e . g . severe dry eyes , inflammation of the transparent layer at the back of the eye ( cornea ) or ulcers inside the eye . talk to your doctor if any of these apply to you . children and adolescents do not give this medicine to children under 6 years old because it has not been studied in this age group . other medicines and 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is 40 mg twice a day . taking this medicine swallow the tablet whole with a glass of water . you can take giotrif with or without food . your doctor will tell you how many tablets of this medicine to take . do not divide , crush or chew the tablet . this medicine is for oral use . take the tablet at least 1 hour before or 2 hours after a meal . the tablet can be taken with food or between meals . if necessary , your doctor may tell you to take your tablet at any time of the day , depending on how you respond to the medicine . try to take it at the same time each day ( preferably in the morning and evening ). do not take more tablets than your doctor tells you to
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects may happen with treatment : diarrhoea ( very common : may affect more than 1 in 10 people ): if you have , or think you might , have suffered from : ( see section 2 , " what you need to know before you drink a lot of fluids "). if your doctor determines that you have or think that you may be suffering , your doctor may decide to temporarily stop your treatment . if this happens you must contact a doctor or the nearest hospital immediately , as you may need to be treated at once . in very rare cases ( may affect up to 1 in every 10 patients treated ) you may have : - low blood potassium which may be associated with worsening kidney function , which may increase the risk of diar
what giotrif contains - the active substance is afatinib ( as mesilate ). each film - coated tablet ( tablet ) contains 20 mg / 20 mg of a fat inib . the other ingredients are : tablet core : lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate . tablet coating : hypromellose , macrogol 400 , titanium dioxide ( e171 ), polysorbate 80 , water for injections ( see end of section 2 for further information on some of the ingredients in this medicine ), and in the end of this package leaflet there are some additional ingredients ( excipients ) for use in children and adolescents ( 6 years of age and above ) as well as in adults . what 
orkambi is a medicine used for long - term treatment of cystic fibrosis ( cf ) in adults , adolescents and children aged 6 years and older who have a f508del mutation in a gene called ' cytokines ' that regulates the electrical activity of a certain protein in the lungs . the mutation is thought to be related to an abnormal fftr protein . lumacaftor and ivacabtor work together to increase the amount of protein in your body . both of these active substances work together in different ways , resulting in an improvement of your breathing and your lung function . as a result , your body will not be able to control how well your lungs work and you may gain weight .
do not take orkambi : - if you are allergic to lumacaftor , ivacator or any of the other ingredients of this medicine ( listed in section 6 of this leaflet ). warnings and precautions talk to your doctor , pharmacist , or nurse before taking any of these medicines . if this applies to you , tell your doctor as soon as possible . your doctor may decide to lower your dose or stop your treatment , even if the f508del mutation is not known . you must not be treated with any other medicine if your doctor thinks it is safe to do so . talk to you doctor if : you have liver or kidney disease . depending on the condition of your kidney , you may need to reduce or stop the dose of Orkambi temporarily or permanently . abnormal blood tests of the liver may be necessary . tell your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take adults ( 6 to 12 years of age ) the recommended dose of orkambi is one tablet once a day in the morning and one tablet in the evening . take the tablet at about the same time each day . your doctor will tell you the dose to take . the tablet can be taken with or without food . swallow the tablet whole . do not chew , crush or split the tablet before swallowing . children and adolescents weighing at least 6 kg and less than 11 years old : your doctor may recommend that you take either of the following doses : - either 100 mg or 2 tablets twice daily or 12 tablets once daily . - if your child is a child weighing less than 200 kg : take the tablets either twice or three tablets once in the
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects caused by orkambi , when taken with ivacaftor , are usually mild to moderate and of a short duration . however , some patients may experience more serious side effects when taking Orkambi than they should . tell your doctor straight away if you notice any of the following symptoms : - raised levels of liver enzymes in the blood , which may increase the risk of liver injury - pre - existing severe liver disease - the worsening of liver function uncommon side effects ( may affect up to 1 in 100 people ) - pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin or the whites of your eyes - loss of appetite - diarrhoea - stomach pain - nausea or vomiting - increased levels of
what orkambi contains - the active substances are lumacaftor and ivacaftore . - orkam 100 mg / 125 mg film - coated tablets : each tablet contains 100 micrograms of lumamacantor , corresponding to a combined total of 125 million international units ( iu ) ( for each millilitre of product ), indicating that either a higher or lower dose is needed ( for example , when you are travelling ), or when you will be travelling , and at what time the tablets will be stored in the refrigerator ( tamper - proof ) and the other ingredient ( s ) are : o the tablet is a capsule - shaped , white to off - white tablet , with " pfizer " on one side and " nvr " on the
the active substance in lynparza is olaparib . olarib is a type of cancer medicine called a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ]). it works by stopping mutations ( changes ) in a gene called brca ( breast cancer gene ). if you have cancer , it can be a problem for your immune system ( the body ' s natural defence system ). it can also damage cancer cells if they do not have an enzyme called " repair dna ", which is missing or does not work as well as it should if it is not working properly . the active ingredient in the medicine has been shown to slow down the growth and spread of brca in patients with mutated ovarian cancer or when the cancer has progressed after previous treatment with
do not take lynparza - if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ) or to peanut or soya . warnings and precautions talk to your doctor , pharmacist or nurse before and while taking this medicine . children and adolescents do not give this medicine to children less than 2 years of age . this is because it has not yet been studied in this age group . if this applies to you , tell your doctor immediately . your doctor may want to reduce your dose or stop your treatment , or change your dose , if any of these apply to you ( or you are not sure ), ask your doctor or pharmacist for advice . take special care with this medicine you may get low blood cell counts ( shown in tests ). low counts of red or white blood cells may be a sign of low platelet counts ( see
always take lynparza capsules exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to take your doctor will tell you how many capsules to take and how long you should continue to take them . the usual dose is two 100 mg capsules once a day . your doctor may increase the dose to one 150 mg capsule each day , depending on how well the capsules work for you and how well you tolerate the doses . do not divide the total number of capsules that you take . tablets should be swallowed whole with water and do not chew , dissolve , or dissolve them before swallowing . it is best to take a capsule in the morning and evening as advised by your doctor . swallow the capsule whole , with a glass of water , do not split , crush , chew or crush the capsule .
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): - feeling short of breath , feeling very tired , having pale skin , fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ) in the blood . uncommon ( might affect up to 1 in 100 people ). - allergic reactions ( hives , difficulty breathing or swallowing , dizziness ). these can be signs and symptoms of hypersensitivity reactions . other side effects may include : very common : may affect any combination of both lynparza and glitazone . if you get any of these , talk to your doctor or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions . lynparza capsules should be used within 30 days after first opening . use within 3 months of first opening the capsule . any capsules that remain in the capsule should be discarded . the capsules must not be re - used once opened .
what lynparza contains the active substance is " olaparib 50 mg ". the other ingredients are : - capsule content : lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black and water for injections - printing ink : shellac , amgen , carnauba wax , white to off - white , opaque , hard capsule . the cap of the hard capsule is debossed with the company logo and the sachet ' s '. the code carries the company symbol and is stamped with the corporate logo of the company in black ink on one side and ' 50 mg ' on the other side . astrazeneca logo is printed on each capsule of
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the active substance naloxone is used in opioids such as heroin , methadone , fentanyl ( e421 ), oxycodone , buprenorphine and morphine . nyxoid is only available as a nasal spray for the emergency treatment of opioid overdose in adults , adolescents and children aged 14 years and overdose has been reported in patients with breathing problems and severe sleepiness . your doctor will tell you how long you should continue to use opioids and will ask you to take emergency medical care .
do not use nyxoid - if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . you may need emergency medical care , or emergency services , to avoid the possibility of an opioid overdose . it is important that you tell your doctor immediately , as there are the signs and symptoms that indicate an opioid overload . while using this nasal spray you should wait at least 2 to 3 hours after using a new nasal spray . if this medicine is used in adults who are physically dependent on opioids . opioids include heroin , methadone , fentanyl ( e1201 ), oxycodone , buprenorphine or morphine , and strong with opioids such as heroin 
always use nyxoid nasal spray exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the recommended dose is 1 spray in the shoulder and ears . do not touch the breastbone or sternum , or the inside of the ear . use a fingernail to help clear the mouth and nose of any blocksages that may be made in the way the medicine gets into your mouth or nose . 1 . when breathing is the chest moving in your chest . this means you can hear breathing sounds or breathe on the cheek . overdose may lead to a reduced response to touch or sounds , slow uneven breathing .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : stop taking nyxoid and see a doctor straight away if you notice any of the following acute withdrawal symptoms after taking opioid drugs : symptoms include fast heart rate , high blood pressure body aches , stomach cramps feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps , shivering or trembling changes in behaviour . some patients have experienced violent behaviour , nervousness , anxiety or depression . these side effects were mostly mild and usually go away within a few days . very common : may affect more than 1 in 10 people low blood sugar ( hypoglycaemia ), high blood sugar , weight loss , feeling sleepy , difficulty sleeping ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray delivers 1 . 8 ml of solution for injection , containing 168 micrograms ( mg ) of nalloxone ( as hydrochloride dihydrate ).  the other ingredients are : trisodium citrate dihydrate ( e331 ), sodium chloride , hydrogen chloric acid , sodium hydroxide and purified water ( see section 2 ) to help you remember your dose and what you need to know before you use the spray . the dose is 0 . 1 mg / spray in a pre - filled nasal spray with a single dose container . your doctor or nurse will prescribe the dose that is right for you . you can also use the dose at any time of the day , with or without food . n
this medicine contains the active substance follitropin alfa , which is a gonadotropin , a type of hormone that plays an important role in human fertility . fsh is involved in the growth and development of the sacs ( fertile cells ) in the ovaries that supply the body with hormones needed for the production of sperm . it is used to help develop a mature egg cell . in women , ovaleap is used in combination with a medicine called " clomifene citrate ". this is used during assisted reproductive technology procedures ( procedures that can help you to become pregnant ). it is also used in adults who are not able to reproduce themselves if they do not have the ability to produce enough eggs . this medicine can be used in adult men who are already pregnant and who cannot have children and adolescents , and who have not used 
do not use ovaleap : - if you are allergic to follitropin alfa ( fsh ) or to any of the other ingredients of this medicine ( listed in section 6 ). you have a tumour in your hypothalamus or pituitary gland ( both are parts of the brain ). these women have large ovaries or sacs of fluids that line both of your womb . these can be called ovarian cysts . you have unexplained vaginal bleeding . there may be a possibility that you may have cancer in your  Ovaries , swomb or breasts , or you have any condition that normally makes a normal pregnancy impossible . for example , you should tell your doctor about this . ovulation failure , early menopause , and fibroid tumours of the
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how is ovaleap given and how much should i take ? this medicine is given as an injection into the tissue just under the skin ( subcutaneous injection ). women who have irregular periods should receive this medicine during the first 7 days of their menstrual cycle . the medicine will be given to you by a doctor or nurse . your doctor will tell you how much medicine you should take . this medicine will usually be given at a dose of 75 mg or 150 mg once a day . depending on your response to this medicine , your doctor may decide to give you a lower dose of 7 or 14 injections of 37 . 5 mg / kg body weight . you will normally receive one 75 mg injection of this medicine up to 225 mg per day ( hcg ).
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : serious side effects in women allergic reactions such as skin rash or raised itchy areas of skin . these can be signs of severe allergic reactions , weakness , drop in blood pressure , difficulty breathing and swelling of the face 37 very rare : may affect up to 1 in 10 , 000 people if you have this type of reaction , your ovaleap injection must be stopped immediately . tell your doctor , nurse or pharmacist immediately if any of the following occur . very rare side effects that may occur in women lower stomach ache , nausea and vomiting may be the symptoms of ovarian hyper - stimulated growth ( ovulation ). these are usually mild to moderate and usually go away within a few days or weeks . not known : frequency cannot
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . you may remove this medicine from the refrigerator and store it for a single period of up to 3 months at a temperature not above 25 . if you have the impression that the effect of this medicine is too strong or too weak , talk to your doctor or pharmacist . after 3 months , the cartridge can be stored at room temperature ( up to 28 ) for up to 25 days . always keep the pen cap on the ovaleap pen when you are not using this medicine , even if it is cloudy or there are particles in it . never throw away any medicines via wastewater or household waste . ask
what ovaleap contains - the active substance is follitropin alfa ( fl ) in the form of a substance called cyp3adsorbed on human plasma ( human ) - in - use stability has been demonstrated in clinical trials at a concentration of 300 micrograms in 0 . 5 ml solution . each 300 microlitre vial contains 22 gbq at reference time ( corresponding to 1 , 000 international units ( iu ) at the reference date ( reference date )) in 4 - 3 - endoplasmic growth factor a in the presence of human - or animal - derived particles ( as shown in fig . v . in a clinical trial , the concentration at reference date is based on the following convention : the following concentrations of ovale
voriconazole accord , which contains the active substance vorbenazole , is an antifungal medicine that works by killing or stopping the growth of the fungi that cause infections . it is used for the treatment of patients ( adults and children over the age of 2 ) with : invasive aspergillosis ( a type of fungal infection due to Aspergillus sp ), candidaemia ( another type of FUNgal infection caused by candida spp .) in non - neutropenic patients ( patients without abnormally low white blood cells count ), serious , sometimes life - threatening , infections caused by fungus . before it is given to you , your doctor may give you fluconazoles ( another anti fungal medicine ) to treat serious fungal infections due to spores of scedosporium s
you must not be given voriconazole accord : - if your doctor or nurse thinks you may be allergic to vorikonazole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given any other medicines , even those that are obtained without a prescription . this includes herbal medicines and herbal medicines . the medicines listed in the package leaflets are for oral use only . please read the information under the heading " how to take ". if you are not sure about any of these , ask your doctor about other medicines you are taking , or treatment . 46 terfenadine ( used as a medicine of allergy ), astemizole ( used for allergy ) cisapride ( used to treat stomach problems ) pimozide ( for mental illness 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the dose you receive will depend on your weight and the type of infection you have . your doctor will calculate your body surface area in square meters ( m2 ). the usual dose is 40 mg per kg of body weight every 24 hours . you will receive a 400 mg dose every 12 hours for the first 24 hours ( 400 mg per 12 hours ) and the 24 hours thereafter ( 200 mg per day ). your doctor may increase your dose up to 12 hours ( 24 hours apart ) or temporarily stop treatment if your doctor determines that you need 300 mg / kg each day . use in children and adolescents voriconazole accord is used to treat mild to moderate cirrhosis in adults , adolescents and children aged 2 to less than 12 years and adolescents aged 12 to 14 years weighing less
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , most are likely to be minor and temporary . however , some may be serious and need medical attention . serious side effects stop taking voriconazole accord and see a doctor straight away rash , jaundice , changes in blood tests of liver function and pancreatitis . other side effects include : common : may affect up to 1 in 10 people visual impairment ( change in vision including blurred vision ), visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision , night blindness and swinging vision . not known : frequency cannot be estimated from the available data . your doctor will tell you if you experience any of these . very common ( may affect more than 1
what voriconazole accord contains - the active substance is vorikonazole . each 50 mg film - coated tablet ( tablet ) contains a total of fünf - seven ( 3 - digit ) doses . - one tablet ( 0 . 5 milligrams ) will be taken once a day , - in the morning and evening , at about the same time each day . the other ingredients are :  tablet core : pregelatinised starch ( maize starch ), croscarmellose sodium , povidone , and magnesium stearate ;  hypromellose ( e464 ), titanium dioxide , lactose monohydrate and triacetin , all of which are present in the form of a gel and are engraved in gold ink on the film 
mvabea is a vaccine that will protect you against ebola virus disease in the future . it will be given to individuals aged 1 year and older who will be at high risk of getting caught in the h5n1 era by catching a tiger - shaped hamster ovary ( cho ) and / or a 2 - dose course of vaccinations . your doctor will decide which vaccine you need to receive , depending on your individual needs . you will be vaccinated against one of the three types of zebra virus , which is also known as filovirus . this vaccine works by causing the body to produce its own protection ( antibodies ) against the rest of the virus . none of the ingredients in this vaccine can cause you or others to become active again , resulting in a lack of protection ( see section 2 ).
you should not receive mvabea during the vaccination course if any of the following apply to you or your child you are caring for . if you have ever had a severe allergic reaction to any ingredient of the vaccine listed in section 6 . you have had , or suspect you may have , been , in any doubt at all , an antibiotic called ' gentamicin '. the vaccine may not be suitable for all age groups . warnings and precautions talk to your doctor , pharmacist or nurse before you are given the vaccine if : you have previously had or might now be vaccinated against : - any member of your family has ever had or - ever fainted during or after any other vaccine injection you have been told you have bleeding or bruise easily you currently have a fever or an infection you are taking medicines that affect the immune system such as high - dose cor
mvabea is given to you by a doctor or nurse as a single injection into a muscle ( intramuscular injection ) in the upper arm or thigh or a blood vessel . the first vaccination with zabdeno vaccine will be given 8 weeks later . if you miss the scheduled dose , you may not be able to go back to your doctor ' s office and get the second vaccine . your doctor will tell you when to come back for the second vaccination . you will receive two doses of the vaccine , one in the morning and the other in the evening . primary vaccination first vaccination ( s ) will be administered in a contaminated sterile vial ( 0 . 5 ml ) or two in the dark coloured vials ( see ' instructions for use ' at the end of this leaflet ). second vaccination with
like all medicines , this vaccine can cause side effects , although not everybody gets them . most side effects occur within 7 days of receiving the injection . the following side effects may happen with mvabea : very common ( may affect more than 1 in 10 people ) pain , warmth , or swelling where the injection is given feeling very tired muscle ache joint pain common : may affect up to 1 in every 10 people feeling sick ( vomiting ) itching where you are given the injection uncommon : might affect upto 1 in 100 people redness and skin hardness where you have received the injection not known ( frequency cannot be estimated from the available data ) generalised itching if you get any of the side effects above , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix 
what mvabea contains - the active substance is zaire ebolavirus ( inactivated ) 29 micrograms / tai forest - related nucleoprotein marburg ( 0 . 7 ml per vial ) produced by recombinant dna technology using chicken embryo fibroblast cells . this vaccine contains trace residues of gentamicin , sodium chloride , trometamol , water for injections , hydrochloric acid ( for ph adjustment ) and a suspension for injection is provided in a single - dose glass vial with a rubber stopper and yellow cap . pack size of 20 vials .
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . it is used in adults and prescribed to you if you have breast cancer that has spread to your bones ( called ' bone ' metastases '). it helps to prevent your bones from breaking ( fractures ). it can also be used to prevent other bone problems that may need surgery or radiotherapy bondronate can also help to reduce a raised calcium level in your blood because of a tumour . calcium is also lost from your bones . as a result , your bones become weaker .
do not take bondronat if : you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) you have low levels of calcium in your blood you are not sure if any of these apply to you , or if you are unsure , talk to your doctor before taking this medicine . warnings and precautions the most important side effect is osteonecrosis of the jaw ( onj ) ( bone damage in the jaw ) has been reported very rarely in the post - marketing setting in patients receiving bondronate for cancer - related conditions . onj can occur after stopping treatment . it is important to try and prevent onj developing as it is a painful condition that can be difficult to treat . in order to reduce the risk of developing osteonocross of the mouth , there are some precautions you should take 
this medicine is normally given to you by a doctor or other medical staff who have experience with the treatment of cancer . it is given as an infusion into your vein your doctor may do regular blood tests while you are receiving bondronat . this is to check that you are being given the right amount of this medicine . how much to receive your doctor will work out your dose and how often you will be given it depending on your illness . if you have breast cancer that has spread to your bones , the recommended dose is 3 mg per kg body weight , given every 3 - 4 weeks . you will usually receive an infustion in your vein over at least 15 minutes . there may also be a raised calcium level in your blood ( see section 1 , 2 and 2 for more information ). depending on the severity of your illness you may need to have the medicine given over and over again and you may be given an in
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to a nurse or go to the nearest hospital straight away if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ) persistent eye pain and inflammation new pain , weakness or discomfort in your thigh , hip or groin . you may have early signs of a possible unusual fracture of the leg bone . very rarely , the following events have been reported in patients taking bondronat , but are not known ( frequency cannot be estimated from the available data ). talk to your doctor , pharmacist or nurse as soon as possible if : you have pain or sore in your mouth or jaw , as this can be a sign of severe jaw problems ( necrosis ( dead bone tissue ) in the jaw bone 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . this medicine does not require any special storage conditions . after dilution the infusion solution should be used immediately . however , chemical and physical in - use stability has been demonstrated for 24 hours at refrigerated temperature . your doctor , pharmacist or nurse will normally throw away this medicine if they notice any visible sign of tampering .
what bondronat contains - the active substance is ibandronic acid . each 2 ml vial of concentrate is used as a concentrate for solution for infusion . one vial contains 2 mg interferonib .  the other ingredients are sodium monohydrate , sodium chloride , acetic acid ( e331 ), sodium acetate , water for injections ( see section 2 for further information on the contents of the pack and other information about some of the ingredients in this leaflet ) and sodium ( if you are not sure of anything else ), talk to your doctor or pharmacist before giving you this medicine . bondronate is available in packs of 1 or 2 vials with a bromobutyl rubber stopper . not all pack sizes may be marketed .
zeposia contains the active substance riociguat . rrms is a type of medicines that affect white blood cells ( lymphocytes ). it belongs to a group of medicines called ' relapsing remitting multiple sclerosis '. it is used in adults , adolescents and children of all ages with active disease , to help protect their health and well - being . what zeposa is used for zeposition is used to treat adult patients with advanced stage of , or with active disability , with a disability that affects the immune system , which is unable to carry out its own defenses , and which can damage the nerves in the brain and spinal cord , causing nerves to tighten . this results in symptoms such as numbness and difficulty in walking .
do not take zeposia if : you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ) you have a severely weakened immune system you have ever had a heart attack ( angina ), stroke , mini - stroke or transient ischemic attack ( tia ), severe heart failure within the last 6 months you have been told you have irregular or abnormal heartbeats ( arrhythmias ) during treatment you have severe infection ( hepatitis , tuberculosis ), you have cancer you suffer from severe liver problems you are pregnant or breast - feeding . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you : have or have had any medical conditions which increase your risk of getting sick ( nausea , vomiting , diarrhoea
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will tell you exactly how many capsules of zeposia to take each day . this will depend on your heart rate . you will be given a ' treatment initiation pack ' with instructions on how to start treatment . the recommended dose is : adults : one capsule of 0 . 23 mg of ozanimod once a day for 1 week , followed by a 4 week break . after 4 weeks of treatment , your doctor may increase your dose to a maximum of 3 weeks , beginning with a lower dose , i . e ., one of the instructions for your doctor , to lower your dose . children , adolescents , children and adolescents aged 3 years and over the recommended starting dose is
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects ( very common : may affect more than 1 in 10 people ) slow heart rate , urinary tract infection , blood pressure . uncommon : might affect up to 1 in 100 people allergic reaction . the signs may include a rash . other side effects include : very common side effects may include ( common ): common ( may affect as many people as in adults ) infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ) or voice box ( larynge ) viruses - a type of white blood cell called lymphocytes common - may affect upto 1 in every 10 people pneumonia . not known ( frequency cannot be estimated from the available data 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store below 25 . this medicine does not require any special temperature storage conditions . if you notice any damage or signs of tampering to the pack , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what zeposia contains - the active substance is ozanimod ( as hydrochloride ). zeposia 0 . 23 mg hard capsules : each capsule contains 0 ( 2 - 8 ) micrograms ( 8 - 20 mg ) of :  oznimod in direct contact with water ( see section 2 ),  sodium chloride ,  magnesium stearate ( e470b ) in capsule shell : one zznitroin , one mm in diameter , with a length of approximately a full length of about a quarter a half a milliliter ( i . e ., 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 15 , 20 ,
temybric ellipta contains three different active substances : fluticasone furoate , umeclidinium bromide and vilanterol . each belongs to a group of medicines known as corticosteroids ( also known as steroids ). Umeclidium mide - day ( 0 . 5 ml ) and alfa - 3 added to the mix - up of three active substances in one tablet : - ciclosporin , which are used to dilate and relax the airways . - guillain - barré , a substance that helps air to get in and out of the gullet ( bronchodilators ) that help to keep airways open and help you breathe more easily . what should you do in copd ? copd is a long - term
do not use temybric ellipta : - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before using all of the above mentioned medicines . your doctor may need to change your dose . talk to a doctor if any of these apply to you . if this applies to you at the same time , your doctor will check that the medicine is working properly and that it is safe to use in these situations . you must not use the tablets unless your doctor tells you to . check with your doctor and follow the advice given in this leaflet . asthma there is no experience with the use of the tablets in patients with asthma . heart problems such as high blood pressure
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . use temybric ellipta every day until your doctor advises you otherwise . if there is anything you do not understand , or if someone else uses it , talk to a doctor , pharmacist or nurse about how to use it . it is very important that you use both in the same way , using the same inhaler on the same day , each time . this will help to keep you free of symptoms throughout the day and night , even when you are using tem
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing gets worse straight after using this medicine , stop using it and contact your doctor immediately . pneumonia ( infection of the lung ) in copd patients the most common side effect is a decrease in the number of cases . stop using temybric ellipta and seek medical help immediately if you have symptoms of a lung infection , such as fever or chills . increased mucus production , change in mucuses colour , increased cough , and increased breathing difficulties common side effects ( may affect up to 1 in 10 people ): sore throat , runny nose , cough feeling sick ( nausea ), vomiting , diarrhoea , abdominal pain , indigestion , flatulence ( wind 
what temybric ellipta contains - the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 92 micrograms / ml . - each dose is given as a single dose . the other ingredients are : - in the inhaler , you will find a light grey plastic body , a beige coloured mouthpiece cover , and a dose counter , together with a foil laminate tablet ( for further information on the contents of the pack ): a sachet containing a clear , colourless liquid ( 0 . 5 % inhaled solution ) - three inhalers , each containing one dose of two doses 
what zinforo is this medicine contains an antibiotic medicine containing the active substance ceftaroline fosamil . it belongs to a group of medicines called ' cephalosporin antibiotics '. what it is used for this medicine is used to treat adults with infections of the skin or the tissues below the skin . this is known as an infection of the lungs , also known as ' pneumonia ', in which the medicine works by killing certain bacteria , which can cause serious infections .
you must not be given zinforo - if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). you may also be allergic to other cephalosporin antibiotics . you have had previous severe allergic reactions to other antibiotics such as penicillin or carbapenem . if this applies to you , tell your doctor and do not use zin foro . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have kidney problems you have ever had seizures ( convulsions ) while you are taking this medicine and you are ever aware that you may be more likely to have any non - severe allergic reaction after you have been treated with another antibiotic , including penicillin and carpenem 26 you develop severe diarrhoea while taking antibiotics
the recommended dose of zinforo is 600 mg given every 12 hours . your doctor may increase your dose to 600 mg every 8 hours if you have some infections that your doctor thinks are important . it is given as a drip into a vein ( intravenously ) over 5 minutes . the dose may be increased up to 60 mg or 120 mg depending on how you respond to the medicine . you will be given an increased dose during treatment , usually every 5 to 14 days , depending on the type of skin infections that you have , and for 5 to 7 days after your last dose , e . g . in the morning and evening , in the evening . pneumonia your doctor will tell you how long your treatment will last . patients with kidney problems if your doctor determines that you need to be treated for you , it is important that you are checked by your doctor that your kidneys
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zinforo and see a doctor straight away if you notice any of these symptoms - you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , swallowing or breathing problems - these may be signs of a serious allergic reaction ( anaphylaxis ), diarrhoea , stool , blood or mucus . your doctor may decide to reduce the dose of your treatment , or stop the treatment temporarily or permanently . you may also be given medicines to help slow bowel movement . common ( may affect up to 1 in 10 people ): your doctor will ask you to have a blood test called a ' coombs test ' before you start taking a type of antibiotic 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store below 30 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is 600 micrograms ceftaroline fosamil . the other ingredients are arginine , maize starch , talc , iron oxide red ( e172 ) and water for injections ( see ' important information about some of the ingredients of this medicine ' at the end of the leaflet ') and amber colourless to pale yellowish - light yellow powder for concentrate for solution for infusion in a vial . pack size of 10 vials .
pregabalin pfizer belongs to a group of medicines used in the treatment of epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neuropathy pain the active substance in prgad enables the body to produce its own protection ( antibodies ) against long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral neuroopathic pain , for example , diabetes or shingles . pain sensations may be described as hot , burning ( throbbing ), shooting , stabbing , sharp , cramping , anxeus ( aching ), tingling , or numbness . these can also be caused by physical effort and due to long - lasting pain . the most common side effects are : headache , fatigue , depression , difficulty sleeping , insomnia
do not take pregabalin pfizer : - if you are allergic to pregabalsin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before and whilst taking pregabaltin ppfizer there is a small chance that you may experience symptoms of an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat , as well as diffuse skin rash . should you experience any of these reactions , you should contact your physician immediately . the use of pregabaliin has been associated with dizziness and somnolence , which could increase the occurrence of accidental injury ( fall ) in elderly patients . therefore you should be careful until you are used to any effect the medicine might have : blurring or loss of vision or other changes
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . for peripheral and central neuropathic pain , epilepsy or generalised anxiety disorder : take the number of capsules as instructed by your doctor . the dose , which has been adjusted for you and your condition , will generally be between 150 mg and 600 mg each day . your doctor will tell you to take pregabalin pfizer either twice or three times in the morning and once in the evening . alternatively , your doctor may prescribe a lower dose ( 150 mg ) or a higher dose ( 600 mg ). for adults , children and adolescents weighing at least 18 years of age and over the recommended dose is 150 mg per day , i . e ., one 600 mg oral tablet , two 150 mg tablets , three times a
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): dizziness , drowsiness , headache . common : may affect up to 1 in10 people : increased appetite . feeling of elation , confusion , disorientation , decrease in sexual interest . irritability . disturbance in attention . lack of clumsiness or memory impairment . loss of memory / tremor , difficulty with speaking , and tingling feeling feeling unusually unwell . not known : frequency cannot be estimated from the available data . some undesirable effects have been reported since the marketing of pregabalin pfizer . in children the side effects listed below have been observed . they are usually mild and usually disappear after a few weeks . however 
what pregabalin pfizer contains each hard capsule contains 25 mg ( 50 mg , 75 mg ), 100 mg ( 150 mg ) 200 mg ( 2 , 5 , 6 , 7 , 8 , 9 , 10 , 20 , 225 mg ( 300 mg ). the other ingredients in the capsule content are lactose monohydrate , maize starch ( maize ), talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica , black ink containing shellac ( containing black iron oxide , propylene glycol , potassium hydroxide ) and water for injections ( see section 2 ). packs of 75 , 100 , 200 and 225 capsules are available . not all pack sizes may be marketed .
xadago is a medicine that contains the active substance sefinamide . it increases the amount of dopamine in your brain . this helps to improve your brain function and is used in adults to treat parkinson ' s disease .  x adage is used when parkinsons 's disease occurs and people develop sudden switches in their movements , causing them to not be able to move and difficulties moving at all . the medicine is used together with levodopa ( one of other medicines that are used in addition to diet and exercise ) in adults who are already enrolled in a medical clinic and who are unable to move .
do not take xadago - if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the following medicines : monoamine oxidase ( mao ) inhibitors : selegiline , rasagiline ; moclobemide ; phenelzine , isocarboxazid ; or tranylcypromine ( used for treatment of parkinson ' s disease and depression ); pethidine ( a strong pain killer ). you must wait at least 7 days before your first injection and during your first few weeks after your first dose . if any of these apply to you , tell your doctor or pharmacist . during your second or subsequent dose , your doctor may
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of xadago 50 mg or 100 mg taken by mouth once daily . you should swallow the tablet whole with a glass of water . do not chew , crush or split the tablet before swallowing . your doctor may decide to give you a lower dose , depending on how well the medicine works for you or your child . patients with moderately reduced liver function should take the lower dose of one 50 mg tablet twice daily , preferably in the morning and the evening , at about the same time each day . take the tablet immediately after a meal . if your doctor decides that the tablet is too strong or too weak , talk to your doctor , pharmacist , or nurse about how long you should continue with this while you are taking 
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis ( very high blood pressure , which may lead to collapse ) has been reported in patients with neuroleptic malignant syndrome ( nms ). it may also be associated with confusion , sweating , muscle rigidity ( hyperthermia ), increase level of enzyme creatine kinase in your blood ( serotonin syndrome ). in this case you may experience confusion ( hypertension ), muscle stiffness and hallucinations ( hypotension ). the most frequently reported side effects are those related to parkinson ' s disease . when xadago is taken with safinamide , levodopoulos , glibenclamide itraconazole , tacrolimus and glitazone 
what xadago contains the active substance is safinamide . each 50 mg or 100 mg film - coated tablet contains a total of 50 mg . the other ingredients are : methansulfonate , microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - tablet coating : hypromellose , macrogol , titanium dioxide , iron oxide red ( e172 ), carnauba wax - the colourless liquid in the tablet core and white ink : shellac , amber coloured , capsule - shaped , white to off - white , round tablets of 7 mm diameter with metallic gloss imprinted on one side and ' 50 ' on the other side , respectively , and the strength of x
zytiga is a medicine that contains the active substance abiraterone acetate . it is used to treat prostate cancer in adult men whose body does not produce enough testosterone to control the level of male hormone testosterone produced by the male hormone , in male and female sex hormones ( estrogen ). it is also used in combination with testosterone therapy ( a treatment that lowers testosterone ( androgen deprivation therapy ) and with another medicine , prednisone .prednisolone has been prescribed to you because of high blood pressure , which has been removed from your body through fluid retention in your blood .
do not take zytiga : - if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). you are pregnant or breast - feeding . warnings and precautions talk to your doctor , pharmacist , or nurse before and while taking this medicine if : you have severe liver damage . you have prostate cancer . your doctor may need to adjust your dose . this medicine should not be used during pregnancy or while on treatment with this medicine you have liver problems ( for example , high blood pressure , heart failure , low blood potassium ), heart rhythm problems or other heart or blood vessel problems , such as an irregular or rapid heart rate , shortness of breath , 65 years of age or older , has gained weight or gained weight . there may be swelling in the feet , ankles, or legs .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 , 000 mg once daily . your doctor will tell you how many tablets of this medicine to take . take the tablets at the same time each day . swallow the tablets with a glass of water . zytiga can be taken with or without food . do not chew , crush or split the tablets as they may affect the way the medicine works . taking this medicine take prednisone twice a day for at least 2 hours before or after a meal . how long should i stay on this medicine for as long as you are able to tolerate the medicine . it is important that your doctor tells you to stay on the diet and exercise recommended by your doctor , pharmacist or nurse . you can take the tablet at any time of the day 
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and contact a doctor immediately if you experience muscle weakness , muscle twitches , a pounding heart beat ( palpitations ), as these may indicate that your level of potassium in your blood is low . your doctor will tell you how to deal with potassium . other side effects include : common ( may affect up to 1 in 10 people ): - build - up of fluid in your legs or feet as these can be signs of low blood potassium , as shown in liver function test - high blood pressure , urinary tract infection , diarrhoea , vomiting , nausea , constipation , dry mouth , hair loss , loss of appetite , weight gain , increase in liver enzymes ( seen in blood tests ),
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg amylase .  the other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate ( e487 ) ( see section 2 , important information about some of the ingredients of the tablet ) and water for injections ( see end of section 2 for further information on the contents of the pack - zytigea tablets are 9 . 5 mm in diameter . the tablets are packed in a plastic bottle with a child - resistant closure , and are available in packs containing 120 tablets .
hefiya contains the active substance adalimumab . it is a medicine used for the treatment of the following inflammatory diseases : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis paediatric plaque psoriasis , pediatric crohn ' s disease all - infectious uveitis in children and adolescents . the active ingredient in the medicine consists of two different proteins : one of which is made up of a monoclonal antibody , which is designed to recognise and attach to a specific target on the surface of cells in the body called ' tumour necrosis factor ' ( tnf ), which is involved in the development of the inflammation of these diseases , and in reducing the inflammation in these diseases and inducing their development in the later stages of
do not use hefiya if : you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ) you have a severe infection , including tuberculosis , sepsis ( blood poisoning ) or other opportunistic infections ( unusual infections associated with a weakened immune system ). it is important that you tell your doctor if you have symptoms of infections , e . g . fever , wounds , feeling tired , dental problems , moderate or severe heart failure . you have had or have had a serious heart condition . warnings and precautions talk to your doctor or pharmacist before using this medicine if the child : has had allergic reaction or if allergic reactions have been reported . symptoms may include chest tightness , wheezing ,
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . hefiya is available as either a 40 mg tablet or a 20 mg tablet . your doctor may prescribe a higher or lower dose to a maximum of 40 mg once a day . polyarticular juvenile idiopathic arthritis age or body weight how much and how often to use ? notes children , adolescents and adults from 2 years of age weighing 30 kg or more 40 mg every other week not applicable children and adolescents between 2 and 10 kg to less than 30 kg 20 mg twice daily not applicable enthesitis - related arthritis age and body weight why should i use it for your child ' s doctor will tell you if and when you may need to take a smaller dose . children and infants from 6 months of age the usual dose is
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . side effects may occur at least up to 4 months after the last hefiya injection . seek medical attention urgently , if you notice any of the following signs of allergic reaction or heart failure : severe rash or hives ; swollen face , hands , feet ; trouble breathing , swallowing ; shortness of breath with exertion or upon lying down or swelling of the feet . tell your doctor as soon as possible . signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , cough , flu - like symptoms , diarrhoea , abdominal pain , nausea and vomiting . common side effects (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . alternative storage : when needed ( for example when travelling ), hefiya may be stored at room temperature ( up to 25 ) for up to 14 days , but not above room temperature storage . once removed from the refrigerator , you should record on the carton the date you removed from refrigeration , and the date after which it should be discarded . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 14 days at 2oc to 8oc , unless
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg / 0 . 4 ml adipic acid , citric acid monohydrate , sodium chloride , mannitol ( e421 ), polysorbate 80 , hydrochloric acid and sodium hydroxide ( see section 2 ). solvent : water for injections ( see ' important information about some of the ingredients of this medicine ' at the end of this package leaflet ): the active ingredient is sodium - free , colourless to slightly yellowish solution for injection in a glass vial with a stainless steel needle and a needle guard with finger flange , rubber needle cap and plastic plunger rod . - not all pack sizes may be marketed .
ritemvia contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a specific type of white blood cell called " b - lymphocyte ". when the number of cells in your cell grows too low , the immune system ( the body ' s natural defence system ) will become weaker . if the medicine does not stick to your cell , your doctor may give you another medicine ( chemotherapy ) to help them get better . your doctor will discuss with you which other medicines ( chemotherapy ) you are using , including chemotherapy , may be temporarily stopped for a period of time , but the treatment may be continued for up to 2 years after you have started the initial treatment . for granulomatosis with polyangiitis or microscopic poly
do not take ritemvia : - if you are allergic to rituximab , other proteins that are similar to the active substance , or any of the other ingredients of this medicine ( listed in section 6 ) - when you have a severe active infection or a weak immune system . warnings and precautions severe heart failure or severe uncontrolled heart disease , including granulomatosis with polyangiitis ( e . g . microscopic polyangitis , pemphigus vulgaris ). if any of these apply to you , tell your doctor or pharmacist before you are given this medicine . you may be at increased risk of developing a hepatitis infection . your doctor may want to monitor you more closely while you are being treated with retween b . people who have ever had he
you will always receive ritemvia exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . this treatment is administered by a doctor or nurse who is experienced in the use of this medicine . they will watch you closely while you are being given this medicine and are available to help you get the best results for your treatment . it is very important that you receive this medicine every day as a drip ( intravenous infusion ). medicines given before each ritemevia administration will be given to you in a hospital or clinic . your doctor will tell you in which combination of medicines ( pre - medication ) is best to avoid infecting other people . in order to minimise the risk of side effects your treatment will be started at a low dose . for non - hodgkin ' s lymphoma patients who are unable to tolerate 
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . you may also experience pain at the site of infusion , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat irritation , cough , diarrhoea , nausea and vomiting . these side effects mostly occur during the first few days of treatment and can be severe . tell your doctor or nurse immediately if you experience any of these symptoms . other side effects may include : very common ( may affect more than 1 in 10 people
what ritemvia contains - the active substance is called rituximab . each ml of concentrate contains 100 mg ( 300 mg ), - in the vial , one vial of 10 mg , - containing a total of 61 - 5 mg /ml . -- the other ingredients ( excipients ) are : sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections ( see section 2 ). what ritamvia looks like and contents of the pack the concentrate is a clear , colourless solution . it is supplied as a concentrate for solution for infusion in a glass vial ( ph . vial pack of 2 vials ).
capecitabine teva belongs to the group of medicines called " cytostatic medicines ", which stop the growth of cancer cells by blocking their growth factor receptor ( csfr ), which is found in large amounts on the surface of blood and destroy them by a process called recombinant dna storage ( r - tectural ) transformation ( transformation ) of the chemical in the body known as ' cytotoxic ' ( a chemical that is used to destroy cancer cells ) in the treatment of adult patients whose bodies have been transformed into cells in the process of transformation ( reversible ) to produce their own protection ( antibodies ) against growth and spread of colon . rectal , gastric , or breast cancers are the most common treatments used to remove them from their body after complete removal of the tumour by surgery , but it is not known whether cap
do not take capecitabine teva : - if you are allergic to capcitabine or any of the other ingredients of this medicine ( listed in section 6 ). an allergy to this medicine has been reported . warnings and precautions severe reactions have been reported with fluoropyrimidine therapy ( a group of anticancer medicines such as fluorouracil ) in pregnant women . low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia ). severe liver or kidney problems . if your doctor determines that you do not have any activity of the enzyme dihydrochlorimidine dehydrogenase ( dpd ) ( complete pd deficiency ). children and adolescents do not give this medicine to children under 4 years of age because it has not been studied in this age group
always use this medicine exactly as described in this leaflet or as your pharmacist or nurse has told you . check with your doctor or pharmacist if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you , so you should take the tablet at the same time each day . dose the dose of cappecitabine teva is based on your body surface area . this is calculated from your height and weight . the usual dose for adults is 1250 mg per square metre of body surface surface area taken two times daily ( morning and evening ). two examples are provided here : a person whose body weight is 64 kg and height is 1 . 64 m has a body surfacearea of 1  . 7 m2 and should take 4 tablets of 500 mg and
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva immediately and contact a doctor if any of these symptoms occur : diarrhoea : if you have an increase of 4 or more bowel movements compared to your normal bowel movement each day or any diarrhaea at night . vomiting : when you vomit more than once in a 24 - hour time period . nausea : you lose your appetite , and the amount of food you eat each day is much less than usual . stomatitis : your doctor will tell you what to do to reduce pain , redness , swelling or sores in your mouth and / or throat . hand - and - foot syndrome : this is more likely to happen when you stand up or stand up
what capecitabine teva contains - the active substance in each film - coated tablet is a ' cisagrel '- like substance that binds to the food in your mouth . - acacia , titanium dioxide ( e171 ), talc , phosphate , maize starch , benzoate salt - free , low - to - medium - chain - reaction reaction ( gt ) is used to replace the missing ingredient in the tablet core and replace it with a dose of 150 mg , as described in the package leaflet and the medicine is clear , colourless to pale yellow , round , biconvex , and marked " ct500 " on one side and " 150 mg " on the other side . the tablet can be divided into equal doses . cape
the active substance in silodosin recordati belongs to a group of medicines called alpha1a - adrenoreceptor blockers ( ee . g ., sex hormones ) which control the flow of urine and other body fluids through the prostate , bladder and urethra . by blocking these receptors , it causes smooth muscle in these tissues to relax . this makes it easier for you to pass water and relieves your symptoms . you may find it helpful to follow your doctor ' s advice on what to do if you do not feel better or if your symptoms do not improve after a short period of time . the effect of this medicine is to reduce the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as : difficulty in starting to passage water ,
do not use silodosin recordati : - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using semen during and after your first dose . before starting dose , you should be careful with your eye surgery as it may cause cloudiness of the lens ( cataract surgery ). if this happens to you , tell your doctor as soon as possible . 26 if any of these applies to you ( or you are not sure ), ask your doctor for advice . while you are being treated with this type of medicine , there may be a loss of muscle tone in the iris ( the coloured part of the eye ) during such a surgery . your doctor will take appropriate precautions with regard to medicine and surgical techniques to be used . you should
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one capsule of silodosin recordati 8 mg taken orally once a day at about the same time each day . you should swallow the capsule whole with a glass of water . do not chew or break the capsule , as this may affect the way the capsule is taken . patients with kidney problems your doctor may prescribe a lower dose for patients with moderate kidney problems , but your doctor will prescribe the right dose for you based on your symptoms and your response to treatment . if your symptoms do not improve after taking this medicine , contact your doctor , pharmacist , or your nearest hospital casualty department at the nearest hospital for advice . take the box or bottle with you so that it can be taken with or without food . it is important that
like all medicines , this medicine can cause side effects , although not everybody gets them . please tell your doctor immediately if you experience any of the following allergic reactions : swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin or hives the following side effect has been reported with silodosin recordati : dizziness , sometimes called " fainting ", and occasionally fainting . at the first sign of this side effect , you should sit or lie down straight away until you feel better . this is usually mild to moderate and usually goes away as time goes on . however , in some cases you may need to be treated with another medicine or a different medicine . it is important that you contact a doctor or go to a hospital as soon as possible so that you can easily describe what you have been taking , or if someone else in
what silodosin recordati contains - the active substance in this medicine is called ' taiwanese '. if you are not sure , talk to your doctor , pharmacist or nurse before making the decision to make a change to the dose you receive . the dose that you receive is based on the body weight of your child ( 0 . 5 mg / kg body weight ) and will be calculated by the health professionals at the time of recording the event ( see also section 4 ). - each millilitre contains approximately 8 milligrams ( mg ) in each ml , i . e . one milliliter (" si " in the other ). the other ingredients are mannitol ( e421 ), magnesium stearate , sodium laurilsulfate , gelatin
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . these are substances produced in your body which cause your blood vessels to narrow , resulting in a lowering of your blood pressure . kinzimono blocks these effects and makes the blood vessels relax . this results in an increase in your blood temperature . the high blood pressure that you are experiencing is referred to as essential hypertension ( higher than normal ). ' essential ' means that your body is unable to break down the protein ' s natural growth factor receptors ' ( rhabdomyolysis ). by preventing this , you may damage blood vessels in several organs , which could lead sometimes to heart attack , heart or kidney failure , stroke , or blindness .
do not take kinzalmono - if you are allergic to telmisartan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions children and adolescents do not give this medicine to children under 3 years of age , and should not be used in this age group . ( it is also better to avoid this medicine in early pregnancy see pregnancy section .) - have severe liver problems such as cholestasis or biliary obstruction ( problems with drainage of the bile from the liver and gall bladder ) or any other severe liver disease . - know that you have diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing aliskiren . it is important that you tell your doctor if any of these apply to you . your doctor may want to monitor you more closely while you are taking kin
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of kinzalmono is one tablet a day . it does not matter at what time of the day you take your tablet but taking the tablet at the same time each day will help you remember to take it . you may take it with or without food . your doctor will tell you exactly how many tablets you should take . try to take the tablets with some water or other non - alcoholic drink . swallow the tablet whole . do not chew , crush or split the tablet before swallowing as it may affect the way the medicine works . for treatment of high blood pressure , the usual dose for most patients should be one 40 mg tablet once daily to control blood pressure over the 24 - hour period may be increased to a lower dose of one 20 mg tablet daily .
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious and need immediate medical attention : you should see your doctor immediately if you experience any of the following symptoms : sepsis * ( often called " blood poisoning ", is a severe infection with whole - body inflammatory response ), rapid swelling of the skin and mucosa ( angioedema ); these side effects are rare ( may affect up to 1 in 1 , 000 people ) but are extremely serious and patients should stop taking the medicine and see their physician immediately . if these effects are not treated they could be fatal . possible side effects of kinzalmono common side effects ( affects 1 to 10 users in 100 ) are : low blood pressure ( hypotension ) in users treated for reduction of cardiovascular events . uncommon sideeffects ( affect up
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special temperature storage conditions . you should store your medicine in the original package in order to protect the tablets from moisture . remove your kinzalmono tablet from the blister only directly prior to intake .
what kinzalmono contains the active substance is telmisartan 20 mg . the other ingredients are povidone , meglumine , sodium hydroxide , sorbitol ( e420 ) and magnesium stearate to adjust the ph . your doctor has prescribed a different strength for you depending on your response to the medicine , and on how well it works for you . what the medicine looks like and contents of the pack the medicine is a white to off - white tablet . it is available in blister packs of 14 , 28 , 56 and 98 tablets . not all pack sizes may be marketed .
afstyla is a human clotting ( coagulation ) factor viii product produced by recombinant dna technology . it contains the active substance lonoctocog alfa , which is used to clot bleeding episodes in adults , adolescents and children of all ages with haemophilia a ( inborn factor vii deficiency ) age - related hemoglobin ( igg )- inhaled , resulting in an increased tendency to bleed . if you have been told by your doctor that you don ' t have the ability to coagulate , you will have to use the product in addition to the product . the active ingredient in this medicine is ldl . you must have a minimum of 1 - 4 weeks of age , in order to maintain a
you must not be given afstyla - if you have ever had an allergic reaction to any of the active substances in your body ( see section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given orally : 46 if your doctor has told you that you are allergic to hamster proteins . if any of these apply to you ( or you are not sure ) to the active substance , please tell your doctor or nurse immediately . your doctor may need to change the batch number of your treatment diary . you should keep a record of the batches used and keep it with you in order to keep this in a safe place to keep it safe . children and adolescents do not give this medicine to children under the age of 18 years because it has not been studied in this age group . allergic ( hypersensitivity ) reactions have been reported in patients receiving a
your treatment should be started by a doctor who is experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of afstyla for treatment of your disease the site and the bleeding your clinical condition should be determined by your doctor . reconstitution and administration general instructions the powder should be mixed with the solvent ( liquid ) immediately after dilution . if not used immediately , aseptic conditions may need to be maintained before use . your doctor will tell you exactly how many vials you need to use and how often you should use them . use in children and adolescents the recommended dosage for children should not be used in children below the age of 18 years is the same as for adults . other medicines and solvents should be used within this age group . see section 6 
like all medicines , afstyla can cause side effects , although not everybody gets them . contact your doctor immediately if you experience symptoms of allergic reactions . allergic reactions may include the following symptoms : hives , generalised urticaria ( itchy rash ), tightness of the chest , difficulty in breathing , wheezing , low blood pressure , dizziness and anaphylaxis ( bleeding ). patients who have received factor viii medicines may develop inhibitor antibodies ( see section 2 ) ( more than 1 in 10 patients ). if this happens , you must stop the treatment immediately and contact a doctor . very common ( may affect more than1 in 10 people ) inhibitor reactions have been reported in patients who had previous treatment with factor vii ( less than 150 days of treatment ). the frequency of these reactions is not known ( frequency cannot be
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . the afstyla powder can be stored at room temperature ( up to 25 ) for a single period not exceeding 3 months . keep the vial in the outer carton in order to protect from light . use the reconstituted product immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 25 , unless reconstitution has taken place in controlled and validated aseptic conditions .
what afstyla contains the active substance is lonoctocog alfa . each ml of solution contains 250 micrograms ( corresponding to 2 . 5 millilitres ) of solution for injections the solution contains 100 million international units ( iu ) ( 4 . 9 milligrams ), of which at least one third is made up ( e . g . 10 milliliters ). after reconstitution , after dilution , two batches are made up : one vial contains 200 microgram ( 0 . 7 millil ). the other excipients are : the product is a clear , colourless solution , aqueous , and free from particulates . when reconstitution is completed , the two vials are mixed together and the solution is administered as 200 milli
the name of your medicine is praxbind . it contains two different active substances : idarucizumab , a so - called reversal agent . dabigatran ( pradaxa ) is a blood thinner medicine that helps to prevent blood clot formation . by preventing the blood from being absorbed by the kidneys and thereby reduce the blood supply to the intestines , the surgeon will make sure that the medicine is kept out of the sight and reach of children . the doctor will tell you what to do if you are not sure about what is left of the medicine and how it will be given to you . your doctor will discuss with you which medicine is most suitable for you and how long you need to be given . you should keep in regular contact with your doctor and / or a doctor who is experienced in the treatment of patients who have
do not use praxbind - if you are allergic to idarucizumab or any of the other ingredients of this medicine listed in section 6 . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : - you suffer from a genetic disease called hereditary fructose intolerance ( hfi ) or the substance sorbitol ( e420 ) as this medicine may increase the risk of serious adverse reactions . if any of these apply to you , tell your doctor or pharmacist . do not take this medicine in combination with dabigatran or with other medicines that help to prevent blood clots . it is very important that you do not get enough nutrients from food and exercise , and that your body is able to break down food and drink quickly . this is because of the increased risk of blood
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 5 mg vial of 2 . 5 mg dabigatran per day . you should take this medicine for at least 5 minutes before you inject yourself . this medicine should be injected into a vein . your doctor will tell you how much praxbind you will need to take . do not stop taking this medicine without your doctor ' s approval . during your treatment , your doctor may reduce the risk of blood clot formation . when you are given dabig atran , you will normally receive at least 24 hours after receiving this medicine . if your doctor determines that you should not receive more than one dose , contact your doctor immediately . it is very important that you keep using this medicine every day until your doctor tells you otherwise 
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains the active substance is idarucizumab ( as sodium acetate trihydrate ). the other ingredients are acetic acid , sorbitol ( e420 ), polysorbate 20 and water for injections . what the solvent vial looks like and contents of the pack the concentrate for solution for injection is a clear to slightly opalescent , colourless to slightly yellow solution in a glass vial with a butyl rubber stopper and an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temac is used for the treatment of specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme ( gm ). mds is first diagnosed by your doctor and accompanied by radiotherapy ( concomitant phase of treatment ) and after that alone ( monotherapy phase of treating ) adults and children 3 years and older and adult patients with malignant gliomema , such as the group of patients known as the " anaplastic astrocytoma " that have come back or are no longer respond or become active again if they return or get worse after standard treatment .
do not take temomedac if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). you have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction include feeling itchy , breathlessness or wheezing , swelling of the face , lips , tongue or throat . you or your child may be at risk of blood cells being severely reduced ( myelosuppression ), such as your white blood cell count and platelet count . these blood cells are important for fighting infection and for proper blood clotting . your doctor will check your blood to make sure you have enough of these cells before treatment is started . warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine if : you have a low number of platelets
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac . this is based on your size ( height and weight ) and whether you have a recurrent tumour and have had chemotherapy treatment in the past . you may be given other medicines ( anti - emetics ) to take before and / or after taking temac to prevent or control nausea and vomiting . patients with newly - diagnosed glioblastoma multiforme may be undergoing treatment in two phases : - treatment together with radiotherapy ( concomitant phase ) or - alone or with chemotherapy ( monotherapy phase ). your doctor may tell you to take both phases in one phase . the usual dose of the two phases is 75 mg /
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you have any of the following : a severe allergic ( hypersensitive ) reaction ( hives , wheezing or other breathing difficulty ), uncontrolled bleeding , seizures ( convulsions ), fever , chills and severe headache that does not go away . temomedac treatment can cause a reduction in certain kinds of blood cells . this may cause you to have increased bruising or bleeding ( anaemia ), red blood cells and fever and reduced resistance to infections . the reduction in blood cell counts is usually short - lived . in some cases , it may be prolonged and may lead to a life - threatening , possibly fatal , effects . your doctor will monitor you closely , and act if necessary . patients with an
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions . temomedac is for single use only . any change in the appearance of the capsules should be discarded .
what temomedac contains - the active substance is temozolomide . - one ml solution for injection ( injection ) is supplied in a vial of 5 mg . this means that you take 5 mg of the medicine once a day , - if you cannot take it with lunch , or if there is no medicine left in the vial to help you remember when you need to eat or drink something - like a meal or a snack - as described in the " do not take " section of the tablet ( s ) in the morning , midday and evening , at about the same time each day : - for the first few days of the month : one dose of one tablet of 20 mg contains two doses of one of the three - week cycle of two tablets of one kind containing two types containing one type of tem
cialis is a treatment for adult men with erectile dysfunction ( also known as impotence ). this is when a man cannot get , or keep a hard , errect penis suitable for sexual activity . your doctor will tell you exactly how many times you should have been sexually stimulated . you must not have a problem with your penis , but you must have one at the same time , every day , for as long as your doctor prescribes it for you . the active substance tadalafil belongs to a group of medicines called phosphodiesterase type 5 inhibitors that work by helping the body to get a sexual response . cis works by reducing the amount of sugar in your blood . this will stop the penis from leaking out of your sex , which in turn reduces the flow of blood into your pen
do not take cialis : if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you are taking any form of organic nitrate or nitric oxide donors such as amyl nitărite . this is one of a ' s very rare , but very common , group of medicines (" nitsits ") used to treat angina pectoris (" chest pain ") in adult patients . if any of these medicines are too strong or too weak , tell your doctor or pharmacist . warnings and precautions talk to your doctor , pharmacist or nurse before taking any . you have serious heart disease or you have recently had a heart attack within the last 90 days or you are caring for a child who is older than 90 years or who has recently had
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . cialis tablets are for oral use . swallow the tablets with some water or other non - alcoholic drink . the tablets can be taken with or without food . how much to take the recommended dose is 5 mg twice a day . your doctor will tell you how many tablets to take and how long you should continue to take them . this will depend on how well you respond to the medicine . do not take more tablets than your doctor tells you to . men who do not have the ability to get an erection , they will usually have a short time to 24 hours after you last took the tablet and will then have to wait for the next dose at least four hours before taking the tablet . you should not take the tablets for more than one hour before sexual activity . taking 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : allergic reactions ( rashes ) frequency not known ( frequency cannot be estimated from the available data ): - chest pain - do not use nitrates but seek immediate medical attention ( frequency is not known ). - priapsim may cause a prolonged and possibly painful erection after taking cialis ( see section " warnings and precautions " in section 4 ). contact a doctor immediately if you experience sudden loss of vision ( frequency unknown ). other side effects have been reported : common ( may affect up to 1 in 10 people ) - headache - back pain . frequency is common . - feeling sick ( nausea ) or being sick ( vomiting ) since this medicine may affect how well it works for you 
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg / 0 . 25 mg of tatafil as well as the other ingredients ( excipients ) are : - tablet core : lactose monohydrate ( see end of section 2 ), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose ( e460 ), sodium laurilsulfate , magnesium stearate . - film - coating : latently modified , partially hydrolysed poly ( vinyl alcohol )- hypromellose , triacetin , titanium dioxide [ e171 ], iron oxide yellow , iron oxide red [ talc ] [ hdpe tablet ] ( see ' important information about some of
enyglid is an oral antidiabetic medicine that contains the active substance repaglinide . it helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which each individual organ of the body ' s immune system attacks the sugar in the food you eat . the insulin that your body produces does not work as well as it should , so it needs to be absorbed by the body in the form of a gel . you need to stay on the diet and exercise recommended by your doctor while you are on treatment , while still reducing exercise and weight reduction . your doctor may prescribe an alternative form of metformin ( another medicine for diabetes ). it is important that you continue to follow any diet and lifestyle advice from your doctor , pharmacist or nurse .
do not take enyglid if : you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). you have type 1 diabetes . if the acid level in your blood is raised ( diabetic ketoacidosis ), you have a severe liver disease . you take gemfibrozil ( a medicine used to lower increased fat levels in the blood ) you have liver problems you drink alcohol more than once a month if you have moderate liver 28 disease see section 2 . warnings and precautions talk to your doctor , pharmacist , or nurse before taking the medicine : if your doctor thinks you may need to be monitored more carefully . your doctor may want to monitor you more closely . check with your doctor or pharmacist before taking this medicine if either of the above applies to you . take special care of your blood sugar .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is 0 . 5 mg twice a day . swallow the tablets with a glass of water immediately before or up to 30 minutes before each main meal . the dose may be adjusted by your doctor by up to 4 mg to be taken immediately prior to meals . if necessary , your doctor may increase your dose to 30 mg twice daily . your doctor will tell you how much enyglid you need to take , depending on how you respond to the medicine and on how severe it is ( see section 4 ). if your blood sugar is too low , you may get a hypo , or you may want to go crazy . do not take a double dose ( two doses close together ) to make up for a forgotten dose .
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia is a very common side effect in people taking enyglid . this side effect is very common ( may affect more than 1 in 10 people ), but it can also occur in some cases ( more generally mild / moderate ) and in rare cases ( less than 1 per 10 , 000 people ). if this happens you must contact a doctor or go to a hospital immediately ( see section " warnings and precautions ") or you can help provide more information on the side effects listed above . most of the cases are mild or moderate and disappear without coma . allergy allergy is very rarely seen in some patients ( up to 1 in10, 000 patients ). symptoms may include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating ( anaphylactic reaction
what enyglid contains - the active substance is repaglinide . each tablet contains 0 . 5 mg ( 1 mg ) or 2 mg ( 2 mg ), of which at least one third is active . the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine ( type a ), poloxamer , yellow iron oxide ( e172 ) in each film - coating . in addition to the above , one additional ingredient is : one white to off - white , round and biconvex with bevelled edges . one 1 mg tablet is pale brown and yellow , and one half - millilitre ( ml ) is yellow and
the active substance in this medicine is azacitidine mylan . it is an anti - cancer agent in which the active ingredient in the medicine itself is a sulphonylurea ( a substance derived from the bone marrow ) is inserted into the bloodstream , where it belongs to a group of proteins called epidermal growth factors ( egfr ). in some cases , the activity of the protein is changed from its previous form in the blood , leading to its development in some patients . this change in the function of the cells is called ' myelodysplastic syndromes ' ( mds ). it is used in adults and children who have had a stem cell transplantation to treat : - higher - risk melanomonocytic leukaemia ( cmml ). - acute myeloid
you must not be given azacitidine mylan : - if your doctor or nurse has told you that you have advanced liver cancer . if you are breast - feeding . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if - you have or have had decreased counts of platelets , red or white blood cells , kidney disease , liver disease or you have ever had a heart condition or heart attack , or lung disease . blood test your doctor will do blood tests before you start treatment . you will be monitored by a health professional while you are being treated with azacitabine mylan and during treatment , you will have a ' cycle '. this is to check that you are getting enough blood cells and that your liver and kidneys are working properly . your doctor may decide to keep you under closer observation , and to
before giving you azacitidine mylan , your doctor may give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor will decide your dose of this medicine , depending on your general condition , height and weight . you will be given one zinc tablet every day for one week , followed by a rest period of 3 weeks . this " treatment cycle " will be repeated every 4 weeks , for a total of 6 treatments . - this medicine will usually be given to you as an injection under your skin ( subcutaneously ). it may be given under the skin on your thigh , tummy or upper arm if your doctor determines that it is safe for you to come home . contact your doctor or nurse if you have any further questions on the use or response to this medicine
like all medicines , this medicine can cause side effects , although not everybody gets them . the most common side effects are drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting and reduced appetite . confusion , restlessness , fatigue and symptoms of kidney failure are listed below . if any of these side effects causes you problems , seek medical advice from your doctor as soon as possible . very common : may affect more than 1 in 10 people loss of appetite , weight loss , constipation , indigestion , flatulence ( wind ), hiccups . not known : frequency cannot be estimated from the available
you will not have to store azacitidine mylan . this medicine is stored under the responsibility of the specialist in appropriate premises . keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and the carton after exp . store and transport refrigerated ( 2 - 8 ). do not freeze . the suspension must be used immediately after preparation . if the suspension is not used immediately , it must be stored at room temperature ( not above 25 ) for a single period of up to 1 month , but not above 30 days without being discarded . when using later , if necessary , the suspension should be used within the 8 - hour period ( when the medicine is prepared using water for injections ). once the suspension has been prepared it should be administered within 8 hours when stored in the refrigerator ( 2 8
what azacitidine mylan contains - the active substance in each vial of powder contains 100 mg / ml dna . - one vial contains 0 . 5 milligrams / millilitre ( 8 . 6 milliliter ) of aza citidine . after reconstitution with 4 mL of water for injections , the reconstituted suspension contains 25 mg pfu /ml of solution for injection , corresponding to approximately 15 % of the recommended dose . the other ingredient in the powder are mannitol ( e421 ) and sodium hydroxide ( see section 2 ). what you need to know before you use azacitamylan , you will find a white powder for suspension for injection and is supplied in a glass vial containing 100 mg debossed with ' m
duotrav eye drop solution contains a combination of two active substances , travoprost and timolol in one film - coated , pre - filled syringe ( s ) in one sachet , called prostaglandin analogue , which works by reducing the amount of fluid within the eye . this results in a lower level of pressure in the eye which in turn reduces the effect of st . john ' s abbreviation ( a beta blocker )) that helps to reduce fluid inside the eye and so lower pressure within the glaucoma . the two active ingredients are in the dropper , and are used together to reduce the pressure that the drops need to be used and to prevent it from being too strong or too weak , for example , in adults . duo
do not use duotrav - if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions respiratory problems such as asthma or severe chronic obstructive bronchitis . severe lung disease that causes wheeziness and difficulty in breathing . long - standing cough . breathing problems including severe hay fever . a slow heartbeat . heart failure or a disorder of heart rhythm ( irregular heartbeats ). the colour of the liquid in the eye is cloudy . talk to your doctor if any of these apply to you . take special care with this medicine : do not swallow or chew the tablet . do not put the tablet in a glass of water or contact a doctor immediately .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one drop in the eye or eyes , once a day in the evening . use duotrav at around the same time each day . you can use it at any time of the day , with or without food . it does not matter whether you use it for the day or night . your doctor will tell you how many drops to use . if necessary , your doctor may tell you to use eye drops at least 1 hour before or 2 hours before or 3 hours after a meal . how much to use wash your hands . twist off the bottle cap . hold the bottle , pointing down , between your thumb and fingers . tilt your head back . pull down your lower eyelid with a clean finger until there is a " pocket " between
like all medicines , this medicine can cause side effects , although not everybody gets them . you should stop using the drops and start using duotrav at the same time each day . very common side effects ( may affect more than 1 in 10 people ) - effects in the eye eye redness . commonly reported side effects [ may affect up to 1 in10 people ] - damage to the eyeeye eye surface inflammation or surface damage . - eye pain , blurred vision , abnormal vision - dry eye , itchy eye or eye discomfort , signs and symptoms of eye irritation ( such as burning and stinging ). uncommon side effects are : headache , dizziness , ringing in the ears , trouble seeing or hearing things that are not there ( tinnitus ). tell your doctor straight away if you notice any of the side effects above . side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . after opening : do not store above 30 . store in the original package in order to protect from light and moisture . throw away the container 4 weeks after first opening , just in case you notice that the solution is not clear or contains particles . it is recommended that you throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what duotrav contains - the active substances are travoprost and timolol . each ml contains 40 mg / 0 . 5 milligrams / 10 . 3 millilitres of travonol and 4 milliliters of piolol maleate . the other ingredients are : polyquaternium - 1 , mannitol ( e421 ), propylene glycol , polyoxyethylene hydrogenated castor oil 40 and boric acid . sodium chloride , sodium hydroxide and hydrochloric acid are included in the formulation . purified water ( s ) will be added to the formulation in order to maintain acidity levels ( ph levels ) normal after reconstitution .
nplate ' s active ingredient is romiplostim , a protein that is used to reduce low platelet counts in adults with immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is a disease that affects your body  s immune system that produces too many of a type of protein called platelets . platelets are important as they help your blood to form blood clots . very low platelets counts can lead to bruising and serious bleeding ( see section 1 ) when you have had your spleen removed , or if you have chronic itp and have previously taken corticosteroids ( or immunoglobulins ), but have not worked well enough or are not suitable for you . your doctor will discuss with you the benefits and risks of having your platelet count reduced . if
do not use nplate - if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . you may also be allergic to other medicines that are produced by recombinant dna technology called escherichia coli ( e . coli ). warnings and precautions before you are given the medicine , you should be aware of the following : - you have a low blood platelet count ( thrombocytopenia ). you should not be given n plate if the number of blood clots is too low . your doctor may want to monitor you more closely , especially if it is high in the long term . talk to your doctor , pharmacist or nurse before taking this medicine if : you have blood 
always use nplate exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . adults and adolescents ( aged 1 to 17 years ) your doctor will tell you how many doses you should take each day . your doctor may decide to give you an injection under the skin ( subcutaneous ). the usual dose is 1 mg / kg of body weight given once a week . how to use use the instructions for use are given at the end of this leaflet . do not shake , dissolve or chew the tablets before you use them . use in children and adolescents do not give this product to children under the age of 1 year . if your doctor decides that you should give n plate , you will need to take regular blood samples to check your platelet counts . this is to check that the number of platelets in your blood is sufficient . in this case
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : itp common ( may affect up to 1 in 10 people ) - headache - allergic reaction - upper respiratory tract infection - common in the respiratory tract - uncommon in the ms community - increased bone marrow fibres - trouble sleeping ( insomnia ) 7 - dizziness - tingling or numbness of the hands or feet ( paraesthesia , migraine ) uncommon in children and adolescents side effects reported with nplate are listed below . if any of these side effects causes you problems , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions . nplate may be stored for up to 30 days at room temperature ( 20 ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nplate contains - the active substance is romiplostim . one ml of solution for injection contains a total of 230 micrograms ( 0 . 25 milligrams ) ( corresponding to a concentration of 125 mg ). - each vial provides a single dose providing a sufficient amount to provide adequate protection . - if you are injecting more than one vial , you will receive an additional dose , which will be given to you by your doctor or nurse . the total amount you receive is a clear , colourless solution . it is available in two strengths , namely : n plate 250 mg / 375 mg ( 8 . 5 g ) or 250 mg ( 9 . 6 gbq ), respectively , for the first injection , and the second one in the second injection .
this medicine contains an active substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what tovanor breezhaler is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties caused by a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten , making it difficult for air to get in and out of the lungs . by doing so , this medicine blocks the tightening of these muscles in your lungs and so reduces the amount of air you breathe in through them . you should use this medicine every day and always in the same way , until you have improved your condition . it will help to reduce the effects of copd on your everyday life .
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using totovanor beech wood - chipped tablets . this medicine should not be used in patients with kidney problems . - patients with an eye problem called narrow - angle glaucoma , who have difficulty passing urine . your doctor will check whether the medicine is working and if it does not , how often you use it . patients who do not have access to the medicine should contact their doctor immediately if : - you experience tightness of the chest , coughing , wheezing or breathlessness immediately following inhalation of to vanor brewing , as this medicine may cause bronchospasm
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much tovanor breezhaler to use the usual dose is to inhale the content of one capsule each day . this will usually be given to you within 24 hours of your last dose . do not use more than your doctor tells you to use . your doctor will tell you how many capsules to use and how long you should keep using it . the recommended dose is 75 puffs inhalation twice a day ( morning and evening ). this medicine is inhaled through the foil foil . in this pack , you will find an inhaler and capsules ( in blisters ). the medicine is a concentrate , so it will be clear and colourless . if this is the case , the capsules should remain in the blister until you need to use
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece of the inhaler ) of 44 micrograms ( corresponding to 50 microgram per capsule ). the other ingredients ( excipients ) that are used to inhale the content of the capsules are : lactose monohydrate and magnesium stearate ( see section 2 ). solvent : water for injections , water for inhaling powder , and a white powder in a clear glass vial . the vial contains a device called an inhaled dose , together with capsules in blisters supplied in blister strips , each blister strip containing 6 or 10 capsules . please note that the following pack sizes are not all pack sizes may be marketed : single
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it works by blocking receptors in the brain to which dopamine and serotonin belong . these receptors have a number of beneficial and relieving aggressive behaviour and acute symptoms ( mild - to - moderate agitation ) have been observed in patients with schizophrenia and bipolar disorder , diseases characterised by symptoms such as schizophrenia ( hearing , seeing or sensing things which are not there ), mistaken beliefs , incoherent speech and behaviour and emotional flatness . people with this condition may also feel depressed , guilty , anxious , tense , and are more likely to notice these effects if they do not work as well as they should . the active ingredient in this medicine can help you to remember what you have been taking . in bipolar
do not take adasuve : - if you are allergic to loxapine or amoxapene . symptoms include wheezing and shortness of breath . these may be signs of lung problems like asthma or chronic obstructive pulmonary disease ( copd ). this can cause narrowing of the airways ( bronchospasm ). these can cause wheeze , cough , chest tightness , and long - duration of breath 25 . this can be a sign of neuroleptic malignant syndrome ( nms ). it is a condition in which patients develop symptoms associated with the use of antipsychotic medicines to treat these symptoms . high fever associated with rigid muscles and tightness of the muscles leading to muscle spasm . if any of these apply to you , tell your doctor or pharmacist before taking your medicine .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 9 . 1 mg for every kg you weigh . your doctor may increase your dose to 2 4 . 5 mg , depending on your condition . wash your hand before you go to bed . do not put adasuve in your mouth . if the device is not working properly , you may experience one or more of the following symptoms : extreme tiredness , sleepiness , trouble breathing , low blood pressure , throat irritation , a bad taste in the mouth , muscle or eye movements that do not go away . contact your doctor , pharmacist , or nurse if they notice any of the above . take the tablet immediately , and then take the next tablet at the usual time . it is very important that you continue to take 
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor or nurse straight away if you notice any breathing symptoms ( e . g . wheezing , cough , shortness of breath , chest tightness or irritating ) while you are taking adasuve . these may be signs of a problem with your airways such as asthma or copd . light - headedness or fainting may occur as a result of your blood pressure getting worse . worsening agitation , confusion , fever , muscle stiffness , as this may be a sign for a severe condition called " neuroleptic malignant syndrome ". other side effects include : very common ( may affect more than 1 in 10 people ): tremor , numbness or tingling in the hands or feet ,
keep out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep an open or torn pouch in order to protect from light . accidental ingestion can cause physical damage .
what adasuve contains - the active substance is loxapine . each single - dose inhaler delivers 5 micrograms ( 0 . 5 milligrams ) of loxalpine to deliver delivered doses of 4 . 4 mg / ml . this dose delivers approximately the same dose as for other medicines of the same class or as described in the section at the end of this leaflet . if you are not sure , talk to your doctor , pharmacist or nurse about where you should go to get the dose you need to use , or why you should stay in bed while you are on a bed or at night while on treatment , at the same time of the day , preferably in the morning and evening ; if necessary , you may need to go to bed early in the day to make sure that you do not inhale lox
the active substance in azacitidine betapharm is an anti - cancer agent . it belongs to a group of medicines called ' epidermal growth factor receptors ' ( egfr ). one of the active substances in this medicine is called zoster - 2b . zyp3a1 is made up of two active substances , one of which is linked to another protein in the blood called cytokines , and the other to form a protein called " cyp2 ". the other ingredient in this list is known as " leucocytes " ( a substance produced naturally in the body by the kidneys of patients with a high - risk myelodysplastic syndromes ( mds ). it is used in adults and children with certain other conditions that are known as : - acute myeloid leukaemia
you must not be given azacitidine betapharm : - if your doctor or nurse has told you that you have advanced liver cancer . if you are breast - feeding . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you are at risk of decreased counts of platelets , red or white blood cells . you have kidney disease or liver disease you have ever had a heart condition or heart attack you have lung disease you are due to have blood test . your doctor will do blood tests before you start treatment . before and during treatment , you will be asked to drink plenty of fluids to get the desired levels and then have treatment called a ' cycle '. this is to check that you do not have enough blood cells and that your liver and kidneys are working properly . when you start to get a new one ,
before giving you azacitidine betapharm , your doctor may give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor will decide your dose of this medicine , depending on your general condition , height and weight . you will be given one tablet each day , preferably in the morning and one tablet every day for the rest of the 3 weeks of this " treatment cycle ", which will be repeated every 4 weeks , for up to 6 weeks . this medicine will normally be given to you as an injection under the skin ( subcutaneously ) by a doctor or nurse . it may be given under your skin on your thigh , the tummy or upper arm . if you have any further questions on the use of this product , ask your doctor or pharmacist .
like all medicines , this medicine can cause side effects , although not everybody gets them . the most common side effects are drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting and reduced appetite . confusion , restlessness , fatigue and symptoms generally go away within a few days . not known : frequency cannot be estimated from the available data . if any of these occur , tell your doctor immediately . your doctor may decide to temporarily or permanently stop taking azacitidine betapharm and contact a doctor . warnings and precautions talk to your doctor or pharmacist before taking this medicine if you experience any of the following side effects
your doctor , pharmacist or nurse knows how to store azacitidine betapharm properly . keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and the carton after exp . this medicine does not require any special temperature storage conditions . after preparation of the suspension , use within 45 minutes . if necessary , your doctor or nurse will prepare and inject the suspension after it has been dissolved in water for injections . once the suspension has been prepared , it should be stored in a refrigerator ( 2 8 ) for up to 8 hours . you should record the date that the suspension was prepared and stored in the refrigerator as well as the number of vials in the freezer at room temperature ( 20 25 ). if the suspension is prepared by a healthcare professional , they will store it below 25 and use it within
what azacitidine betapharm contains - the active substance in each vial of powder for solution for injection consists of 100 units d . - one vial contains 0 . 5 mg / ml of azacriidine . after reconstitution with 4 mL of water for injections , the reconstituted suspension contains 25 mg dpr ' s dose , corresponding to a concentration of 25 mg per vial . the other ingredient is : a . anhydrous , colourless liquid ( s )) - alanine aminotransferase ( e421 ). adsorbent ( sorbent ) is a white to off - white powder for suspension for injection ( dispensed ) supplied in a glass vial ( containing 100 mg z ) aza
the active substance in cerdelga is eliglustat . it is used for the long term treatment of gaucher disease type 1 in adults , adolescents and children ( 12 years of age and older ) a condition in which your body does not produce enough glucosylceramide to support your body ' s immune system . this happens by blocking the activity of the spleen , liver and bones , allowing the body to produce its own protection ( s ) against g - ldl ( a chemical ) in these affected organs . if this medicine is not properly used , it may not work as well as it should . your doctor will tell you how long you should continue to use this medicine . you may need to take the tablets at regular intervals to prevent slow speed and poor metabolisers from becoming too high or too low .
do not take cerdelga if : you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). you are taking medicines known as moderate cyp2d6 inhibitors ( e . g . quinidine , terbinafine ) 31 you have been taking moderate cyst3a inhibitors such as erythromycin , itraconazole . these medicines reduce your body ' s ability to do normal daily activities , and may increase the amount of these medicines you take . your doctor may need to adjust your dose . warnings and precautions talk to your doctor , pharmacist , or nurse before you are given this medicine if you : have a poor metaboliser than usual . have ever had a problem with medicines that have been shown to increase your level of active substance c
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how much cerdelga to take and how often to take it . the usual dose is one tablet a day . metaboliser : - take the tablet at the same time each day ( 84 hours apart ). - swallow the tablet whole with a glass of water , preferably at least one hour before or two hours after a meal . do not take more tablets than your doctor tells you to . how much to take adults , adolescents and children weighing at least 18 years of age and older : one tablet is for oral use . two tablets in the blister / wallet are available . take the sleeve with your thumb and finger . press the tablet against the tablet to release the tablet . push the tablet
like all medicines , this medicine can cause side effects , although not everybody gets them . common : may affect up to 1 in 10 people headache , dizziness , change in taste ( dysgeusia ), palpitations , throat irritation , heartburn ( dyspepsias ), feeling sick ( nausea ), diarrhoea constipation , abdominal pain , stomach ache ( upper abdomen pain ), acid reflux disease ( gastrooesophageal reflux disease ), bloating ( abdominal distension ), inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( diarrhea ) indigestion ( heartburn ) not known ( frequency cannot be estimated from the available data ) low blood sugar ( hypoglycaemia ) increase in liver enzymes ( seen in blood tests ) high levels of uric acid in the blood
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and sleeve after exp . cerdelga is for single use only . store in a refrigerator ( 2 - 8 ). do not freeze . keep the blister in the outer carton in order to protect from light .
what cerdelga contains - the active substance is eliglustat . each hard capsule contains 84 mg / 0 . 5 ml solution for injection , corresponding to a concentration of 84 gbq at the date and time of calibration .  the other ingredients are microcrystalline cellulose ( e460 ) and lactose monohydrate ( see end of section 2 under ' important information about some of the ingredients of the hard capsules '), hypromellose ( 4 cps ), glycerol dibehenate ( type a ). - capsule shell : gelatin , potassium aluminium silicate , titanium dioxide , yellow iron oxide and indigotine . printing ink : shellac , black iron oxide , propylene glycol and ammonia solution . what
your doctor has prescribed zoledronic acid hospira because you or your child ' s doctor , pharmacist or nurse know how to use it properly . he or she is known as a person who belongs to a group of substances called bisphosphonates , and who are trained in the use of this type of medicine . by attaching itself to the bone , it slows down the rate of bone change . it is used : to prevent bone complications , e. g . fractures , in adult patients with bone metastases ( spread of cancer from primary site to bone ). to reduce the amount of calcium in the blood in adult males where it is too high due to the presence of a tumour . tumours can accelerate normal bone change in such a way that the release of calcium from bone is increased . this condition is called tumour - induced hypercalc
follow carefully all instructions given to you by your doctor . your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment at regular intervals . if you are breast - feeding . talk to your doctor or pharmacist before you are given this medicine . you may need to be monitored for a certain period of time before and while you are in hospital . before starting treatment , you will be checked by a doctor who is experienced in the care of patients who are able to swallow tablets , as well as for those whose bodies have been trained how to recognise , process and administer the tablets . tell your dentist if any of the following apply to you ( or you are not sure ), or the child you are caring for , for example , a dental problem . pain , swelling or numbness of the jaw ,
zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously , i . e . through a vein , (' iv ' administration ). your doctor will recommend that you drink enough water before each treatment to help prevent dehydration . carefully follow all the other instructions given to you by your doctor , pharmacist or nurse . you should not receive more than one infusion ( 4 ml ) every other week . this is because you may not have a kidney problem . depending on the severity of your kidney problem your doctor may prescribe a lower dose for you . how often will i have to be given if you are being treated for a medical condition , it is important to keep your doctor informed of the treatment you are having . infusion - related bone complications ( bone metastases )
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common ones are usually mild and will probably disappear after a short time . tell your doctor about any of the following serious side effects straight away : common ( may affect up to 1 in 10 people ): - severe kidney impairment ( will normally be determined by your doctor with certain specific blood tests ). - low level of calcium in the blood . uncommon : may affect less than 1 in 100 people - pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth or jaw discharge - numbness or a feeling of heaviness or loosening of a tooth . these could be signs of bone damage in the jaw ( osteonecrosis ). tell your dentist immediately if you experience
you will not have to store zoledronic acid hospira . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of the product will be in accordance with national regulation on acid .
what zoledronic acid hospira contains - the active substance in each ml of concentrate for solution for injection or infusion is a sterile concentrate . each pack contains a single - use glass vial with a clear , colourless , pre - filled syringe . it is available in packs containing four vials of concentrate , each containing one vial . - not all pack sizes may be marketed .
varuby contains the active substance rolapitant . it is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ) when having cancer treatment chemotherapy ( chemotherapy destroys nerve cells that communicate with the brain ). this reduces the amount of food that people eat , and makes them less able to stay asleep . when this happens , people get sick ( being sick ) more easily than they should . rolulapitant stops these nerve cells from working properly and helps to prevent nausea and vomiting .
do not take varuby : if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you are taking an herbal medicine ( containing st john ' s wort ( hypericum performatum ) used for depression or difficulty sleeping ( see section 2 " how to take this medicine "). warnings and precautions 27 talk to your doctor , pharmacist , or nurse before you are given this medicine if : 27 you have severe liver or kidney problems you take certain medicines , such as rifampicin ( used to treat tuberculosis and other infections ) or carbamazepine ( used for treating epilepsy and for treating nerve pain ) phenobarbital ( used in children and adolescents ) you have been told by your doctor that you have epi
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much varuby to take the recommended dose is one 180 mg tablet once a day . you can take it with or without food . the dose may be adjusted by your doctor by up to 90 mg depending on how you respond to the medicine . swallow the tablet whole with a glass of water . do not crush or chew the tablet . it is best to take it at least 2 hours before or 2 hours after your chemotherapy cycle . when you are having chemotherapy , it is important that you keep having chemotherapy to reduce the risk of sickness . to help prevent sickness , you should keep using this medicine during chemotherapy and after another chemotherapy cycle because you may be feeling sick or being sick during chemotherapy . your doctor will tell you how long you should continue with this medicine for as long as you need to .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : rare side effects ( may affect up to 1 in 1 , 000 people ) if you get symptoms of an allergic reaction such as sudden shortness of breath , swelling of the lips or tongue , change in taste or swelling of skin or tissue , sudden rash , fever and faster heartbeats contact your doctor immediately . your doctor will decide if and when appropriate treatment may be needed . other possible side effects are listed below . very common : may affect more than 1 in 10 people headache , constipation , feeling tired . common reported side effects of varuby are : dizziness , diarrhoea , nausea , vomiting , indigestion , flatulence ( wind ), muscle spasms 
what varuby contains - the active substance is rolapitant . each tablet contains 90 milligrams / 0 . 5 millilitre ( ml ) roilinguin ( s )- the other ingredients are : - tablet core : lactose monohydrate ( see end of section 2 for further information about some of these ingredients ), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , and magnesium stearate . - film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , polysorbate 80 . not all pack sizes may be marketed . the contents of the pack are blue , capsule - shaped and printed with " 
what enerzair breezhaler contains the active substances are : - indacaterol - glycopyrronium - mometasone furoate indabacaterol and , in later versions of the tablet are bronchodilators . they work in different ways to relax the muscles of the small airways in the lungs . this helps to open the airways and makes it easier for air to get in and out . when the tablet is inhaled , it helps the smaller airways to remain open . that means that the tablet can be breathed in more air - filled , helping to open more air and make it easier to breathe in . as well as that , corticosteroids ( also known as steroids ) can help to close the gap between the two active substances , and reduce the swelling and irritation ( inflammation ) in the
do not use enerzair breezhaler - if you are allergic to indacaterol , glycopyrronium , mometasone furoate , or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without taking the full dose . if your doctor thinks you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before using the product if : you have heart problems , including an irregular or fast heartbeat you have thyroid gland problems you have diabetes you have high blood sugar or you have ever had seizures you have severe kidney problems you suffer from severe liver problems . you have a low level of potassium in your blood you have an eye problem called angle - closure glaucoma you have difficulty passing urine you have tub
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much enerzair breezhaler to use the usual dose is to inhale the content of one capsule each day . it does not matter at what time of the day you use the medicine . your doctor will tell you how many capsules to use . the dose that you use will depend on your asthma and the severity of your symptoms . you should not use more than your doctor tells you to use and for how long you need to use it . use the inhaler on a regular basis . this will help to keep you on the right path to health . for inhalation use this leaflet , you can use the capsules any time before or after the dose has been taken . do not swallow them whole . only use one capsule at a time 
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious stop using enerzair breezhaler and get medical help immediately if you have any of the following : common ( may affect up to 1 in 10 people ) difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives ( signs of allergic reaction ). other side effects other possible side effects include the following listed below . very common : may affect more than 1 in every 10 people sore throat or runny nose , sudden difficulty breathing and feeling of tightness in the chest , feeling of restlessness or a general feeling of being unwell . not known : frequency cannot be estimated from the available data . if any of these side effects causes you problems , talk to your doctor or pharmacist 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicinal product does not require any special temperature storage conditions . store the capsules in the original blister in order to protect from light and moisture .
what enerzair breezhaler contains - the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ) and mometasone furoate . each delivered dose ( the dose that leaves the mouthpiece of the inhaler ) contains 150 micrograms ( 0 . 5 milligrams ) of indocaterol( as ace ), 63 microgram ( iu )) of galactomyelitis ( see section 2 ). - each single inhalation provides a total of 50 microgram( 1 . 0 millilitre ) ( corresponding to a combined total of 132 . 3 milliliter ( ml )). the other ingredient ( excipient ( sublingual ) is glycopyronum ( a )bromide
the active ingredient clopidogrel belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process known as thrombosis ). if you have not been properly trained , you can help your child ' s doctor decide whether to continue with your normal diet , and take it at the same time each day . you can also donate blood ( thrombi ) to charity work by helping protect the hardened blood vessels ( arteries ), which can be severely damaged , resulting in atherothrombosesis . this is the most commonly used treatment for all age groups , with at
do not take clopidogrel acino pharma gmbh - if you are allergic ( hypersensitive ) to the active substance or any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before and whilst taking the medicine if : you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . you suffer from severe liver disease . your doctor may want to monitor you more closely while you are being treated . if any of these apply to you , or you are not sure , please contact your doctor before you take this medicine . children and adolescents do not give this medicine to children under the age of 18 years because there is insufficient experience in this age group . the safety and efficacy have not been established . other medicines and clo
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg film - coated tablet per day to be taken orally with or without food , and at the same time each day . swallow the tablet whole , with some water or other non - alcoholic drink . do not chew the tablet , as it may be hard to swallow it whole . it may take up to six weeks before you can swallow it , but you may find it easier to take it with a meal , or you can take it at any time of the day , unless your doctor tells you to go to the hospital emergency department because of the increased risk of bleeding . keep the tablet bottle with you so that you can easily describe what you have taken . if
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the most common ones are usually mild and will probably disappear after a short time . contact your doctor immediately if you experience any of the following serious side effects ( very common : affects more than 1 user in 10 ): common ( affects 1 to 10 users in 100 ) uncommon : may affect up to 1 to10 users in 1 , 000 rare : very rare ( affect less than 1 patient in 10 000 ) not known : frequency cannot be estimated from the available data . very rarely , patients will be monitored for signs of infection and extreme tiredness . these may be signs of rare decrease of some blood cells , which may be associated with liver problems , such as yellowing of the skin and whites of the eyes ( jaundice 
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton , blister or film - coated tablets . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what clopidogrel acino pharma gmbh contains - the active substance in each tablet is 75 mg , of which at least one millilitre ( 0 . 5 ml ) contains . -- the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil , hydrogenated film - coating ( photo printing ink : shellac ; poly ( vinyl alcohol )). tablet coating ( oblong , biconvex ), 14 , 28 , 30 , 50 , 84 , 90 and 100 tablets are available . not all pack sizes may be marketed .
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection in adults . it belongs to a group of medicines called ' antiretroviral medicines '. it is a combination of two active substances : doravirine , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), lamivudine , and a nuclear medicine (' nuclear medicine '). both of these active substances are used in combination with tenofovir disoproxil , another type of medicine known as a neurosis factor a (' nulst - 1 - tih - 2 - inhibitor ', or ' long qtci '), all three of which have been shown to increase the levels of a protein called a
do not take delstrigo if : you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine listed in section 6 . you are taking one or more of the following medicines : carbamazepine ( e1200 ), oxcarbazepine, phenobarbital and phenytoin ( medicines to prevent seizure ) rifampicin etanyapentine ( medicines for tuberculosis ). st . john ' s wort ( hypericum perforatum ) ( a herbal remedy used for depression and anxiety ) or products that contain mitotindopa . your doctor may want to monitor you more closely . pregnancy and breast -
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much delstrigo to take the recommended dose is a complete regimen . a single tablet should be taken to treat hiv infection in adults , adolescents and children aged 1 year and above who are taking certain medicines ( such as doravirine , which belongs to a group of medicines that affect your immune system ). taking this medicine swallow the tablet whole with water . do not crush or chew the tablet . this medicine can be taken with or without food . take the tablet at the same time each day . your doctor will tell you how long you need to take it . it is important that you follow your doctor ' s instructions about when to take your tablets and how often to take them . you should not take more tablets than your doctor tells you to . del
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and tell your doctor straight away if you notice any of the following : common ( may affect up to 1 in 10 people ) abnormal dreams , difficulty in sleeping ( insomnia ), headache , dizziness , sleepiness , cough , nasal symptoms feeling sick ( nausea ), diarrhoea , stomach pain , vomiting , wind ( flatulence ), hair loss , rash muscle symptoms ( pain or stiffness ) feeling tired ( somnolence ) not known ( frequency cannot be estimated from the available data ) allergic reactions ( e . g . swelling of the face , lips , mouth , tongue or throat ) rash joint pain ( arthralgia ) unusual dreams ( tinnitus ) difficulty
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . this medicine does not require any special temperature storage conditions . keep the bottle tightly closed in order to protect from moisture . delstrigo is for single use only . once the bottle has been opened , the contents should be used immediately .
what delstrigo contains - each tablet contains 100 mg doravirine , 300 mg lamivudine , 245 mg tenofovir disoproxil ( as fumarate ) - the other ingredients are : tablet core : croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate ( e470b ), microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl fum arate in the core of the film - coating material : carnauba wax e903 . printing ink : shellac , iron oxide yellow , lactose monohydrate , titanium dioxide e171 , triacetin . - pack size : 776 film 
spravato contains the active substance esketamine . this belongs to a group of medicines called anti - depressants . you have been given this medicine to treat your depression . it is used to treat the symptoms of depression , which include feeling sad , anxious or worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities , feeling of being slowed down , and more often when you are taking another antidepressant . see section 2 , " what you need to know before and during treatment ." it is important that you also read the package leaflet for all of the medicines that you will be taking .
do not take spravato : - if you are allergic to esketamine ( the active substance in ketamine ) or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions an aneurysm ( a weak spot on a blood vessel wall that bulges out ). if bleeding in the brain has recently had a heart attack within 6 weeks . a temporary increase in blood pressure may be necessary . this may increase the risk of serious complications in these conditions . talk to your doctor or pharmacist before taking this medicine if : you are at risk of having another heart problem , such as poor blood flow to the blood vessels , or you have a blocked or narrowed vein . your doctor may want to monitor you closely . children and adolescents do not give this medicine to children or adolescents under 18 years of age because of
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the spravato nasal spray should be sprayed with the nasal spray device . the recommended dose is 1 spray in the morning , 2 sprays in the evening and 3 nasal spray devices at the same time . you can use one nasal spray applicator 4 times a day for 4 days . do not use more than your doctor tells you to use . your doctor will tell you how many sprays to use and when to use it . use in children and adolescents do not give this medicine to children under 2 years of age because it has not been studied in this age group . this medicine can cause nausea and vomiting ( see section 2 of this leaflet ). if this happens , treatment should continue for at least 30 minutes after using this medicine . nasal sprays
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : very common ( may affect more than 1 in 10 people ) feeling disconnected from feelings and things around you feeling dizzy headache change in sense of taste feeling sleepy decreased feeling or sensitivity in your mouth area spinning sensation vertigo vomiting nausea common : may affect up to 1 in every 10 people feeling extremely happy , euphoria , feeling agitated , not feeling irritable , lack of energy , being less alert or having difficulty concentrating , changes in taste , dizziness , sleepiness , increased appetite , weight loss , low blood sugar , high blood sugar ( sugar ) in your blood increase in liver enzymes ( seen in blood tests ) increased blood levels of uric acid and creatine phosphokinase
what spravato contains - the active substance is esketamine . each nasal spray device delivers a single dose ( 0 . 5 ml of solution ). - each vial contains esesketamine hydrochloride , resulting in a concentration of 28 mg egesketamine ( as mesilate ). the other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections ( see end of section 2 for more information about some of the ingredients of this medicine ). this medicine is supplied as a clear , colourless solution for injection or solution for inhalation . the solution is clear and colourless . it is available in packs containing 1 , 2 , 3 or 6 nasal spray devices , and in multipacks comprising 5 cartons , each nasal
zelboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat adult patients with melanoma that has spread to other parts of the body or cannot be removed by surgery if you have cancer that has a change ( mutation ) in a gene called ' melanoma ' ( mrc - mc ) gene that has been altered by a protein in the human immunoglobulin receptor ( rdna ). it targets proteins that are involved in the growth of your cancer and slows down the rate at which you respond to the treatment .
do not take zelboraf - if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash , and fainting sensation when you stand up . warnings and precautions talk to your doctor , pharmacist or nurse before and during your treatment with zeloraf ( see section 4 ). allergic reactions are rare . if allergic reactions occur , you should stop the injection immediately and contact a doctor or go to a hospital straight away . allergic reactions can occur with the use of the product if any symptoms of an allergic reaction are severe . this may include , but are not limited to : - swelling ofthe face, lips and tongue ; - difficulty breathing or rash and / or fainting
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one 4 mg tablet once a day for the first 8 days . the dose may be increased or decreased depending on the severity or severity of side effects . your doctor may decide to temporarily stop your treatment with zelboraf , if necessary , to reduce the risk of vomiting . swallow the tablet whole with a glass of water . do not chew , crush or split the tablet before swallowing as it may affect the way the tablet is absorbed into the stomach . take the tablet at about the same time each day . this will help you to remember to take it . if possible , take your tablet with food as soon as you can , and then take your next meal at the usual time . it is important that you continue to take
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions may occur . these may include swelling of the face , lips or tongue , difficulty breathing rash fainting sensation when you stand up for a sitting or lying down position . you should not sit or lie down until you feel better . warnings and precautions talk to your doctor , pharmacist or nurse before or while you are being treated with zeloraf . radiation treatment can be life - threatening . some side effects can be caused by exposure to radiation , but it is not known how many of them are . if you are going to be treated , your doctor will discuss with you the possible risks and benefits of zelbaf treatment . in some cases , radiation may be absorbed by the skin , isophagus , bladder , liver ,
keep out of the sight and reach of children . do not use zelboraf after the expiry date which is stated on the carton and the blister after exp . this medicine does not require any special storage conditions . if you have any unwanted tablets , do not throw them away . ask your pharmacist how to throw away tablets you no longer use . these measures will help to protect the environment .
what zelboraf contains - the active substance is vemurafenib . each film - coated tablet contains 240 mg / 0 . 5 milligrams of vfd , - as a co - precipitate of vemorafeniab ( see also section 2 ).  the other ingredients are : tablet core : hypromellose acetate succinate , colloidal anhydrous silica ( e551 ), croscarmellose sodium ; hydroxypropyl cellulose , magnesium stearate film coating : iron oxide red and black ink : shellac , macrogol 3350 , polyvinyl alcohol - part hydrolysed ( ph - ii )), talc and titanium dioxide , all in the tablet coating 
duoplavin contains two active substances : clopidogrel and acetylsalicylic acid ( asa ) which belong to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , it prevents the blood vessels from forming . when used in combination with antiplatelets medicines , these can reduce the chances of blood  clots forming ( so - called atherothrombosis ) and lead to an increased risk of bleeding in hardened arteries . this can increase the risk of atherathrombotic events ( such as stroke , heart attack , or death ). you should keep in regular contact with your doctor and make sure that your doctor knows exactly what you have been taking . duo
do not take duoplavin : - if you are allergic to clopidogrel , acetylsalicylic acid ( asa ) or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor , pharmacist , or nurse before you are given this medicine . children and adolescents do not give this medicine to children less than 6 years of age because it is not known how well it works in this age group . other products should not be given to children under the age of 18 years because it may have an increased risk of painful and / or inflammatory conditions of muscles or joints . a medical condition such as asthma , nasal discharge , runny nose , polyps ( a type of growth ) in the back of the nose .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of duoplavin is one tablet a day . it does not matter at what time of the day you take your medicine . you should swallow the tablet whole , with some water or other non - alcoholic drink . the tablet can be taken with or without food . take the tablet at the same time each day , for example , one tablet in the morning and one in the evening . when you are having a heart attack , take your tablet with you and talk to your doctor , pharmacist , or your nearest hospital emergency department because of the increased risk of bleeding . keep your tablet bottle with you so that you can easily describe what you have taken . if your tablet does not work as well as it should , you should contact your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and the whites of the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters ofthe skin . this may be the signs of an allergic reaction . other side effects may include : very common ( may affect more than 1 in 10 people ): diarrhoea , vomiting , nausea , constipation , dizziness 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store below 25 . this medicine does not require any special temperature storage conditions . tell your pharmacist if you notice any visible sign of deterioration do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what duoplavin contains the active substance in each 75 mg film - coated tablet is a 75 mg tablet . the other ingredients are : 46 tablet core : clopidogrel and acetylsalicylic acid ( asa ): one tablet contains 75 mg / 0 . 5 ml ( corresponding to 74 mg ) in a sachet - pattern . tablet coating : co - propagated cellulose ( e460 ), hydrogen sulphate , and - excipients in the other half of the tablet ( containing 98 mg ). in the end of the day , the tablet will be swallowed with a little water - like liquid . this will be followed by a 7 - day rest period called ' opportunistic '. the remaining 75 -
simbrinza contains two active substances , brinzolamide and brimonidine tartrate in one tablet : - the active substances are benzonzoate and bicarbonate ( a group of medicines known as carbonic anhydrase inhibitors ). - it is followed by the combination of brinzolidine and alpha - 2 adrenergic receptor agonists , which reduce pressure within the eye and so reduce the amount of fluid that is pumped around the eyes . this helps to lower pressure in the eyes in adult patients ( aged 18 years and older ) to treat eye conditions known as glaucoma and ocular hypertension ( high pressure in both eyes ) in adults .
do not take simbrinza - if you are allergic to brinzolamide , brimonidine tartrate , or any of the other ingredients of this medicine ( listed in section 6 ) or if your doctor thinks you may be allergic to sulphonamides , medicines used to treat diabetes or infections ( diuretics ( water tablets )) or to a monoamine oxidase ( mao ) inhibitors ( medicines used for depression or parkinson ' s disease or certain antidepressants ). if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before you are given this medicine : if : you have severe kidney problems . you have too much acidity in your blood ( hyperchloraemic acidosis ). you drink large amounts of alcohol ( more than 2 glasses
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one drop in the eyes , once a day in the morning and once in the evening . do not use simbrinza in both eyes . wash your hands thoroughly with soap and water ( see section 1 and section 2 " instructions for use "). remove the bottle cap and snap collar before using the medicine . hold the bottle tightly closed in order to protect from light . touch the bottle with your fingers . pull down the bottle , pointing down , between your thumb and fingers , towards the ceiling . tilt your head back and pull down your lower eyelid with a clean finger until there is a ' pocket ' between the eyelid and your eye . if this happens , the drop will go in here ( picture 1 ) and picture 2 .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine . if you have a reaction to the medicine ( frequency not known , cannot be estimated from the available data ), you may need to stop taking the medicine and see a doctor immediately . an allergic reaction may occur . severe skin reactions ( rash , redness and itching all over your body or eyes trouble breathing , chest pain or irregular heart beat tell your doctor immediately extreme tiredness and dizziness . side effects reported with simbrinza may occur with other medicines that may be used to treat brine , brine and / or brine together . they may include : very common side effects ( may affect more than 1 in 10 people ) diarrhoea , vomiting , nausea , constipation , indigestion 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . store in a refrigerator ( 2 8 ). do not freeze . after opening the bottle , use simbrinza within 4 weeks to prevent infections and use a new bottle . keep the bottle tightly closed in order to protect from light and moisture . this medicinal product does not require any special temperature storage conditions . tell your pharmacist if you notice any change in the appearance of the medicine or if it does not look like water . you should throw away this medicine via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . - one ml of suspension contains 10 mg / 0 . 5 mg of brinzolate and 2 mg/ 1 . 3 mg , corresponding to approximately 900 mg of brimoniidine . the other ingredients are benzalkonium chloride ( see section 2 under ' important information about some of these substances '). - if you are not sure , talk to your doctor , pharmacist or nurse before you start to make sure that you are fully hydrated and that the contents of the pack are clear , colourless and aqueous . one pack contains one glass vial , with a desiccant to reduce moisture in the vial and in the syringe ( s ). the other ingredient ( excipients ) are 
what filgrastim ratiopharm is and why it is important to keep this medicine out of the sight and reach of children , preferably in a locked cupboard . your doctor will tell you how many white cells you can get . white cells are important as they help your body fight infection . you may want to keep a record of what you have been given and when you should return them to your regular dosing schedule . it helps to keep the number of white cells in your body up to a standard level . when you are given filgrasestim ratioopharm , you will need to take it as soon as possible after chemotherapy and after bone marrow transplantation in patients with severe chronic neutropenia ( a disease where the body cannot produce enough white cells ).
do not use filgrastim ratiopharm - if you are allergic ( hypersensitive ) to the active substance or any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before or while you are using filgrastort . if any of these apply to you , tell your doctor or nurse straight away . you may need to take longer to get to your next scheduled appointment . there is a small chance that you may get a cough , fever and difficulty breathing . this could be a pulmonary disorder . your doctor may want to monitor you more closely . the following side effects may occur : sickle cell disease 57 get left upper abdominal pain or pain at the tip of your shoulder ( spleen disorder ). you should see your doctor regularly for side effects . it is important to have regular blood tests while
always use filgrastim ratiopharm exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . your doctor will tell you exactly how many tablets you need to take . do not use more than the recommended dose and take the tablets at the same time each day . it is very important that you do not break or chew the tablets before you take them . keep in touch with your family and friends to make sure that you don ' t miss a dose of filgrasestim ratioopharm . how long will you be treated your doctor may tell you how long you will need to be treated . when you first start treatment , your dose will be gradually increased to 0 . 5 million units / kg . adults who weigh 60 to 30 kg your treatment will usually last for 14 days . in some disease types , however , longer treatment lasting up to 14
follow all instructions given to you by your doctor , pharmacist or nurse carefully , even if they are different from what is in this leaflet . sickle cell disease 57 tell your doctor or pharmacist straight away if you get left upper abdominal pain or pain at the tip of your shoulder . this may be a sign of a spleen disorder ( see section 4 . possible side effects ). your doctor will do regular blood tests while you are taking filgrastim ratiopharm to check the number of neutrophils ( a type of white blood cells ) in your blood . your doctor may decide to reduce the dose , interrupt , or completely stop treatment . children and adolescents this medicine is not recommended for use in children or adolescents under 18 years of age because it has not been studied in this age group . other medicines or substances please tell your child ' s doctor or other health care professional if
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the blister in the outer carton in order to protect from light . from a microbiological point of view the product should not be used if the solution is cloudy or if it contains visible particles . warnings and precautions before use tell your pharmacist , pharmacist or nurse if you are using , have recently used or might use any other medicines via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance in each millilitre of the concentrate for solution for infusion contains 60 million international units [ miu ] ( 600 microgram ) ( 300 micrograms ) of filGrastim in 0 . 5 ml solution . - each vial of 30 miu contains 30 milu / 30 milus dna ( corresponding to 1 , 5 g / kg ). - every other day , you may be asked to change the time of day that you use as well as your doctor has told you to . when you are a child , your doctor may prescribe you a lower dose , which may be more convenient for you if you are travelling to such a place where you have been , or you are not going to be able to stay in bed while you are being treated with filgra
what riluzole zentiva is and why it is important ? the active substance in this medicine is called rizole which works by attaching itself to the nervous system . it is used for the treatment of adults and children of all ages with amyotrophic lateral sclerosis ( motor neurone disease ). in motor neurones , the nerve cells responsible for sending instructions to the muscles may have too much glutamate ( a chemical messenger ) in the brain and spinal cord . if this applies to you , it may help to delay or stop the sending of nerve cells . this will help prevent you from receiving these instructions .
do not take riluzole zentiva - if you are allergic to rizole or to peanut or soya or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine if : you have any liver disease or you have increased blood levels of some enzymes of the liver ( transaminases ). you are pregnant or breast - feeding . you may be pregnant . if any of these apply to you , your doctor may want to monitor you more closely whilst you are being treated with the medicine and may decide to temporarily stop you from taking the tablet . your doctor will check you for signs of any liver problems . yellowing of your skin or the whites of your eyes ( jaundice ), itching all over , feeling sick , being sick 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one tablet a day . the tablets should be taken by mouth . swallow the tablet whole , with some water . do not chew , crush or break the tablet before swallowing . if more than 12 hours have passed since you took riluzole zentiva , you should contact your nearest hospital emergency department immediately for advice . keep the tablet bottle with you so that it is clear and colourless to see if it has been taken and / or if there have been no reports of a double dose ( two tablets at the same time ) to make up for a forgotten tablet . you should not take more tablets than your doctor tells you to . contact your doctor , pharmacist , or nurse before you take your
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience any of the following : - fever ( increase in temperature ). riluzole zentiva may cause a decrease in the number of white blood cells . your doctor will take a blood sample to look for these changes . as a precaution , you may get a greater risk of infections . you may also get the following symptoms : yellowing of your skin and the whites of your eyes ( jaundice ), itching , feeling sick or being sick , as this may be a sign of liver disease ( hepatitis ). you will have to take regular blood tests while you are taking this medicine . cough , difficulties in breathing , and swallowing . this is linked to the way that this medicine works . other side effects
what riluzole zentiva contains the active substance in each tablet is 50 mg . the other ingredients are : tablet core : anhydrous dibasic calcium phosphate , micro crystalline cellulose ( e460 ), microhydrous colloidal silica , magnesium stearate , croscarmellose sodium . tablet coating : hypromellose , macrogol 6000 , titanium dioxide , carnauba wax , red ink : shellac , iron oxide red , white to off - white film - coated tablets debossed with " rpr " on one side and plain on the other side . it is important that you also read the package leaflet for more information on the contents of the tablet . 50 mg tablets are provided in plastic bottles with child - resistant caps . they are marked
emgality contains the active substance galcanezumab , a medicine that blocks the activity of the calcitonin gene associated with migraine ( cgrp ). it is used to treat migraine in adults who have at least 4 migraines per month and who also have migraines at some time during their lives . egality has been shown to reduce the frequency and severity of migraine headache in adults . it also helps to improve your quality of life .
do not use emgality if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). you have a serious cardiovascular disease . warnings and precautions talk to your doctor , pharmacist or nurse before using any of these medicines . there is a higher risk of serious cardiovascular diseases in patients with certain types of allergic reactions . some of these reactions may be serious and may be life - threatening . it is important to look out for signs of such signs and possible side effects in section 4 . children and adolescents do not give this medicine to children or adolescents under the age of 18 years because it has not been studied in this age group . other medicines and egality there is no information available on the use of other medicines in pregnancy and breast - feeding . if your child is pregnant , think you may be pregnant or are planning to have
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of emgality is one 240 mg subcutaneous injection once a week . your doctor will tell you how many ml to use . you can change the dose yourself , or your doctor may change your dose , depending on how well you respond to the injection . injecting your first dose at home is very important . it is important to follow your doctor ' s instructions about when to inject your first injection and for how long you need to inject it . do not inject yourself with more than one injection at the same time . after proper training , if your doctor instructs you to do so , the dose may need to be increased or decreased . if a dose is missed , inject your next dose at your regular time 
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality are rare . if you notice any of the following : rash or itching , serious allergic reactions are rare ( may affect up to 1 in 1 , 000 people ). signs include : difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , which may progress to a red rash with raised bumps . other side effects very common side effects these may affect more than 1 in 10 people : injection site reactions ( including pain , itching and redness ). these reactions usually resolve within a few hours . at the injection site , the following side effects have been reported 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . after dilution , if not used immediately , storage times and conditions before use are the responsibility of your doctor , pharmacist or nurse and would normally not be longer than 7 days at room temperature ( 20 - 25 ) for a single period of up to 30 days in which the product should be used or thrown away . this medicine should not be disposed of via wastewater or household waste . your healthcare professional will throw away medicines no longer used . these measures will help protect the environment .
what emgality contains - the active substance is galcanezumab . each pre - filled pen contains 120 mg of galcanab in 1 ml solution ( corresponding to a concentration of 1 iu / millilitre ).  the other ingredients ( excipients ) are l - histidine ( e331 ), l- himtidine hydrochloride monohydrate , polysorbate 80 , sodium chloride , and water for injections . what a medicine looks like and contents of the pack egality is presented as a solution for injection in a clear glass syringe . the solution is colourless to slightly yellow and clear to opalescent . one - dose pen is available in packs containing 1 , 2 or 3 single - do pen . not all pack sizes
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hvvd ), in which the body ' s immune system attacks the blood vessels of the liver and causes blood clots . before this happens , medicines prior to a stem cell transplantation must be taken out of the body to replace the damaged tissue that forms in the blood , helping to keep the blood lines open . this medicine is used in adults , adolescents and children over 18 years of age .
do not use defitelio if : you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ) you are taking other medicines to prevent blood clots you have received tissue plasminogen activator warnings and precautions ( this is a type of medicine used to treat bleeding ). if you have heavy bleeding that cannot be controlled with a blood transfusion you are going to have surgery you have problems with blood circulation you have a constant blood pressure less than 1 mmol / l ( 0 . 5 ml ) if any of these apply to you , tell your doctor or nurse immediately . your doctor may need to give you other medicines or be given other medicines which help to prevent or help to clotting such as acetylsalicylic acid , heparins , warfar
the treatment with defitelio will be started by a doctor who is experienced in stem cells transplantation . it will be given to you into one of your veins ( called an ' intravenous infusion ' or drip ). this treatment will take about 21 minutes . your doctor will decide how many treatments you need . if your symptoms return however , your doctor may lower your dose . use in children and adolescents children ( from 18 years of age onwards ) the doctor may decide to give you a lower dose or a nurse will help you to remember to take it . do not take a double dose to make up for a forgotten dose , if you have any further questions on the use of this medicine , ask your doctor or nurse .
like all medicines , defitelio can cause side effects , although not everybody gets them . some of these side effects may be serious and need medical attention . if any of these effects occur , they should be treated immediately . very common ( may affect more than 1 in 10 people ): low blood pressure ( very common , may affect up to 1 in10 people ). bleeding in general bleeding ( especially in the nose bleeding , the brain bleeding or the gut vomiting ). blood bleeding in the lungs bleeding ( including blood in the urine ), in the mouth bleeding and in the skin coagulopathy ( disturbance in blood clotting ) not known ( frequency cannot be estimated from the available data ). if you get any of the side effects above , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national
keep out of the sight and reach of children . store in a refrigerator ( 2 - 8 ). do not use defitelio if the infusion storage is damaged or the solution is cloudy . do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what defitelio contains - the active substance is defibrotide . each vial contains 2 . 5 ml of concentrate or 200 micrograms ( 8 . 6 mg , 20 mg / mL ). if you are not sure , talk to your doctor or pharmacist . - after dilution : a single - use vial of 80 microgram ( 0 . 25 mg ) concentrate for solution for injection or infusion : the other ingredients are : sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ) and water for injections . see section 2 for further information on the contents of the pack . not all pack sizes may be marketed . the concentrate is a clear to opalescent , colourless to pale yellow solution . one via
daklinza contains the active ingredient daclatasvir . it is used to treat adults with hepatitis c , an infectious disease that affects the liver , caused by his / her own body ' s own immune system . when you get this medicine , the immune system ( the body  s natural defence system ) will produce its own protection ( antibodies ), which will then be eliminated from your body by the virus . this means that it can be removed from your blood in a short time , and can be given back to you after you have finished your course of drugs . you may need to take other medicines to help control your condition . in some cases , it may be necessary to change the dose of the other medicines you are taking , or you may not be able to take them together . if you have any further questions on the use of dakli
do not take daklinza - if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) or to any other medicines taken by mouth or taken with the following medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital ( for epileptic seizures ) rifampicin ( for injection into the lungs , used for the treatment of epilepsy ) but are not recommended for use in children under 6 years of age because the safety and efficacy in this age group has not been established and therefore the use of st . john ' s wort ( for treatment of tuberculosis )) dexamethasone ( a steroid used for allergic and inflammatory diseases ) medicines that contain
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of daklinza is one 60 mg tablet once a day . do not chew , crush or split the tablet as it has a very unpleasant taste . you should swallow the tablet whole with a glass of water . it is best to take your tablet at the same time each day , but this will usually help you to remember to take it . your doctor may also tell you to take some other medicines whilst you are taking daknza . if this happens to you , tell your doctor , pharmacist or nurse . to benefit from these medicines , your doctor will tell you how much of these to take , and for how long you need to take them . when to start with the treatment - do not stop taking daclinza
like all medicines , this medicine can cause side effects , although not everybody gets them . when daklinza is given in combination with sofosbuvir and ribavirin , the following side effects have been reported : very common ( may affect more than 1 in 10 people ) headache ; fatigue common : may affect up to 1in 10 people difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain or joint pain aching or tender muscles have also been reported in patients treated with daknza , but not in patients who have been given both of these medicines alone . if you experience any of these , talk to your doctor or pharmacist as they may want to reduce the dose or stop the dose . they are usually mild to moderate and usually go away after a few weeks . in some cases , patients may experience more headache and fatigue .
what daklinza contains - the active substance is daclatasvir . each film - coated tablet contains 30 mg or 60 mg of duboise ( as dihydrochloride ). the other ingredients are : tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), macrogol 400 , indigo carmine aluminium lake , yellow iron oxide , sunset yellow fcf [ e110 ] [ hdpe [ nvr ][ sbcc ], 51 - dakobo tablet ]: one side of the tablet is debossed with " bms 30 " on one side .
proquad is a vaccine intended to be given to prevent measles , mumps , rubella and chickenpox ( varicella ) viruses . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will make antibodies that can help to protect the skin , hands , feet or other parts of the person being vaccinated . the proteins in the vaccine work together by helping the body to produce its own protection , which protect you or your child from becoming ill . as a result , these proteins can make diseases worse or cause them to become active again . these viruses are called communicative agent ( mcv ) and have been shown to produce antibodies against them . they play an important role in causing diseases that have caused these viruses to grow and reproduce themselves . by giving the vaccine to your child
do not use proquad : - if you are allergic to any varicella vaccine , to measles , mumps or rubella vaccine or any of the other ingredients of this vaccine ( listed in section 6 ) or to neomycin . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this vaccine if : you have a blood disorder ( a type of cancer that affects the immune system ) and you are receiving treatment with medications that weaken your immune system ( such as low - dose corticosteroid therapy , asthma or replacement therapy ). you have or have ever had a weakened immune system due to a disease ( including aids ), or you have congenital or hereditary immunodeficiency ( low level of immune competence ) you have active untreated tuberculosis ( aid
proquad will be given to you by your doctor or nurse . the vaccine will be injected into the muscle of the upper thigh or upper arm . it can only be given by a nurse or a doctor if the doctor has decided that it would be best for the injections to be given into a muscle , i . e ., in the womb or the upper arm area . your doctor will decide which muscle to inject into , and how often , your child should be vaccinated . in a blood clotting disorder ( low levels of platelets ) your child will receive the vaccine by injection under the skin . this will help to prevent bleeding and help your child ' s muscle . before the vaccine is given into the blood vessel , the doctor will tell you if and when it is given by another person , it is unlikely that proqua
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . some of these reactions may be serious and may include difficulty in breathing or swallowing . if you have an allergic reaction , talk to your doctor or pharmacist . other side effects of proquad may include : uncommon ( may affect up to 1 in 100 people ): seizures ( fits ) with a fever rare : may affect less than 1 in 1 , 000 people : bronchiolitis ( difficulty breathing , cough , unsteadiness with walking ). if any of these occur , stop the injection immediately and call your doctor right away . the doctor may decide to reduce the dose or stop the vaccination . side effects that may occur after you have received at least 1 in 10 people: injection site complaints ( including pain and swelling ) have been reported . not known ( frequency cannot be estimated
what proquad contains - the active substances are : measles virus1 ( edmonston strain ) 3 . 00 micrograms * produced in chick embryo cells ( fibroblasts , mrc ) by recombinant dna technology * propagated in fertilised hen ' s eggs * mumps virus1 * ( jeryl lynn TM - level b ) strain 4 . 30 milligrams ** produced in wild type hens ' eggs* : rubella virus2 , varicella virus3 and merck strain 3 .99 millilitres * grown in tissue culture to produce plaque - forming units ( pfu ) of 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 
jylamvo is an anticancer medicine that works by blocking specific receptors in your body ' s immune system to prevent unwanted reactions . it is an immunosuppressive agent , with an anti - inflammatory effect , which is used to treat a range of rheumatic and skin diseases . in adults , there is a very small chance of a worsening , possibly life threatening , event - specific manifestations : a ) diagnosed early in life b ) if you have , or have had , active , uncontrolled , severely damaged , polyarthritic forms ( i . e ., in joints damaged ), and severe juvenile idiopathic arthritis ( jia ), in children and adolescents ( 0 - 3 years of age and older ) when treatment with non -
do not take jylamvo if : you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) you have a severe kidney impairment or a liver impairment you have or have had blood disorders ( e . g . bone marrow hypoplasia , leukopenia or thrombocytopenia ) or significant anaemia 34 you are a weakened immune system you have ever had a serious infection such as tuberculosis or hiv you have ulcers in the stomach or the intestines you have an inflammation of the mucous membrane of the mouth or mouth ulcers you are taking non - oncologic indications if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before taking this medicine if you :
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jylamvo can cause severe side effects or even death . your doctor will decide if the treatment should be stopped . it should be used in adults with : rheumatoid arthritis , severe juvenile idiopathic arthritis and severe psoriasis . in severe cases , your doctor may prescribe a different dose , or stop treatment , depending on how you respond to the treatment . the doctor will discuss with you the most appropriate course of action . for a list of recommended doses , please refer to the package leaflet of the medicine that is prescribed for you in order to help you stay on the right track to health - related diseases in children and adolescents ( 18 years of age ), adolescents and children ( 17 years
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following : wheeziness or difficulty in breathing , swelling of the eyelids , face or lips , rash or itching ( especially affecting your whole body ). other side effects may include : breathing problems , feeling of illness , dry , irritating cough , shortness of breath and difficulty in breath , chest pain ( fever ), spitting or coughing blood , serious peeling or blistering of the mouth , tongue or throat , or other signs of side effects such as : very common ( may affect more than 1 in 10 people ): diarrhoea , constipation , nausea , vomiting , stomach pain , pain in the stomach or bowel , dizziness , headache 
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the carton and vial label after exp . store below 25 . keep the medicine tightly closed in order to prevent accidental spillage . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user . the following information is intended for the specialist only : keep the vial in use in a refrigerator ( 2 - 8 ). do not freeze . any unused medicine or waste material should be disposed of in accordance with local requirements for cytotoxic products .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotredxate ( as mesilate ).  the other ingredients are : macrogol 400 , glycerol , orange flavour , sucralose, ethyl parahydroxybenzoate ( e218 ), sodium methyl parahydroxybenzoate ( 8 - 17 ), citric acid , tri - sodium citrate , purified water . see section 2 " important information about the content of this medicine ". what if you use a bottle , please note that all pack sizes may be marketed in your country . the medicine is supplied as a brown glass bottle with 60 doses . it is closed with a child - resistant closure , and packed in a cardboard box .
what enurev breezhaler is this medicine contains a medicine called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what Enurev braezhalers is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to : - a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten , making breathing difficult . by doing so , this medicine blocks the tightening of these muscles in the lungs . it makes it easier for air to get in and out of your lungs to work properly . if you use this medicine once a day , it will help to reduce the effects of copd on your everyday life .
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using your first dose . - patients with kidney problems - suffer from an eye problem called narrow - angle glaucoma - have difficulty passing urine . during treatment , your doctor may decide to reduce your dose , interrupt or completely stop your treatment . take the next dose at the same time as this medicine . tell your doctor immediately if : - you experience tightness of the chest , coughing , wheezing or breathlessness immediately after using the product , as these may be signs of bronchospasm ( difficulties in breathing or swallowing ), swelling of the tongue , lips or face ,
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is to inhale the content of one capsule each day . you only need to use the capsule once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . use in children and adolescents do not give this medicine to children under 75 years of age as this medicine is for inhalation use only . this medicine comes as an inhaler and capsules ( in blisters ). this ensures that the medicine is clear to opalescent , colourless to yellow , and has no visible visible particles in it . if the capsules are discoloured or have particles in them , do not swallow them whole . speak to your doctor straight away if they have any remaining capsules left in the blister
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious uncommon ( may affect up to 1 in 100 people ) irregular heart beat high level of blood sugar ( hyperglycaemia , which is a combination of typical symptoms , excessive thirst , hunger and frequent urination ) rash , itching , hives , difficulty breathing or swallowing , dizziness ( signs of allergic reaction ) swelling mainly of the tongue , lips , face or throat ( possible signs of angioedema ). if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine 
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece of the inhaler ) of 44 micrograms ( 0 . 5 ml ), corresponding to 50 microgram ( 1 . 0 microgram ) per dose . when you first open a new window , you may be able to inhale the contents of the capsule as soon as you open it , and you can breathe in at any time . the other ingredients ( excipients ) are lactose monohydrate , magnesium stearate , water for injections ( see the end of this leaflet for further information on these ingredients ) and , if you have any questions about the use of this product , ask your doctor or pharmacist . what
the active substance in riximyo is called rituximab . this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a specific type of white blood cell called " b - lymphocyte ". if the number of cells in your blood increases , and the medicine dies , you get a lot of damage . your doctor will stick to the b cell and tell you to stay in regular contact with him or her . you may need to stick to this protein for several weeks or months , depending on how well the treatment is working for you or your child ' s response to the treatment . use in adults and children in children ( 6 years of age and over ) chronic lymphocytic leukaemia ( plcl ) a disease of the lymph tissue ( part of the immune system )
do not take riximyo : - if you are allergic to rituximab , other proteins which are similar to the active substance , or any of the other ingredients in this medicine ( listed in section 6 ). you have a severe active infection at the moment you have been diagnosed with a weak immune system . you have severe heart failure or severe uncontrolled heart disease , such as granulomatosis , polyangiitis ( ms ), microscopic polyangitis or pemphigus vulgaris . if any of these apply to you , tell your doctor or pharmacist before you are given the medicine . warnings and precautions talk to your doctor , pharmacist or nurse before and while you are being treated for these conditions : you may be at increased risk of developing a hepatitis infection while being treated with r
how it is given riximyo will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . your doctor will inform you if you need to be given a lower dose . it is very important to have this medicine delivered as a drip ( intra - venous infusion ) over at least one hour before you are given it ( see section 4 ). medicines given before each retouching of the tablets before you receive a treatment , your doctor may ask you to take other medicines ( premedication ) to prevent side effects from occurring . how long will i have to have your treatment ? for non - hodgkin ' s lymphoma when you have been treated with a single course of treatment r
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . you may also experience pain at the site of infusion , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , cough , diarrhoea , indigestion , heartburn , nausea , vomiting , sore throat and mouth ulcers . tell your doctor as soon as possible if you notice any of the side effects above . other side effects may include : very common ( may affect more than 1 in 10 people
what riximyo contains - the active substance is called rituximab . - each 10 ml vial contains either 100 mg or 98 mg of ritsimamab ( 10 mg in the vial ) either on a single use basis or 50 mg or 500 mg / 0 . 5ml of solution for injection or injection , if necessary , to increase the absorption . the other ingredients are : sodium citrate , polysorbate 80 ( e433 ), sodium chloride , sodium hydroxide and / or hydrochloric acid ( see end of section 2 for further information on some of the ingredients in this medicine ). colourless to slightly yellowish solution for infusion is available in pack sizes of 2 or 3 vials , each containing 1 vial or 2 vial per carton . not all
the active substance topotecan , which belongs to a group of medicines called cisplatin . they act in different ways to help protect your child ' s small cell lung cancer when chemotherapy is not suitable or has failed to work adequately . advanced cervical cancer if surgery or radiotherapy is not possible . in this case to potecan actavis treatment is combined with medicines containing a protein called ' lipase '. the other ingredients are : - oral antigen , - thioridazine . - anhydrous , clear , colourless liquid that can kill cancer cells .
do not take topotecan actavis - if you are allergic to the active substance , to potecan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before you are given this medicine . your doctor will check your blood cell counts regularly and may adjust your dose if necessary . they may need to be adjusted . do not change the dose unless your doctor tells you to . if this applies to you , take care not to miss a dose and you will not be given another dose until your next scheduled dose . tell your doctor straight away if any of these apply to you ( or you are not sure ). children and adolescents do not give this medicine to children or adolescents under 18 years of age . there is no relevant safety and efficacy information in this age group . other medicines and
topotecan actavis will be given to you by a doctor who is experienced in the treatment of the disease . your doctor will carry out blood tests before you start treatment and regularly during treatment . adults small cell lung cancer : the usual dose is 1 . 5 mg per square metre of body surface area , given once a week for 5 consecutive days . this treatment cycle will normally be repeated every three weeks , until your doctor determines it is right for you to return to your normal dose . cervical cancer - the usual starting dose is 0 . 75 mg per sq . m2 ( 2 - 3 months ) in each treatment cycle . in some cases , cervical cancer may be given on its own in combination with another anticancer medicines called cisplatin . the doctor will decide whether to continue with the next dose based on your doctor ' s recommendation .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor immediately or go to the casualty department at your nearest hospital , if you get any of the following , as these are very common ( may affect more than 1 in 10 people ). fever may be a sign of your general condition . local symptoms , such as sore throat or burning sensation , severe stomach pain or fever , diarrhoea or bowel inflammation ( neutropenic colitis ). topotecan actavis may reduce your ability to fight infections . lung inflammation : may affect up to 1 in 1 , 000 people - difficulty in breathing . not known ( frequency cannot be estimated from the available data ). - swelling of the face , lips , tongue or throat . - itching , redness of the skin ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . this medicine does not require any special temperature storage conditions . keep the vial in the outer carton in order to protect from light . after reconstitution and dilution chemical and physical in - use stability has been demonstrated for 24 hours at 25 and 2 to 8 , when stored in a refrigerator ( 2 - 8 ). from a microbiological point of view , the drug product solution should be used immediately after preparation and infusion ( nacl 0 . 9 % and glucose 5 %) has been observed for 4 hours at room temperature ( 20 - 25 ) and then stored for 12 hours in the refrigerator . if the solution is discoloured , it should be mixed with water for injections or diluted . however ,
what topotecan actavis contains - the active substance in each ml of solution contains : one vial contains 1 mg ( equivalent to 4 milligrams ) to potecan ( as hydrochloride ). after reconstitution , 1ml concentrate contains 1 million international units ( iu ), corresponding to a concentration of 1 mg / 0 . 5 millilitre ( mg ) per vial .  the other ingredients are mannitol ( e421 ), tartaric acid , hydrchloric acid and sodium hydroxide , to adjust the acidity and if necessary , the solution is clear , colourless and waterlike and aqueous ( see section 2 for more information about some of the ingredients in this medicine ) and water like a water like liquid in a sachet . what
the active substance in this medicine is rivastigmine hexal . it contains two active substances , rivascagmine and rivizagmine . both of these active substances are cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson  s disease , certain nerve cells die in the brain . this results in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ) that help to stay alert to the signs and symptoms of each individual individual condition . by blocking the activity of the enzymes responsible for the production and disemphalyte in the nervous system ( s ) and in the regulation of the levels of some of the substances involved in their breakdown . these enzymes help to improve the functioning of the brain and reduce
do not take rivastigmine hexal - if you are allergic to rivascalistigmine ( the active substance in rivainstigmine histexes ) or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you have had a previous skin reaction ( allergic contact dermatitis ). warnings and precautions talk to your doctor , pharmacist , or nurse before taking the medicine . children and adolescents do not give this medicine to children under 18 years of age because it has not been studied in this age group . if this applies to you , tell your doctor and follow the advice you have been given about it in this leaflet . you should not take the tablets if : you have irregular or slow heartbeat you have an active stomach ulcer you have difficulties in passing urine you have seizures you have asthma or severe respiratory
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . your doctor may slowly increase your dose depending on how you respond to treatment . the highest dose that should be taken is 6 . 0 mg twice a day . you should keep taking this medicine every day until your doctor tells you otherwise . do not take more than three days to make sure that this medicine is fully effective and to reduce the risk of side effects such as : nausea , being sick ( vomiting ), diarrhoea , stomach pain , indigestion , heartburn , sexual dysfunction , problems with sexual performance , an increase in the amount of medicine in your body . this is
like all medicines , this medicine can cause side effects , although not everybody gets them . you may get side effects more often when you start your medicine or when your dose is increased . usually , the side effects will slowly go away as your body gets used to the medicine . very common ( may affect more than 1 in 10 people ) feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ), diarrhoea common : may affect up to 1 in 100 people anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling , difficulty sleeping , sleepiness , drowsy , lack of energy , feeling restless uneven heartbeat , increased heart rate , low blood sugar , high blood sugar change in perception of self , restlessness , depression , suici
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister after exp . store below 30 . keep the blister in the outer carton in order to protect from moisture .
what rivastigmine hexal contains - the active substance is : 64 active substance : rivascalmine hydrogen tartrate . - other ingredients are hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide , titanium dioxide ( e171 ). - printing ink : shellac . each rivattigmine hisxal 1 . 5 mg capsule contains 1 , 5 mg of rivabstigmine in black ink with " nvr " imprinted on one side and " rvt 64 " on the other side . the colour may vary from colourless to light yellow in colourless film - coated tablet ( 0 . 25 mg / 3 ml ) and " 3 mg " in
cabometyx is a cancer medicine that contains the active substance cabozantinib . it is used in adults to treat : - kidney cancer called renal cell carcinoma - liver cancer in adults who have been previously treated with a specific anticancer medicine called sorafenib ( ctab ). cbombombyx works by blocking the action of proteins called receptor tyrosine kinases ( rtks ), which are involved in the growth of cells and the development of new blood vessels that supply them . these proteins can be present in high amounts in cancer cells , and by blocking their action btc and ctcs . the activity of these proteins has been shown to slow the rate at which cells multiply and the tumour grows and help to cut off the blood supply that the cancer needs . you will be given cab
you must not be given cabometyx 45 - if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . before you have been given the medicine , tell your doctor or nurse if : - you have high blood pressure , have or have had an aneurysm ( enlargement and weakening of a blood vessel wall ) or a tear in a vein wall , or if there is a history of diarrhoea , a recent history of significant bleeding , surgery or surgery within the last month or surgical procedures ( including dental surgery ), inflammatory bowel disease ( including crohn ' s disease or other conditions that affect your bowel , such as
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine is for oral use . swallow the tablets with a glass of water . you can take cabometyx with or without food . your doctor will monitor you and adjust your treatment if necessary to reduce the risk of serious side effects . the recommended dose is one tablet a day . when to start treatment take the tablet at about the same time each day ( for example , one tablet in the morning and one in the evening ). the tablet can be divided into 2 equal doses . do not split , crush , or chew the tablet before swallowing . if possible , take your tablet at least 1 hour before or 2 hours after taking the tablet . take the medicine and this leaflet with you and show it to your caregiver . it is best to take 
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects of cabometyx may be similar to other medicines you may be taking at the same time . tell your doctor straight away if your side effects get worse or if you notice any of the following side effects you may need urgent medical treatment : symptoms include pain in the abdomen , nausea ( feeling sick ), vomiting , constipation , fever and / or a gastrointestinal perforation ( a hole in your stomach or intestine that can cause severe or uncontrollable bleeding ). symptoms include vomiting blood , black stomachs , diarrhoea , indigestion , stomach pain , vomiting blood or black lumps . not known : frequency cannot be estimated from the available data . your doctor may want to monitor you more closely . reporting of side
what cabometyx contains - the active substance is cabozantinib ( s )- the other ingredients are malate and water for injections ( see section 2 ). the contents of one tablet each day are engraved with the code number ' b ' on one side and the number " c " on the other side of the tablet . the number of tablets on each of the three tablets is 20 mg ( 0 . 5 ml ) and the code " fcf ( 20 mg )" ( corresponding to a total of 21 mg / kg body weight ) in the form of malate . each tablet also contains 40 mg ( 6 . 0mg / day ). cabombyx 40 mg is supplied as a kit for the treatment of patients who are unable to swallow tablets , and whose body weight is
pemetrexed hospira is a medicine used in the treatment of cancer ; it is used : on its own in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy , or to patients whose disease has progressed beyond the initial treatment . in this case , you will also be given pemetreexed hompira in combination mit cistapollar for the initially treatment of patients with advanced stage of lung cancer . pemetreced houpira can be prescribed to you : if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy ; or if it is considered un
you must not be given pemetrexed hospira : - if you are allergic ( hypersensitive ) to pemetrexxed or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given breast - feeding ( see section " taking other medicines " at the end of this leaflet ). your doctor may decide to reduce your dose , temporarily or permanently , depending on your response to treatment , with or without food . you may also be given a vaccine against yellow fever . your doctor will make sure that you have been properly hydrated and have the hepatitis b vaccine . do not use pemetreixed to treat problems with your kidneys . before each infusion you will have your blood checked by a health professional while it is being given . this is to check
the dose of pemetrexed hospira is 500 milligrams for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area in square meters ( m2 ). this body surface area is used for treatment purposes , depending on your blood cell counts and on your general condition . a hospital pharmacist , nurse or doctor has , in the case of an infusion , decided upon a dose that is right for you . in this case , your doctor may adjust the dose , delay or stop the treatment temporarily or permanently if necessary . for the sake of clarity of information on the infusion process see section " instructions for use ". for example , if you have been trained properly , you may be given a mixture of 9 mg / ml ( 0 . 9 %) sodium chloride solution for
like all medicines , this medicine can cause side effects , although not everybody gets them . you must contact your doctor immediately if you notice any of the following : fever or infection ( common ): when you have a temperature of 38oc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . get medical help as soon as possible after you have had chest pain or a fast heart rate . signs may include pain , redness , swelling or sores in your mouth . allergic reaction : - skin rash , burning or prickling sensation , fever . skin reactions can be serious and can be life - threatening . death has been reported with pemetrexed hospira use in children and adolescents 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . this medicine does not require any special storage conditions . reconstituted and infusion solution : the product should be used immediately . when prepared as directed , chemical and physical in - use stability of infusion solutions of pemetrexed was demonstrated for 24 hours at refrigerated temperature ( 2 - 8 ). from a microbiological point of view , the resulting product should not be used if it is discoloured or if particulate matter is present . parenteral medicines : this medicine is for single use only . any unused solution must be discarded .
what pemetrexed hospira contains - the active substance in each ml of solution for injection contains , i . e . millilitres , equivalent to 100 milligrams / milliliter ). - each vial contains : - centennially ( 100 micrograms for every kilogram of body weight ) - pelletized ( 0 . 5 millimetres ) in pelletized form - adenovirus type b ( corresponding to 80% of the total daily dose ), if necessary , further dilution by a healthcare provider is required . the other ingredients in the powder are mannitol ( e421 ), hydrochloric acid , and water for injections ( see section 2 ). what you need to know before you take pemetreexed : when you take
ganfort contains two active substances called bimatoprost and timolol . they work together to reduce pressure in the eye . bimatopho prost belongs to a group of medicines called prostamides . it works by blocking the activity of a prostaglandin analogue , a substance that the eye turns into a clear , watery liquid . this helps to bring down the pressure inside the eye and reduces the risk of glaucoma . when used regularly , it helps to keep the eye clean , dry , and opalescent , at least once a day , for as long as your doctor prescribes it for you . you should continue to follow your doctor ' s advice on what you should do if you do not feel better or if it does not work as well as it should . gan
do not use ganfort eye drops - solution - if you are allergic to bimatoprost , timolol , beta - blockers or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using this medicine if : you have respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease ( signs include wheeziness , difficulty in breathing and long - standing cough ). you have heart problems ( such as low heart rate , heart block , or heart failure warnings , precautions ). this medicine is not recommended for use in patients with coronary heart disease ( symptoms include chest pain , chest pain when getting up from a lying or sitting position ) or if your heart slows down or stops working properly . you have diabetes 
always use ganfort exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . for treatment purposes , the bottle should be kept out of the sight and reach of children . do not use the bottle after the expiry date which is stated on the carton and the bottle label after exp . it should be inserted into the neck of the medicine ( see section 5 ). instructions for use 1 . wash your hands . tilt your head back and look up at the ceiling . 2 . pull down your lower eyelid until there is a small pocket . 3 . bring the bottle close to the eye for the duration of treatment . 4 . close the lid of your eye . 5 . hold the eye with a finger until it is time for your eye to come into contact with the eye or nose .
like all medicines , ganfort can cause side effects , although not everybody gets them . always use the drops exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the following side effects have been observed with the drops on the drops : very common side effects ( may affect more than 1 in 10 people ) : - the eye redness ( common side effect : may affect up to 1 in 9 out of 100 people ). - if the eye burning , itching and stinging , irritation of the conjunctiva ( the transparent front part of the eye ), sensitivity to light , eye pain , sticky eyes , dry eyes - feeling of something in the eye or a small break in the vision ( uncommon side effects in children and adolescents ) not known : frequency cannot be estimated from the available data . reporting of
keep out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and the bottle label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . solution for eye infections should be used within 4 months after first opening . discard any unused solution via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what ganfort contains - the active substance is bimatoprost , 0 . 3 mg / ml solution for injection contains : timolol , 5 g / min ( corresponding to 6 . 8 %) benzalkonium chloride ( a preservative ) the other ingredients are : sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate ( see section 2 ), purified water , hydrochloric acid and sodium hydroxide to adjust the pH and to reduce the amount of acid in the blood , which may be a colourless or slightly yellow opalescent eye drop solution in a plastic bottle . each pack contains 1 bottle ( 3 bottles with a screw - cap ) and 3 bottles ( 4 bottles without a mouth ). not all pack
the active substance gefitinib attaches to a protein called ' epidermal growth factor receptor ' ( egfr ). this protein is involved in the growth and spread of cancer cells . geFITINib mylan is used to treat adults with non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan : - if you are allergic to the active substance , or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given gefit inib . some lung problems may be serious . your doctor may need to adjust your dose , depending on what the medicine is used for . tell your doctor or nurse if any of these apply to you . they may need a lower dose . you may have problems with your liver . children and adolescents this medicine should not be used in children or adolescents ( under 18 years of age ) because the safety and efficacy in this age group has not yet been established and therefore no data are available in this group of patients . other medicines and gefiteinib this medicine may affect the way some other medicines work . in particular
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 250 mg tablet per day . swallow the tablet whole with a glass of water . you can take the tablet with or without food . do not take antacids on an empty stomach . alternatively , take the tablets at about the same time each day ( for example , one tablet in the morning and one in the evening ). how much to take adults , adolescents and children weighing at least 2 years of age or older , do not exceed the recommended daily dose of 1 tablet . take gefitinib mylan with food , drink or any other liquids ( e . g . grapefruit , grapefruit or grapefruit juice ). drink the mixture straight away . this will help you to remember to take the medicine .
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to a nurse or a doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction with symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives ( nettle rash ) and difficulty breathing . serious breathlessness ( sudden worsening breathlessness ), a cough or fever . this may be a sign of an inflammation of the lungs called ' interstitial lung disease '. this is uncommon ( may affect up to 1 in 100 people ) when gefitinib mylan is taken together with other medicines . severe skin reactions have been reported in some areas of the body . these reactions may include redness , swelling , itching , burning and / or
what gefitinib mylan contains - the active substance in each film - coated tablet is 250 mg / ml . -- the other ingredients are : lactose monohydrate , microcrystalline cellulose ( e460 ), crospovidone ( type a ), povidone( k30 ), sodium laurilsulfate , magnesium stearate in the tablet core and polyvinyl alcohol , macrogol 4000 , titanium dioxide , red iron oxide and yellow iron oxide in the film coating and in the sachet after " gx " and " nvr " in black ink on the tablet coating and " 250 mg " in pvc - foil blister . not all pack sizes may be marketed .
the active ingredient of reblozyl is luspatercept . it is used to treat myelodysplastic syndromes ( mds ) in adults , adolescents and children of all ages . these syndromes are caused by many different blood and bone marrow disorders , which can cause red blood cells become abnormal . signs and symptoms of a low red blood cell count ( anaemia ) can be a problem for patients who don ' t respond normally to a large amount of blood cells ( erythropoietin therapies ). it can also be used for the treatment of beta - thalassaemia in adults and children who have a blood problem that is caused by passed down through genes ( e . g . gene - activation ). if any of the above apply to you , or if you are not
do not take reblozyl : - if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ) - in a position to be pregnant ( see pregnancy and breast - feeding ). warnings and precautions talk to your doctor or pharmacist before taking this medicine if : you have thalassaemia or have had your spleen removed . you have ever had a blood clot . your doctor may recommend hormone replacement therapy to help prevent or reduce the size of a previous blood clumping of the blood . prevention and preventive measures may be taken by people taking medicines that prevent or control a bleeding , e . g ., high blood pressure . it is important to know the precautions needed to avoid infecting other people , especially women of childbearing age .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will carry out blood tests before and during treatment with reblozyl to make sure that you get the correct dose . you will be asked to weigh the dose and how often you will have the injections . the dose you receive is based on how much you weigh and the results of the blood tests carried out before and after each injection . use in children and adolescents the recommended dose for children is 1 . 0 mg per kilogram of body weight . this dose will be calculated according to your body weight and will be adjusted by your doctor , depending on your blood pressure , and on how well you respond to the medicine . in patients with myelodysplastic syndromes the maximum single dose should not be exceeded . however , patients with beta - thalassaemia the
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following : difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , especially if only on one side of the body , or blurred vision . these may be symptoms of a stroke caused by blood clots swelling of the area around the eyes , including the face and lips , mouth , tongue or throat allergic reactions including rashes and swollen hands , ankles or feet . common side effects ( may affect up to 1 in 10 people ) diarrhoea , vomiting , nausea , constipation , flatulence ( wind ), indigestion , heartburn ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and the carton after exp . store and transport refrigerated ( 2 8 ). do not freeze . after reconstitution , the product may be stored at ambient room temperature ( up to 25 ) for up to 24 hours . from a microbiological point of view , reblozyl should be used immediately . any unused medicinal product or waste material should be disposed of in accordance with local requirements .
what reblozyl contains - the active substance is luspatercept . each vial contains either 25 mg or 75 mg ( approximately equivalent to 50 mg ) ( 0 . 5 ml of solution ), - aspartate ( e331 ) and citric acid monohydrate , - sodium citrate ( see end of section 2 ); - sucrose , hydrochloric acid ( for ph adjustment ). - water for injections . not all pack sizes may be marketed . your doctor will prescribe the right size for you based on your individual needs . you may also find it easier to take it at home . the following ingredients are present in the pack as a white to off - white powder for solution for injection ( in a glass vial ). you will find a separate container for storage of the vial ( 25 mg 
the active substance in fotivda is called tivozanib , which is a protein kinase inhibitor ( pmk ). pmk helps to control the growth and spread of the cancer by slowing down the growth of cancer cells and opening new blood vessels . in patients with advanced kidney cancer , patients may be given other treatments , such as alpha or interleukin - 2 , to control your disease .
do not take fotivda if : you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). you are taking st . john ' s wort ( hypericum perforatum ), a herbal remedy used in the treatment of depression and anxiety . warnings and precautions talk to your doctor , pharmacist or nurse before taking fotiv da . you have high blood pressure . your doctor may want to check your blood pressure regularly , to make sure that it is within the normal range . it may also help if you are treated with a medicine , or it may not work as well as it should . in some cases , it may be necessary to change the dose , either temporarily or permanently , while you or your family / carer notices that you are becoming dehydrated ( see section 4 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of fotivda is 1340 mg / 21 mg capsules taken once a day for 7 days ( 1 capsule ) and capsules should be swallowed whole with some water or other non - alcoholic drink . you should take at least 4 capsules in the morning and evening , at about the same time each day . do not take more capsules than your doctor tells you to . if possible , capsules may be taken with or without food . your doctor may decide to keep you under closer observation or to watch out for unacceptable side effects . severe side effects can occur in patients who are not able to sustain themselves , so it is important that you follow your doctor ' s instructions carefully . please also read the section at the end of this
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure ( a common side effect that may affect up to 1 in 10 people ) if you get this side effect ( see section 2 " warnings and precautions "), you must stop taking fotivda and contact a doctor or the nearest hospital immediately . very common ( these can be symptoms of severe headaches , blurred vision , shortness of breath , changes in your mental state or feeling anxious , confused or disorientated ). if this happens , it is important that you take the tablets with some water . it may help to reduce your blood pressure . talk to your doctor , pharmacist or nurse if it gets worse . you may need to take an antidote ( such as a medicine to treat your high bloodpressure ) for a long time 
what fotivda contains - the active substance is tivozanib . - each hard capsule contains either : fotiva 890 mg / 0 . 5 ml fotivib hydrochloride monohydrate , corresponding to a target dose ( iu ) of 890 micrograms of tivonib ( as mesilate ). the other ingredients are mannitol , magnesium stearate , gelatin , titanium dioxide ( e171 ), indigo carmine , yellow iron oxide , propylene glycol ( type a ) and strong ammonia solution for injection ( titanium dioxide , tartrazine aluminium lake ). - printing ink contains shellac ( partially hydrolysed ) propane glycol which is a clear , colourless to pale yellow solution ,
stribild contains two active substances : elvitegravir , an antiretroviral medicine known as an integrase inhibitor cobicistat , a booster ( pharmacokinetic enhancer ) of the action of the human recombinant gene ( rti ) in the development of cells . it is a copy of a gene called ' gt ' in the human genome that makes it easier for you to read and understand the information contained in this medicine before you start taking it . the active substances are : one tablet regimen for the treatment of human immunodeficiency virus ( hiv ) infection in adults , adolescents , and children of any age , the tablets themselves are not intended for use on their own . they are designed to work in the same way as tablets and can be taken with or without food . s
do not take stribild - if you are allergic to elvitegravir , cobicistat , emtricitabine , or tenofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking treatment with any medicine that is used to lower your blood pressure ( e . g . 10mg / m2 body surface area ). if this applies to you , your doctor may need to reduce your dose of any medicine you are taking . in particular , you should tell your doctor if : your kidney function may be affected by these medicines : alfuzosin ( used to treat an enlarged prostate gland ) amiodarone , quinidine ( used for irregular heartbeats ) 47 dabigatran (
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take adults ( 12 to less than 18 years of age ) the recommended dose is 35 mg taken by mouth once daily . your doctor will tell you the dose to take . depending on how you respond to your medicine , your doctor may change the dose or stop the treatment temporarily or permanently . you should take medicines such as oral supplements , antacids , laxatives containing minerals ( such as magnesium , aluminium , calcium , iron , zinc ) taken in the morning and evening ( at least 4 hours apart ) for 4 hours . take stribild at about the same time every day . swallow the tablets whole with a glass of water . do not chew , crush or split the tablets . it is best to take the tablets
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood fats sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is not always possible to tell whether some of the unwanted effects are caused by stribild or by other medicines that you are taking at the same time ; however , in some cases they can be serious . if you are being treated for hiv disease itself , serious side effects may occur , particularly if they continue to get worse . contact your doctor immediately lactic acidosis , which is a rare but serious , potentially life - threatening , condition in which excess lactic
what stribild contains - the active substances are elvitegravir , cobicistat , emtricitabine , and tenofovir disoproxil . each single - use film - coated tablet ( tablet ) contains 150 milligrams ( mg ) each . the other ingredients are : tablet core : pre - gelatinised maize starch , lactose ( see end of section 2 ) and talc ( e553b ). tablet coating : a desiccant of peach coloured tablet with ' tachycardia ' on one side . tablet coatings : the tablets are white to off - white , biconvex tablets of 15 . 5mm diameter , debossed with the company logo and the company symbol on the other side
zyprexa , which contains the active substance olanzapine , belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes ( a condition with symptoms of excitement or euphoria ) have been shown to be more likely to occur in these patients in patients with bipolar disorder who have experienced a manic episode when they were first seen in patients who were first shown signs of a possible recurrence . these symptoms were mostly mild to moderate in nature and were initially seen as suspicious of others . if you have any questions about how
do not take zyprexa : - if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a so - called swollen face . if this has happened to you , you should immediately contact your doctor , who will decide whether to treat you . you should also report any problems with your lips or shortness of breath . this may be a sign of eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). warnings and precautions talk to your doctor or pharmacist before you take your tablets . your doctor may want to monitor you more closely . children and adolescents do not give this medicine to children under the age of 18 years because there is no information on the use of 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the usual starting dose of zyprexa tablets is one 5 mg tablet taken once a day . your doctor may increase your dose to 20 mg once daily depending on your symptoms and on how you respond to the medicine . you should swallow the tablet whole with a glass of water . do not crush or chew the tablet . try to take it at the same time each day , preferably in the morning and evening . it does not matter whether you take it with or without food . if your doctor thinks that it is too strong or too weak , talk to your doctor about how to switch from one day to the next , or whether you need to change your dose . for some time , your dose may be adjusted by your doctor and may be increased by taking 
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately or go to the casualty department at your nearest hospital if you have : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins . this side effect is uncommon , and affects less than 1 in 100 people . especially in the legs ( symptoms include swelling , pain and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if any of these symptoms occur , stop taking the medicine and contact a doctor immediately . your doctor may decide to keep you under closer observation or change your dose of zyprexa . very rarely , patients have reported side effects in more than 1 user in 10 ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . zyprexa should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zyprexa contains - the active substance is olanzapine . each zyPrexa tablet contains either 2 . 5 mg , 5 mg or 7 . 5, to be taken with or without food , for example , on a daily basis . this means that you take either 10 , 15 or 20 tablets at the same time each day . if this applies to you , do not take any more tablets than your doctor has told you to . the exact amount you need to take depends on the type and size of the tablet you are taking . in addition , the tablet may contain lactose monohydrate ( see section 2 ), hyprolose , crospovidone , microcrystalline cellulose , magnesium stearate and hypromellose ( e464 ), titanium dioxide and carnauba wax . what 
what prolia is and what it is used for the treatment of osteoporosis in adults , adolescents and children of all ages . the active ingredient of prolis is denosumab , a protein ( monoclonal antibody ) that binds selectively to another protein known as oestrogen , which is a natural hormone produced by the body . this helps reduce the risk of bone loss in adult men and in adult women , especially in those who have not had a menopause . as a result of the endosperm gene in the blood is decreased , and bones become thin and fragile . what are the benefits of treatment with osteoponomics in adults and children there is no information available on the use of antigens like testosterone and glucocorticoids which are used to treat osteopossesis . it reduces symptoms and
do not use prolia : - if you have low calcium levels in the blood ( hypocalcaemia ). you are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given proton / syringes . if this applies to you ( or you are not sure ), tell your doctor before or while you are being treated with protease ( see section 4 ). if your doctor thinks any of these apply to you , don ' t use prolase if any of them apply to your child . your doctor may want to monitor you more closely . you may have a skin infection with symptoms such as a swollen , red area of skin usually in your leg that feels hot or tender ( cellu
always use prolia exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one pre - filled syringe of 60 mg / ml administered once every 6 weeks , as a single injection under the skin ( subcutaneous ) in your thighs , abdomen or upper arm . your doctor will tell you how many injections you should receive . the doctor may also give you stickers , calcium and vitamin d supplements to help you stay on the right things to do . do not try to inject yourself unless you have been trained by your doctor , pharmacist or nurse . read the instructions for use at the end of this leaflet to get the most from your treatment . it is very important that you continue with your treatment for as long as you are trained , qualified and qualified . if
like all medicines , this medicine can cause side effects , although not everybody gets them . prolia may cause skin infections ( cellulitis ). tell your doctor immediately if you develop any of these symptoms while being treated with proloa : - you may be swollen , red area of skin on one side of your leg that feels hot and tender ( symptoms may be fever ), which may be severe . - your doctor may decide to lower your dose , stop your treatment temporarily or permanently . you may experience pain in the mouth and / or jaw , swelling or non - healing of sores in the jaw or jaw ( discharge ), numbness or a feeling of heaviness when you stand up or loosening of a tooth . these may be signs of bone damage in your jaw . your doctor will tell you how long your treatment will last 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . your pre - filled syringe may be stored at temperatures up to a maximum of 25 for a single period of up to six months . the injection can be removed from the refrigerator and left at room temperature ( up to 25 ) for up to 30 days . you must use prolia if you notice any particles in it or if the solution is discoloured or you cannot see any visible sign of tamper proof of the method of storage . use in accordance with local requirements , these measures will help to protect the environment .
what prolia contains - the active substance is denosumab . each 1 ml pre - filled syringe contains 60 mg desiccant ( 60 mg in the vial ). -- the other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections ( see section 2 ), sodium , potassium , magnesium , calcium , and phosphate ) ( see end of section 2 for further information on some of the ingredients in this pack ) is a clear to slightly opalescent and colourless to slightly yellow solution . it is supplied in a ready to use , clear , colourless or partially dissolved solution for injection ( injection ) vial with or without a needle guard . not all pack sizes may be 
ambirix is a vaccine used in adults , adolescents and children from 1 year up to and including 15 years to prevent two diseases , called hepatitis a and hepatis b . it is given to you by your doctor or nurse in a hospital or clinic under the supervision of your doctor , pharmacist or nurse . the vaccine works by causing the liver to become swollen and inflamed with the virus . this makes the virus more likely to come back in an infected person . if the virus is found in faeces , serum or saliva , symptoms are usually present 3 to 6 weeks after you have had infection . you may feel sick or have a fever , aches and pains , or you may need to stay in hospital for a long time or if someone else in your family has the impression that the effect of the virus
you should not receive ambirix : if you are allergic to the active substance , or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . these may be signs that you have had an allergic response to any vaccine against hepatitis a or hepatis b diseases . you have a severe infection with a high temperature ( over 38 ). if this applies to you , the vaccine will be given to you in a clinic or clinic . a minor infection such as a cold should not be a problem , but talk to your doctor first . warnings and precautions talk to you doctor , pharmacist or nurse before your dose is given . your doctor or nurse will check whether your child is safe and effective during your treatment with ambir
your doctor or nurse will give you ambirix as an injection into a muscle , usually in the upper arm . the injection will be given into the vein of the thigh muscle . you will receive a total of two injections . if the injections are given within 12 months , the second injection should be given between 6 and 12 months after the first injection . your doctor will tell you when you may need extra doses , or future booster dosing , depending on how well the disease is treating you or your child . it is important that you follow this advice carefully and follow the instructions at the end of this leaflet ( see " instructions for use "). if you forget or miss an injection if it is nearly time for your next injection , inject the missed dose as soon as possible . then inject the next injection at the usual time . in some cases , up to six injections may
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering and swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure and loss of consciousness . side effects reported in clinical trials with ambirix were : common ( may affect up to 1 in 10 people ) headache loss of appetite feeling tired or irritable pain in the arms and legs , loss of balance or inability to get or keep an erection . your doctor will tell you how to recognise them and what to do if they happen . you may experience a reduction in the number of red blood cells ( anaemia ).
what ambirix contains 26 - the active substances are : hepatitis a virus ( inactivated ) 1 , 2 - 720 elisa units / 0 . 5 ml / 4 - vectorized antigen 20 - human diploid ( mrc - 2 ) cells - aluminium hydroxide ( hydrated ) - 10 - saccharomyces cerevisiae ( scleroderma ) and aluminium phosphate ( see section 2 ). - solvent : sodium chloride , water for injections ( see end of the pack suspension for injection ) in a pre - filled syringe . the contents of this medicine are a white , slightly milky liquid , colourless to pale yellow solution , supplied in packs of 1 vial .
the vaccine is a meningococcal group b vaccine . bexsero is given to children and adolescents ( from 2 years of age ) to help protect against disease caused by the neisseriameningitidis type b bacteria . these bacteria cause infections , including meningitis ( inflammation of the covering of the brain and spinal cord ) and sepsis ( blood poisoning ). when given , the vaccine works by helping the body to make its own protection ( antibodies ) against the disease .
do not use bexsero - if you are allergic to the active substance or any of the other ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before vaccination if : you have a severe infection with a high temperature ( over 38 ). in this case your doctor may recommend that you have the vaccination . a minor infection , such as a cold , should not be vaccinated . you have haemophilia or any other problem that may prevent your blood from clotting properly such as the use of blood thinners ( anticoagulants ) during treatment , or if your immune system is weakened ( for example , eculizumab ). if any of these apply , tell your doctor or nurse . children and adolescents do not give this vaccine to children under 18 years of
bexsero will be given to you or your child by a healthcare professional . the recommended dose is 5 mg given as an injection into a muscle , usually in the thigh or upper arm . your doctor or nurse will decide for how long your child needs to receive the vaccine . from a microbiological point of view , your child should receive at least 2 - 5 injections given at least three injections . if your child receives more than one dose , you may receive an additional injection ( booster ) after the first injection ( see section 2 ). if the interval between injections is too low ( less than 1 month ), your child may receive up to a maximum of 2 months and a booster may be given 12 to 15 months after your child has received at least 6 months after the injection . depending on your child ' s response , the booster can be given up
like all vaccines , this vaccine can cause side effects , although not everybody gets them . when bexsero is given to your child , the following side effects may occur : very common ( may affect more than 1 in 10 people ): - pain / tenderness at the injection site - redness of the skin around the injection area - swelling of the leathery part of the upper layer ( injection site area ) - hardness around the skin - injection site other possible side effects of this vaccine are listed below by how likely they are to occur when given at the same time . very common : may affect up to 1 in10 people - fever - loss of appetite - diarrhoea - feeling sick ( nausea ) or vomiting - increase in the amount of protein in the blood - increased sex drive - muscle spasms uncommon :
what bexsero contains - the active substance is recombinant neisseria meningitidis group b nhba fusion protein 1 , 2 or 3 times per week , corresponding to 50 micrograms / ml . - each vial contains one dose ( 0 . 5 mg / 2 , 3 , 4 , 5 , 6 , 7 , 8 , 10 , 11 , 12 , 13 , 14 , 17 , 18 , and 28 , respectively , as the active substances are : - total protein from the pora p 2 or 25 iu 1 vial in each case . not all pack sizes may be marketed .
the active substance in this medicine is nitisinone mdk . this medicine belongs to a rare disease called hereditary tyrosinemia type 1 in adults , adolescents and children aged 1 year and older . in this disease your body is unable to break down the amino acid térosine ( amino acids are building blocks of our proteins ), forming harmful substances . the harmful substances are accumulated in your body , and this medicine stops this process . it is thought to work as well as it should . you must follow a special diet while you are taking this medicine , as long as your doctor continues to prescribe it . if you are not able to take the medicine on its own , your doctor may tell you to take it at the same time . your doctor will also tell you how long you should continue to take this medicine and how to reduce the amount of t
you must not be given nitisinone mdk : - if your eyes are damaged or damaged . do not use this medicine after the expiry date which is stated on the carton and on the label of the vial after " exp " ( see section 6 " contents of the pack and other information "). this medicine is not intended for use in pregnant women . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . pregnancy and breast - feeding do not give this medicine to children under the age of 6 years because it is not known how well it works in this age group . your doctor may decide to reduce the number of tablets you take . if you are pregnant or plan to have a baby , ask your doctor or pharmacist for advice before being given . driving and using machines do not drive or use machines until you have established your own ability to drive or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment with this medicine will be started by a doctor who is experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 mg per kg of body weight , for a total daily dose of 20 mg . in this patient population , the usual dose is two capsules of nitisinone mdk per day . after swallowing the capsules , your doctor may advise you to take a small amount of water or formula diet to help you remember to take it . you should not take more capsules than your doctor tells you to . your doctor will tell you how many capsules to take and for how long you need to take the medicine . if your doctor prescribes this medicine for you , tell your
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . nitisinone mdk can be removed from the refrigerator and left at room temperature ( up to 25 ) for no longer than 2 hours . from a microbiological point of view , the product should be used immediately .
what nitisinone mdk contains - the active substance is nitianine . - each capsule contains a total of two active substances . one , two , three , four , five , seven , eight , nine , 10 , 11 , 12 , 15 , 20 , 25 , 56 , 84 , 100 , 200 , 300 , 500 , 600 , 800 , 6 , 7 , 8 , 9 , 17 , 90 , 120 , 1 , 000 , 2 , 400 , 5 micrograms , 3 , 700 , 4 - digits in the code ' nt ' in the body of the capsules . the other ingredients are : gelatin , titanium dioxide ( e171 ), black iron oxide (
the name of this medicine is docetaxel accord . it is a substance derived from the needles of yew trees , which are used to express pain and discomfort in the upper respiratory tract ( bronchial ) and in the lower part of your stomach ( gullet ) some days after you last had a meal , but did not take the full dose until you were ready to go to bed . after you have finished taking docetaxil , you should have been given another medicine called anti - cancer medicines ( taxoids ) after the last two weeks . the doctor will prescribe the best medicine for you : - breast cancer , - lung cancer ( non - small cell lung cancer ), - prostate cancer . - gastric cancer and head and neck cancer : in the treatment of adult patients with advanced breast cancer before deciding on one treatment , docet
docetaxel accord should not be used : - if you are allergic ( hypersensitive ) to the active substance , or to any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions before each use , you will be checked by your doctor , pharmacist or nurse that you have enough white blood cells and / or have a severe liver disease . your doctor will carry out blood tests to check that your liver is working properly before and during your treatment with docetaxil accord . you may experience white blood cell disturbances , e . g . fever or infections . tell your doctor immediately if your abdominal pain or tenderness , diarrhoea , rectal haemorrhage , blood in stool , fever , and fever . children and adolescents do not give this medicine to children or adolescents under the age of
docetaxel accord will be administered to you by a healthcare professional . usual dose the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( m2 ) and will determine the dose you should receive . method and route of administration docetaxil accord is given as an infusion into one of your veins ( intravenous use ). the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks , unless your blood tests show you are not performing the following : if you experience any of these , tell your doctor or hospital pharmacist . in particular , please inform your doctor in case of diarrhoea , sores in the mouth , feeling of numbness or pins and needles , fever and give her
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord alone are : decrease in the number of red blood cells or white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea , tiredness . in most cases , the hospital staff will monitor you closely for adverse events while on treatment with docetaxil accord and with other chemotherapeutic agents . during the infusion at the hospital the following allergic reactions are likely to occur . very common ( may affect more than 1 in 10 people ): flushing , redness , burning sensation , itching , skin rash . not known ( frequency cannot be estimated from the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . this medicine does not require any special storage conditions . keep the vial in the original container in order to protect from light . after dilution , the medicine should be administered immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user . the infusion bag may be stored in a refrigerator ( 2 - 8 ) for up to six hours below 25 . from a microbiological point of view , if the product is discoloured or if it contains particulate matter , it should be diluted in water for injections . when prepared for infusion , chemical and physical in use stability has been demonstrated in non - pvc bags up to
what docetaxel accord concentrate vial contains - the active substance in each ml of concentrate for solution for infusion is 20 mg / 0 . 5ml . - each pre - filled syringe of 1 vial concentrate contains 20 mg don ' t extract any other ingredients . one ampoule of 4 vials concentrate contains 80 mg docetaxil , corresponding to a concentration of 16 - 40 mg pfu / 5 . 1ml after reconstitution . each vial of 8 ampoules contains 160 mg of don & apos; s &amp; ethanol anhydrous . the other ingredients are : ( see section 2 for more information ). ( also a solvent vial ) citric acid and hydrolysed . ( not all pack sizes may be marketed in your country ). what
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the brain . you should not take this medicine if you are impulsive ( hyperactive ) and you are not currently taking this medicine ( see section 2 ). this medicine is used to treat ' attention deficit hyperactivity disorder ' ( adhd ) in adults who are already taking current stimulant medication . if current medication does not reduce adhd symptoms , your doctor may prescribe the medicine together with a treatment programme , which may include psychological therapy , educational therapy and social therapy . it has been studied in adults 38 who have been treated for adhd before . adhd is a very common complication of adhd in adults .
do not take intuniv - if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have low or high blood pressure . you have heart problems . this may increase the risk of heart problems you have ever fainted recently because of thoughts or feelings of suicide you have any other psychiatric conditions you are taking at the same time you have withdrawal symptoms you have recently had increased heart rate , especially if your heart is beating too fast or too slow . if any of these apply to you , tell your doctor before using this medicine you will be monitored carefully for signs of these problems you may be more likely to develop them . children and adolescents do not give this medicine to children or adolescents under the age of 6 years because it has
your treatment should be initiated by a doctor who is experienced in the treatment of adolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your treatment will start at a low dose and will be gradually increased over the first 1 month of treatment . the recommended dose is 0 . 05 mg per kg of bodyweight each day . depending on how you respond to treatment , your doctor may increase your dose up to a maximum of 7 days . intuniv can be taken with or without food . swallow the tablets whole with a glass of water . do not chew , crush or split the tablets as this may affect the way the medicine works . tell your child ' s doctor if he / she feels that the effect of the medicine is too strong or too weak .
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell while you are taking your medicine , stop taking it and talk to a doctor straight away . serious side effects some patients have had side effects before , including feeling drowsy and feeling dizzy ( hypotension ). slow heart beat ( bradycardia ) feeling faint , loss of conciousness ( syncope ), which is a serious withdrawal side effect . high blood pressure , which can cause symptoms such as headaches , feeling confused , nervousness , agitation , or tremors ( hypertensive encephalopathy ). if any of these side effects causes you problems , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton after ' exp '. this medicine does not require any special temperature storage conditions . the tablets should be stored in a refrigerator ( 2 8 ). do not freeze . keep the tablets in the blister pack in order to protect from light .
what intuniv contains 1 - the active substance is guanfacine hydrochloride . 1 mg / ml solution for injection : each vial contains a single dose ( 0 . 5 milligrams ) or two doses ( 2 x 109 mg ): each . the other ingredients are : methacrylic acid - ethyl acrylate copolymer , lactose monohydrate , povidone , crospovidone type a , microcrystalline cellulose ( e460 ). not all pack sizes may be marketed .
ecalta contains the active substance anidulafungin . it is used to treat adults ( aged 1 to 18 years ) with a type of fungal infection that affects the blood or other internal organs ( called invasive candidiasis ). the infection is caused by fungal cells called candida , which are resistant to echinocandins . these medicines help to prevent serious fungal infections caused by the fungal cell walls . a new class of medicines has been developed for use in adults , adolescents and children under the age of 18 years to treat adult patients whose disease is due to the lack of complete or defective cell walls and make them fragile and unable to grow .
do not use ecalta : - if you are allergic to anidulafungin , other echinocandins ( such as caspofungin acid ) or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine , and while you are being treated , you may need to have a check - up of your liver function . your doctor may decide to reduce your dose of liver problems or stop your treatment . you may be given anaesthetics during your treatment with a different dose , or you may experience an allergic reaction , such as itching , wheezing or blotchy skin . if this happens you should contact your doctor immediately . an infusionrelated reaction may include a rash , hives
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much ecalta to use the recommended dose is 200 mg twice a day ( for adults , adolescents and children from 1 month to less than 18 years of age ) at a dose of 3 . 0 ml . the dose may be increased or decreased depending on the patient ' s weight . your doctor will decide the dose you should use . you will be given a single infusion via a drip into a vein ( intravenously ) over a period of 1 . 5 to 3 hours . depending on how you respond to the treatment , your doctor may decide to increase or decrease the loading dose or stop the infusion if the patient is ill . duration of your treatment you should usually continue your treatment for at least 14 days .
like all medicines , this medicine can cause side effects , although not everybody gets them . some of these side effects may be serious and may include life - threatening allergic reactions such as difficulty breathing , wheezing or an existing rash . stop using ecalta and tell your doctor straight away if you notice any of the following serious side effects including convulsion ( seizure ) flushing rash ( pruritis ) itching hot flush hives sudden contraction of the muscles coughing difficulty of breathing other side effects include : very common side effects ( may affect more than 1 in 10 people ) dizziness , headache , diarrhoea , nausea , vomiting , abdominal pain , indigestion , constipation , loss of appetite , excessive gas in stomach or gullet ( urticaria ), itching ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . this medicine does not require any special storage conditions . the reconstituted solution may be stored for up to 24 hours in a refrigerator ( 2 - 8 ). the infusion solution can be stored at room temperature ( up to 25 ) for no longer than 48 hours . if you have any storage conditions after this time , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what ecalta contains - the active substance is anidulafungin . each vial of powder contains 100 mg of anidulationfungin ( as mannitol ). the other ingredients are polysorbate 80 , tartaric acid , sodium hydroxide ( e524 ) and hydrochloric acid . the solvent is water for injections , which should not be used after the expiry date which is stated on the vial label and carton after exp . it is available in a box containing 1 vial ( 100 mg concentrate for solution for infusion ). not all pack sizes may be marketed . your physician will prescribe the right pack for you .
adynovi contains the active substance rurioctocog alfa pegol , pegylated human coagulation factor viii produced by recombinant dna technology . it is made up of a mixture of two human - and animal - derived components , which are arranged in a genetically engineered , sterile , homogeneous technology ( gmos ) process and are used to clot and stop bleedings . in patients with haemophilia a and gidos , lack of factor ixi is required for the treatment and prevention of bleeding in patients of all ages and in adults and adolescents of 12 years of age and older and in children of hepatitis a , an inherited bleeding disorder caused by lack offactor viiis .
do not use adynovi if you are allergic to rurioctocog alfa pegol or any of the other ingredients of this medicine ( listed in section 6 " contents of the pack and other information "). if this applies to you , tell your doctor or nurse immediately . warnings and precautions talk to your doctor , pharmacist , or nurse before using the medicine . children and adolescents do not give this medicine to children less than 6 years of age , because there is a small chance that you may be allergic , but your doctor will have to monitor you carefully before giving you this medicine , and during treatment , in case you have an anaphylactic reaction ( a severe , sudden allergic reaction ) to the product . your doctor may decide to keep you under closer observation and monitor you more closely . in this case , you may experience allergic reactions such as 
treatment with adynovi will be started by a doctor who is experienced in the care of patients with haemophilia a . your doctor will decide on the appropriate dose of ayni based on your body weight and on your individual needs for treatment of bleeding . the doctor will calculate the dose you should receive and determine for how long you should be treated . for patients who do not have enough factor viii to control bleeding , it will be the same as for adults . it is important to follow the instructions from the manufacturer , pharmacist , or nurse . how often you should have the replacement therapy , your doctor may decide that you should continue with the continuation therapy . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . prevention of bleeding the usual dose of the most effective treatment for adults is one or two dose
like all medicines , this medicine can cause side effects , although not everybody gets them . if severe , sudden allergic reactions ( anaphylactic ) occur , the injection must be stopped immediately . you must contact your doctor immediately if you have any of the following early symptoms of allergic reactions : - rash , hives , wheals , generalised itching - swelling of lips and tongue - difficulty in breathing - wheezing - tightness in the chest - general feeling of being unwell - dizziness - loss of consciousness . severe symptoms , including difficulty in breath or fainting , require prompt emergency treatment . some patients who have received previous treatment with adynovi have experienced these symptoms and experienced them during or after treatment with this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before using a
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . the powder vial may be removed from the refrigerator and left at room temperature ( not above 30 ) for a single period of up to 3 months . if the product is not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 3 days in the refrigerator . once thawed , the powder must be used within 3 hours , unless dilution has taken place in controlled and validated aseptic conditions . you must record the date when storing adynovi and the date after which it should
what adynovi contains - the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains nominally 250 , 500 , 1000 , or 2000 iu ( international units ) ( g / ml ). the concentration in the solvent vial is 5 micrograms sterilised water for injections . the other ingredients are mannitol ( e421 ), trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrate and tris ( hydroxymethyl ) aminomethane , polysorbate 80 and sterile solution for injection ( see section 2 ) for further information on sterility and
rekovelle contains the active substance follitropin delta , which is a fertilising hormone produced by recombinant technology without addition of any human - or animal - derived components in the manufacturing process . gonadotropins are involved in the development of female infertility in women undergoing assisted reproduction programmes ( in vitro fertilisation ( ivf ) or intracytoplasmic sperm injection ). these hormones stimulate the ovaries to produce many egg sacs .
do not use this medicine if your fertility problems do not improve if you are allergic to follicle stimulating hormone ( fsh ) or any of the other ingredients of this medicine ( listed in section 6 ). you have a tumour of the uterus ( ovaries ) in your breasts , pituitary gland or hypothalamus ( ovarian or womb ) you have or have ever had enlarged oaries . you have cysts on your  Ovaries that do not work properly ( called polycystic ovarian disease ), bleeding from the vagina or an early menopause ( malformations of the sexual organs ). warnings and precautions talk to your doctor , pharmacist or nurse before using rekovelle if : you are at an increased risk of pregnancy , or you are found at high risk of fibroids of the
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will calculate the rekovelle dose for you during your first treatment cycle . you will be given anti - millerian hormone ( hcg ), a medicine that will stimulate your ovaries to respond to stimulation with gonadotropins . the dose you receive is based on your body weight . a blood sample taken within the last 12 months will be used to measure the duration of treatment . this will be calculated by your doctor and will be injected at the same time each day . how much you weigh - the doctor will tell you how many follicles you need to have each day and for how long you should be treated . treatment will be started at a dose of one ml per day for the first 12 months of treatment and on your
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects may occur due to the changes in hormones involved in infertility . this medicine may cause a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms may include pain or discomfort , swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain , and difficulty breathing . contact your doctor immediately if you experience any of these symptoms . a side effect is common ( may affect up to 1 in 10 people ). headache and nausea have been reported in women treated with this medicine . not known ( frequency cannot be estimated from the available data ). you may experience a very rare , but serious , reaction to rekovelle , which may be life - threatening . in a small number of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . rekovelle may be stored at room temperature ( up to 25 ) for a single period not exceeding 3 months . from a microbiological point of view , if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 3 months below 25 . after the treatment any unused solution should be discarded . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what rekovelle contains - the active substance is follitropin delta . each multidose cartridge contains 12 micrograms ( corresponding to 0 . 6 millilitres of solution ). after dilution : one ml of solution contains 33 . 3 million international units [ iu ] (  - fl ]).  the other ingredients are : phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrate and concentrated phosphoric acid and sodium hydroxide . - solution for injections . what retinol looks like and contents of the pack refinoll is a clear and colourless solution . it is supplied in a pack containing 1 cartridge and 3 pen injection needles 
the active substances of revinty ellipta are fluticasone furoate and vilanterol . two different active substances in one tablet are used : - on the first day of each month - the other two in the morning and the other in the evening . - when you wake up , the thought of having a meal is different ? - if you cannot stand or lie down straight after you have finished your meal , do not lie down until you are ready to go to bed , and then take your next meal at the usual time . how much to take adults : the recommended dose for adults is 92 - 15 minutes . the dose for children and adolescents ( 12 years of age and older ): the starting dose is 184 - 20 minutes after the start of the meal . adults with chronic obstructive pulmonary disease ( copd )
do not use revinty ellipta - if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you use your first or second injections . your doctor may decide to temporarily or permanently stop your injection if any of these apply to you . if the above applies to you ( or you are not sure ), discuss with your doctor the potential risks and benefits of using revinety it is important that you tell your doctor about all of your medical conditions . you may have liver disease , as these may be more serious and difficult to treat . in case of side effects , you should take the first and moderate or severe liver disease ( see also section 4 ). you should continue to use the lower strength of revinnty
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use asthma the recommended dose to treat asthma is one inhalation ( containing fluticasone furoate and 22 micrograms of vilanterol ) once a day . for severe asthma , the higher strength inhaler should be used . this dose should not be used after the expiry date which is stated on the label and carton after exp . your doctor will tell you how many puffs you need to use . the dose to inhale revinty ellipta is the same as for adults : - to help you breathe more easily throughout the day and night , at the same time each day ( preferably in the morning and evening ). this will also help you to remember when to use it ( e . g .
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to revinty ellipta are rare ( may affect up to 1 in 1 , 000 people ). contact your doctor immediately if you get any of the following symptoms while you are taking this medicine : skin rash ( hives ) or redness swelling , sometimes of the face or mouth ( angioedema ). becoming very wheezy , coughing or having difficulty in breathing , feeling weak or light headed or having fits ( stevens - johnson syndrome ). these may be signs of an upper respiratory tract infection ( thrombocytopenia ). your doctor may prescribe an anti - fungal medicine for the treatment of your hepatitis c infection . signs include : very rarely , allergic reactions have been reported in patients taking revin
what revinty ellipta contains - the active substances are fluticasone furoate and vilanterol . - each 92 mg inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 92 micrograms , corresponding to a total of 22 microgram ( 0 . 25 milligram ) ( equivalent to 92 millilitres ). - this corresponds to the total daily dose ( mg ), which is taken in the morning , and in the evening , at about the same time each morning and inhale the contents of the tablet . the other ingredients are : lactose monohydrate ( see section 2 ) and magnesium stearate ( see end of section 2 for more information about some of the ingredients in the form of sugar ) in the breath and a light grey inhaler with a
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ) in adults ; and emtricitabine , also known as a nuclear medicine doctor ( a neurosurgeon - specialist in treating human ipple - like illness ) and tenofovir , another human immunosuppressive medicine , which is thought to work in different ways . these active substances are antiretroviral medicines that work by interfering with the synthesis and reversible gene that the virus needs to grow and reproduce itself . in the end of this leaflet there is a clear benefit for you when you are an adult and / or a child who is taking other antir
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet taken by mouth once daily . you can take atripla with or without food . swallow the tablet whole . do not chew , crush or split the tablet before swallowing . take the tablet at about the same time each day ( for example , one tablet in the morning and one in the evening ). it is best to take your tablet on an empty stomach at least 1 hour before or 2 hours after a meal . in some cases , some side effects ( e . g . dizziness , drowsiness ) may occur . your doctor will tell you how long your treatment will last . keep the tablet bottle with you so that you can easily describe what your tablet looks like and contents of the pack . when to take at
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood fats sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any of these , especially if they are treated with atripla , you may experience a reduction in the amount of lactic acid in the blood . these are rare ( may affect up to 1 in 1 , 000 people ). this is a very rare but serious side effect that can be fatal . the most serious side effects listed below are listed below : the most common ones are : deep rapid breathing , drowsiness , feeling sick ( nausea ), being sick ( vomiting ), stomach pain 
what atripla contains - the active substances are efavirenz , emtricitabine , and tenofovir disoproxil . - each atripla film - coated tablet contains 600 mg ( 0 . 5 mg ) eifavirenz ( corresponding to 200 mg / ml ) in three sachets . this corresponds to a daily dose of 245 mg ( 4 x 108 ) on the day of the week . the other ingredients are : tablet core : croscarmellose sodium ( e468 ), hyprolose , magnesium stearate , microcrystalline cellulose , sodium laurilsulfate ( see section 2 under " what you need to know before you take "). tablet film coating : iron oxide black and iron oxide red ( 
the active substance of orgalutran , ganirelix , belongs to a group of medicines known as anti - gonadotrophin , which stimulates the production of follicles . gnrh regulates and inactivates this hormone which is involved in the growth and development of children . it is used in combination with other reproductive techniques ( in vitro fertilisation ( ivf )) and other methods to stimulate the release of hormones involved in reproduction . these hormones play an important role in human fertility and in fertility . however , in some cases , even in children , it may not be possible for the egg to develop and release the mature egg cells . they are then released into the ovaries , where they are grown and dividing , and in the process of assisted reproduction techniques known as ' fl - containing hormones '
you must not be given orgalutran if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). you are hypersensitive to gonadotrophin releasing hormone ( gnrh ) or to any other similar antigen ( s ) you have a moderate or severe kidney or liver disease you are pregnant or breast - feeding warnings and precautions talk to your doctor or pharmacist before you are given or galutran allergic reactions if your doctor determines that you have an active allergic condition . your doctor may recommend additional monitoring during treatment if allergic reactions occur . allergic reactions may be generalised such as hives ( urticaria ), swelling of the face , lips tongue and / or throat that may cause difficulty in breathing or swallowing ( angioedema or anaphylaxis ). if any of these apply to
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will decide on the correct dose of orgalutran . the treatment is started by a doctor experienced in the use of assisted reproduction techniques ( in vitro fertilisation ( ivf ), followed by ovarian stimulation with follicle stimulating hormone ( corifollitropin ) on day 2 or 3 of each cycle . you will be instructed by your doctor how to inject or inject yourself under the skin ( subcutaneous injections of 5 to 6 times a day ). your doctor may decide to give you or your child fsh . for details on the preparation of the preparation , please refer to the instructions for use at the end of this leaflet . different injection sites are available for daily treatment . it is very important that you do not inject yourself directly into the egg
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effect , talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . very common ( may affect more than 1 in 10 people ) local skin reactions ( redness and swelling ). the local reaction usually disappears after 4 to 4 days or is more likely to affect up to 1 in 100 people . headache , nausea , malaise 10 , 000 people allergic reactions rash facial swelling and difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat which may cause difficulty in breathing or swallowing ( hypoglycaemia ) not known ( frequency cannot be estimated from the available data ) allergic reactions such as rash , facial swelling , difficulty breathing , ( hypono
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . syringes should be stored in a refrigerator ( 2 - 8 ). do not freeze . store in the original package in order to protect from light . clear , particle - free solutions should be used immediately after dilution .
what orgalutran contains the active substance is ganirelix . each vial contains 0 . 5 ml of acetic acid . the other ingredients ( excipients ) are mannitol and water for injections ( to adjust the ph ) and sodium hydroxide ( e524 ) in the solvent . aqueous solution for injection or subcutaneous administration is provided in a clear glass vial with the needle inserted in the vial . dry natural rubber / latex is used to control the pH ( iu ) produced by recombinant dna technology ( a type of protein ) supplied by the national reporting system listed in appendix v . by reporting the end of this leaflet , you can help provide more information on the safety of this medicine . it is available in packs of 1 via
blitzima contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a specific type of white blood cell called " b - lymphocyte ". if the number of cells in your cell grows too low , and the medicine dies , you get a new " antigen ". your doctor may stick to the new protein but stick to it for as long as your doctor or pharmacist prescribes it for you . your physician may give you ( or your child ) another medicine called " chemotherapy ". in this case , it may not work as well as it should . you may still develop a condition called " lymphocytic leukaemia " ( cll ) in adult patients who have a disease of the lymph tissue ( part of the immune system ) that
do not take blitzima : - if you are allergic to rituximab , other proteins which are similar to the active substance , or to any of the other ingredients in this medicine ( listed in section 6 ) if your doctor thinks you may have a severe active infection due to a weak immune system ( severe heart failure or severe uncontrolled heart disease , granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris ). warnings and precautions talk to your doctor , pharmacist or nurse before and while you are taking this medicine if : you are at risk of developing a hepatitis infection . your doctor may want to monitor you closely . you may need closer monitoring of your progress and to check that you are not sure . it is important that you do not get he
blitzima will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . your doctor will decide how many treatments you need . you will always have access to the product via a drip ( intravenous infusion ) over one or two hours . medicines given before each bblisima administration before you are given the dose , your doctor may ask you to take other medicines ( pre - medication ) to prevent or reduce possible side effects and reduce your dose . during your treatment you will be monitored for non - hodgkin ' s lymphoma . if you are treated for a condition that requires immediate medical attention , you may receive up to 4 treatment courses at the same time . repeated treatment courses with b
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . you may also experience pain at the site of infusion , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , cough , diarrhoea , indigestion , heartburn , nausea , vomiting , sore throat and mouth ulcers . tell your doctor as soon as possible if you notice any of the side effects above . other side effects may include : very common ( may affect more than 1 in 10 people
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light .
what blitzima contains - the active substance is called rituximab . each 10 ml vial contains either 100 mg or a single dose ( i . e . 10 mg ), 50 mg or 500 mg ( corresponding to 5 . 5 mg /ml ). the other ingredients ( excipients ) are : sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections ( see section 2 ) for further information about some of the ingredients of the solution for infusion . pack sizes of 2 vials of 50 mg and 1 vial . not all pack sizes may be marketed in your country .
roactemra contains the active substance tocilizumab , a monoclonal antibody - a type of protein that recognises and attaches to a specific target in the body called interleukin - 6 ( igrp ). this helps to reduce the inflammation in your body and reduces the activity of a protein called ' pd - 1 receptor ' ( pmrra ). it is used in adults if symptoms such as pain and swelling in your joints start to worsen . by attaching to pmrp you reduce the damage to the cartilage ( the bone that supports your joints ) that your body has made - these proteins have been made from time to time , and improve your ability to do normal daily activities if they do not work as well as they should . the body can also attach itself to the disease . 
you must not be given roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). you have an active , severe infection at the time of the infusion . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have ever had allergic reactions , such as chest tightness , wheezing ( severe dizziness or light - headedness ), swelling of the lips or skin rash at the site of the injection . if any of these apply to you , tell your doctor or nurse immediately . you have signs of infection , including signs of infections , while you are being treated . tell the nurse or doctor immediately if your body ' s ability to fight infections or treat an existing infection . your doctor may want to monitor you
roactemra will be given to you directly into a vein by a healthcare professional or a nurse . your doctor or nurse will supervise the intravenous infusion and will decide on the dose you should receive . the treatment will start with a course of 8 courses ( 4 weeks ), followed by 4 courses ( 8 weeks ). your doctor will decide how many courses of courses you should take . if you have been given more than one course of courses , you may be given up to four courses of 6 courses ( 5 courses ) at the same time . it is very important that you continue with your course for as long as your doctor , nurse or pharmacist keeps you informed . depending on how you respond to the treatment , your doctor may decide to increase the dose or stop the administration . for adults , children and adolescents : the recommended dose for adults is 4 mg / kg body weight
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : very common ( may affect more than 1 in 10 people ): allergic reactions . difficulty with breathing , chest tightness , light - headedness . rash , itching and hives . swelling of the lips , tongue or face . serious infections . fever and chills . in the mouth and / or mouth . not known ( frequency cannot be estimated from the available data ). if you get any of these symptoms , seek medical advice straight away . your doctor may prescribe an anti - fungal medicine to help prevent them from coming into contact with your child . tell your doctor or pharmacist if they happen to you . they are usually mild to moderate and go away within 3 days after you stop taking 
keep this medicine out of the sight and reach of children . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . this medicine may pose a risk to the environment . do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment
what roactemra contains - the active substance is tocilizumab . each vial contains either : one vial of 4 ml concentrate or 80 mg or as a concentrate for solution for infusion . when reconstituted , the solution contains either 20 mg ( 20 mg ) or 200 mg ( 200 mg ), or a concentration of 2 . 5 mg ( 1 . 0 mg , 100 mg or 0 . 25 mg ( 10 mg / 20 mg concentrate ). after dilution : the concentrate is a clear , colourless liquid . it is available in packs containing sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphata dihydrate and water for injections . not all pack sizes may be marketed . the product information contained in this leaf
onbrez breezhaler contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . it relaxes the muscles in the walls of the small air passages in the lungs . this helps open up the airways , making it easier for air to get in and out . you have been given this medicine to make breathing easier for adults who have breathing difficulties because they have a lung disease called chronic obstructive pulmonary disease ( copd ). in copd these muscles get tighter ; this makes breathing difficult . using this medicine eases the tightening of these muscles in your lungs and so improve the flow of air into the pulmonary passages . your doctor will show you how to use them . if you have any questions about how this medicine works or why this medicine has been prescribed for you , ask your doctor .
you must not be given onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have asthma ( your doctor may need to adjust your dose ). you have heart problems . you have epilepsy you have thyroid gland problems ( thyrotoxicosis ) you have diabetes if any of these apply to you , your doctor will be able to decide if treatment should be continued . if the above applies to you ( or you are not sure ), talk to a doctor or pharmacist before using the product . children and adolescents do not give this medicine to children or adolescents under the age of 18 years because it has not been studied in this age group . other medicines and on
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one capsule each day . you only need to inhale once a day because the effect of the 150 microgram capsule lasts for at least 30 minutes . your doctor will tell you how many capsules to use during the treatment . do not use more than your doctor tells you to use . use your inhaler at the same time each day for up to 24 hours . onbrez breezhaler is available in different pack sizes . this ensures that you always have the impression that the medicine is clear and colourless . it does not matter whether you use it for the first time or if it has been inhaled . in this pack , you will find an inhalers and capsules ( in blisters ) that contain the medicine as in
what onbrez breezhaler contains the active substance is indacaterol . the other ingredients ( excipients ) are lactose and the capsule ( the capsule ) is made of gelatin . each off - white label ink is provided in an inhaler together with capsules in blisters . it is printed with the company logo and / or company logo on the capsule as well as in the black ink on the cap . your doctor or pharmacist will have prescribed the right dose for you based on your weight and which strength is best suited to you . you will find this information when you first open the capsule and it is important that you also read the information later in this leaflet ( see the other sections of the package leaflet for more information about ingredients ). the capsules contain a white powder that can be inhaled in the morning and evening . one onb
clopidogrel hcs contains the active substance triazolam . it belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , a process that clumps together during blood clotting . by preventing this clumpeding the body ' s own platelet ( thrombocyte ) from forming ( forming ) clots , which may then become dynamozygous ( t - thrombosis ) and should be taken under the supervision of a healthcare professional while : - the active ingredient in the medicine is a substance in the food chain called ' platelets '. these are formed in hardened blood vessels ( arteries ), which can be a target for atherothrombosesis , with an increased risk of at
do not take clopidogrel hcs : - if you are allergic to prednisolone or any of the other ingredients of this medicine ( listed in section 6 ). -if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain , or severe liver disease . if this applies to you , then your doctor may decide to reduce your dose of clopizide . warnings and precautions there is little information available on the safety and efficacy in general . you should tell your doctor before you are given , and while you are being treated , at all times , if your doctor determines that you should be able to take the tablets . talk to your doctor , pharmacist or nurse before and whilst you are taking it : you should inform your doctor about all possible risks and benefits of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . you should swallow your tablet with some water or other non - alcoholic drink , ensuring that you do not have any symptoms of severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg , but your doctor will tell you how much to take ( usually between 75 mg and 75 mg ) once at the start of treatment . then , the doctor may tell you to take a higher dose of 75 mg once a day ( see section 4 ). you
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and the whites of the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters ofthe skin . this may be the signs of an allergic reaction , particularly if taken with clopidogrel hcs . common side effects ( may affect up to 1 in 10 people ): diarrhoea , vomiting , nausea
what clopidogrel hcs contains - the active substance in each film - coated tablet is 75 mg / 0 . 25 milligram ( corresponding to 7 . 9 mg ) of clopizid ( as hydrochloride ). ( see section 2 ' important information about some of the ingredients in this medicine '): - tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castor oil . - film coating : polyvinyl alcohol , titanium dioxide ( e171 ), talc , macrogol 3000 . not all pack sizes may be marketed . your doctor will prescribe the best medicines for you based on your condition and the weight of your child ' s condition . what 
fetcroja contains the active substance cefiderocol , which is an antibiotic medicine . it belongs to a group of antibiotics called cephalosporins . antibiotics help the body to fight bacteria that cause infections . f et Croja is used to treat infections caused by bacteria when other antibiotics are not suitable .
you must not be given fetcroja - if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). you may also be allergic to other antibiotics , such as cephalosporins . you may have had a severe allergic reaction to certain antibiotics ( e . g . penicillins or carbapenems ). this may lead to severe skin peeling and swelling of the hands , face , feet , lips , tongue or throat that may cause difficulty swallowing or breathing . warnings and precautions talk to your doctor or pharmacist before you are given the medicine if : you have had any allergic reaction after you have been given the antibiotics in the past . your doctor may need to change your dose or stop your treatment in order to continue a low sodium diet . it is important that
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how is fetcroja given and how much should i take ? your doctor will give you this medicine as an infusion ( a drip ) into a vein . it will take about 3 hours . your doctor may change your dose , sometimes up to 2 weeks , depending on how well the medicine is tolerated . the recommended dose is one vial once a day . depending on the type of infection you have , the doctor will decide how much medicine you should take and how often you need to have it ? if your infection does not go away , or if there is any pain you can get after the febrcroja infusion . this will usually be given to you by a doctor or nurse . use in children and adolescents there is no experience with
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : severe allergic reaction - you may experience sudden swelling of your lips , face , throat or tongue , as well as a severe rash or other severe skin reactions , with difficulty swallowing and breathing . this reaction may also be preceded by diarrhoea and stools that may contain blood or mucus . your doctor may advise you to stop treatment with medicines that may slow bowel movement . other side effects include : very common side effects ( may affect more than 1 in 10 people ): - a common complication of a heart attack ( heart attack ) - dizziness - feeling sick ( nausea ) or feeling weak or generally unwell 
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . 1 mg / ml solution for injection or infusion is provided in a vial . the other ingredients are sucrose , sodium chloride , and sodium hydroxide to adjust the pH of the solution when reconstituted in water for injections ( see section 2 ). what you need to know before you make your first injection ? if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse . this is because it is a white to off - white powder for solution for infusion . pack size of 10 vials .
depocyte is used in adults to treat : lymphomatous meningitis ( a condition in which tumour cells invade the membranes of the brain and spinal cord ) in adults and children aged 2 years and above with lymphoma tumour cells . this is a rare but potentially life - threatening condition .
do not take depocyte if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). you have a meningeal infection . you have severe neurological side effects . warnings and precautions talk to your doctor , pharmacist , or nurse before you are given this medicine : you have symptoms that affect the nervous system ( such as convulsions , pain , numbness or tingling , blindness , visual disturbances ). if any of these symptoms occur , stop taking any depamethasone tablets and tell your doctor straight away . your doctor may decide to reduce the dose or stop your treatment if these unwanted effects occur . if your side effects do not improve or get worse or any new side effects while you are taking other medicines , including medicines obtained without a prescription . pregnancy ,
there are strict laws on the use , handling and disposal of depocyte . this product will only be used in special controlled areas , under the supervision of a physician experienced in the treatment of cancer . the following information is intended for the specialist only : keep this medicine out of the sight and reach of children . do not use lumber sac after the expiry date which is stated on the label of the vial and on the carton after exp . it is not intended for use in children under the age of 5 years . dexamethasone is to be used as a substitute for 5 ml of water for injections . use in elderly patients if the product has been frozen , it should not be administered to you . each despocyte dose should be diluted according to the manufacturer ' s instructions . if you experience any side effects , please inform your doctor .
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss the possible side effects with you and will explain the potential risks and benefits of your treatment . the following side effects have been reported in clinical trials : very common ( affects more than 1 user in 10 ) common : affects 1 to 10 users in 100 % not known ( frequency cannot be estimated from the available data ) very commonly reported among patients with 10  1 , 000  10 and more commonly reported adverse events have been observed in patients receiving depocyte in combination with other chemotherapeutic agents . very common in children and adolescents ( 0 . 25 ml ): nausea vomiting weakness , confusion fever headaches dizziness diarrhoea feeling sick ( nausea ) vomiting pain in the stomach stomach ( stomach ) indigestion , stomach ache 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . depocyte can be removed from the refrigerator and left at room temperature ( up to 25 ) for a single period not exceeding 4 months . keep the container tightly closed in order to protect from light . this medicine must not be used : if you notice severe discolouration , a changed appearance or a defective container , or if it contains part of the medicine called cytarabine . any unused product should be discarded .
what depocyte contains - the active substance is cytarabine . one ml of suspension contains 10 mg cytokines ( 5 mg ) per vial , corresponding to 50 mg / 0 . 5 mmol / kg of cytokine .  the other ingredients are : cholesterol , triolein , dioleoylphosphatidylcholine ( e331 ), dipalmitoylapizidyllglycerol , sodium chloride , and water for injections ( see section 2 ). whatdepocyte looks like and contents of the pack despocyte is a clear and colourless solution for injection . each pack contains 5 vials as a single injection , or one vial as multipacks comprising five cartons each . not all pack sizes may be 
the active substances of bemrist breezhaler are indacaterol and mometasone furoate in one tablet . indabacaterol belongs to a group of medicines called bronchodilators . it relaxes the muscles of the small airways in the lungs , making it easier for air to get in and out . this helps the airways to remain open . when used regularly , it helps to open more airways , which helps to keep the smaller airways open more easily , and so prevents breathing problems . corticosteroids also help to prevent attacks of asthma . your doctor will recommend the most appropriate treatment for you . if you have any questions about asthma , ask your doctor .
do not use bemrist breezhaler - if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have heart problems ( such as an irregular or fast heartbeat ) you have thyroid gland problems . you have diabetes ( high blood sugar ) or you have ever had seizures you have a low level of potassium in your blood you have severe liver problems you have tuberculosis ( tb ) of the lung , or any long - standing or untreated infections . your doctor may decide to keep you under closer observation while you are receiving treatment . if any of these apply to you
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much bemrist breezhaler to inhale the content of one capsule each day will help you to remember to use it . you only need to use the medicine once a day . do not change the dose unless your doctor tells you to . your doctor will tell you how many capsules to use , when to use and how long you should continue to use them . this will help to keep you on the right path to health and your symptoms will be controlled by your doctor , and it is very important that you do not miss a dose . if it is almost time for your next dose , skip the missed dose and go back to your regular schedule . find the inhaler provided in this pack . the capsules should remain in the blister until you need
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious . tell your doctor straight away if you notice any of the following : common ( may affect up to 1 in 10 people ) difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives ( signs of allergic reaction ). uncommon ( may effect up to1 in 100 people !) swelling , sometimes of your tongue / lips / face or throat ( possible signs of angioedema ). other side effects are listed below . if any of these side effects causes you problems , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special temperature storage conditions . store the capsules in the original blister in order to protect from light and moisture .
what bemrist breezhaler contains - the active substances are indacaterol ( as acetate ) and mometasone furoate . each inhaler delivers a delivered dose ( the dose that leaves your mouthpiece ) of 125 micrograms / 62 . 5 microlitres , corresponding to a deliverable dose ( i . e . 1 microgram each time you inhale a single dose ). - each delivered dose is equivalent to 173 microgram ( equivalent to 127 . 3 microgram of indocaterol - one 150 microgram dose ) taken as two separate inhalers . the other ingredient ( s ) in the other exhaler is inhalation purplish ( a white to off - white powder ). the delivery device ( the mouthpiece of the
the active substance of zyllt , clopidogrel , belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products cut off the blood supply that keeps it forming . this is called thrombosis and is life - threatening . zllt is taken by adults to prevent new clots ( thrombi ) forming in hardened blood vessels ( arteries ), which in turn reduce their size , in a way that the blood cannot be pumped around the blood ( a process known as atherothrombosesis ). this can lead to atherotrothrombotic events ( such as stroke , heart attack , or death ). you have been prescribed
do not take zyllt if : you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . you suffer from severe liver disease . if any of these apply to you , or if you are in any doubt at all , consult your doctor before taking zylt . warnings and precautions before you take the medicine you should tell your doctor : if the medicine is used in adults , adolescents and children under 18 years of age . your doctor may want to monitor you more closely , and may give you a lower dose if necessary . talk to your doctor about all of your medical conditions that you have been in close contact with someone who is known or suspected to have internal bleeding ( for example , a
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . in case of severe chest pain ( unstable angina or heart attack ), your doctor may increase your dose to 300 mg . your doctor will tell you how much to take ( usually between 75 mg and 75 mg ) once at the start of treatment . then , the usual dose is two 75 mg tablets per day as described above for as long as you are benefiting from the 75 mg dose . you should swallow the tablets whole with water . do not chew , crush or split the tablets . try to take zy
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and the whites of the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters ofthe skin . this may be the signs of an allergic reaction . other side effects may include : very common ( may affect more than 1 in 10 people ): diarrhoea , vomiting , nausea , constipation , dizziness 
what zyllt contains - the active substance is clopidogrel . each film - coated tablet contains 75 milligrams ( as hydrogen sulphate ). the other ingredients are : - tablet core : lactose ( see section 2 under ' important information about some of these ingredients '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the tablet core as well as hypromellose , titanium dioxide ( e171 ), red iron oxide and talc and propylene glycol in the film and ink : shellac , indigo carmine , iron oxide red and white to off - white , round tablets , with " gsi " debossed on one side and " cb " on the other side . what
what lamivudine teva is and what it is used for the treatment of adults , children and adolescents ( 6 years of age and older ) with long term ( chronic ) hepatitis b infection in adults and children ( aged 12 years and above ) at risk of exposure to a potentially life - threatening species of virus called ' nucleoside analogue reverse transcriptase inhibitors ' ( nanalogues ). nasilomania b is a type of virus that infects the liver . it is , in rare cases , a target of a virus , which can inactivate and infect other people . this can lead to liver damage . when used in patients with a condition such as a patient whose liver is damaged but still functions normally ( compensated liver disease ). treatment with
do not take lamivudine teva : - if you are allergic to or have ever been told to by your doctor or nurse about any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 talk to your doctor , pharmacist , or nurse before you are given orally ( by mouth or by injection ). you may need to be closely monitored while you are being given and when you should have been treated for 28 days at the same time as with other similar medicines , because these may increase the risk of serious side effects . you have liver disease ( e . g ., hepatitis c .) you are overweight . your doctor may ask you to have blood tests , especially at the start of your medication . see section 4 for more information . don ' t change the dose unless your doctor tells you to
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take your doctor will tell you how many tablets of lamivudine teva to take each day . this will help you get the best results for your health . it also helps to control your condition when you get older . your doctor may also tell you to take a different dose if needed . do not change your dose unless your doctor tells you to . if your hepatitis b infection does not control your infection or stop your illness from getting worse , and you may need to take more tablets than you should . take the tablets every day at the same time of the day , preferably in the morning , with food . swallow the tablets whole with water . you may find it easier to take lam
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects of lamivudine teva are related to other conditions linked to hepatitis b . it is important that you inform your doctor or pharmacist if you experience any of the following side effects during or after therapy with hpt ': - the side effects listed below have been reported in some patients who have had , or are now considered to be related to , some or all of the conditions listed below . if these side effects occur , they should stop treatment temporarily or permanently . in some cases , patients may also develop a further , more serious , life - threatening situation , including :  tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort and pain , nausea , vomiting , diarr
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . lamivudine teva should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what lamivudine teva contains - the active substance in each film - coated tablet is 100 mg debossed with " lilly " on one side and " gilead " on the other side . the other ingredients are : tablet core : microcrystalline cellulose , sodium starch glycolate ( type a ), magnesium stearate . tablet film coat : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow , and iron oxide red , all in the tablet coating : carnauba wax , white to off - white , marbled , round tablet : 32 mm in diameter , marked with ' lt ' and the company logo in black ink on the body and in the pocket : the tablet can be divided
nespo is an anti - anaemic . it is used to treat your anaemia , which is caused by an increase in the amount of red blood cells in your blood . this helps to reduce the symptoms ( fatigue , weakness and shortness of breath ) caused by the low levels of the natural hormone erythropoietin in your kidneys . by doing so , your bone marrow becomes receptive to the increased production of white blood cells . darbepecin alfa is used for the treatment of adult patients with chronic renal failure , who are at high risk of having a lower level , but who have a higher than normal level of symptomatic anemia . there is a link between the treatment and the patient ' s kidney failure . patients with kidney failure who have had kidney failure before had a problem with their kidney
do not use nespo : - if you have high blood pressure , or are taking other medicines that are high in fat ( e . g ., darbepoetin alfa ) or r - hoepo , as these may affect your ability to use medicine for sickle cell anaemia . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you have a history of epileptic fits ( seizures ). you have history of fits ( convulsions , sometimes called fits ), you have liver disease or you are taking drugs that can affect your condition . you have been told that you have an aemia caused by an allergy to latex . the needle on the pre - filled tiee contains a derivative of latex and may cause symptoms such as unusual tiredness or lack of
your doctor will carry out blood tests before you start using nespo and regularly check your haemoglobin level . the usual dose is 10 micrograms / kg body weight , given once a week . if you need to change your dose , your doctor may start you on a higher or lower dose . it is preferable to use the pre - filled syringe directly into a vein ( intravenously ). in adult patients with chronic renal failure , a single injection may be given subcutaneously under the skin , or intravenous ) and your anaemia will be checked by your doctor . dose the recommended dose for you depends on your body weight in kg ( between 0 . 75 and 0. 45 mmol / ml ). you will need to take regular blood samples at regular intervals while you are being treated to monitor the status of
like all medicines , nespo can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : 471 very common ( affects more than 10 users in 100 ): high blood pressure ( hypertension ) with fluid retention ( oedema ). uncommon ( impact affects 1 to 100 users in 10): blood clots ( thrombosis ). pain in the area injected rash , redness of the skin rare ( effect affects less than 1 user in 10 , 000 ). serious allergic reactions including sudden life - threatening allergic reactions ( anaphylaxis ) which may include swelling of the face , lips , mouth , tongue or throat that may cause difficulty in swallowing and / or breathing ( angioedemo ). not known ( frequency cannot be estimated from the available
keep out of the reach and sight of children . do not use nespo after the expiry date which is stated on the carton and on the syringe label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the container in the original package in order to protect from light . after first opening , you may not be able to see the contents of the vial when opened . you may remove a vial from the refrigerator and store it at room temperature ( not above 30 ) for a single period of up to 7 days in the outer carton when you are not using it . your doctor or pharmacist will advise you how to store medicines that are not in compliance with the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of medicines used to provide this information .
what nespo contains - each pre - filled syringe contains 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 , or 500 iu of the active substance darbepoetin alfa . - the other ingredients are : the solvent is a clear to slightly pearly , colourless to slightly yellow solution , which is essentially ' water for injections '. the solution is clear and colourless , and free from visible particles . each pack contains : one single - use pen . one multidose pen is also available for single use only . not all pack sizes may be marketed .
macugen is a solution that is injected into the eye by a doctor or a nurse . it contains the active substance pegaptanib . this medicine reduces the formation of new blood vessels in the eye and so slows down their absorption . macusgen is used for the treatment of patients with macular degeneration . patients with this disease may experience vision loss or damage to the part of the retina called the macula , which forms the backbone of the eye . in patients with amd , abnormal blood vessels grow and contract in the retina and become damaged over time . your doctor will work out how to repair these new cells . if you have an amd diagnosis , tell your doctor .
do not use macugen if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). you have an active or suspected infection in or around your eye . warnings and precautions talk to your doctor , pharmacist or nurse before you are given Macugen you may be at risk of developing an infection or bleeding in the eye whilst you are being treated , or after you have been properly supervised by a doctor or a nurse . at the first sign or location you should be aware of the following symptoms : eye pain increased discomfort , worsening eye redness , blurred or decreased vision , increased sensitivity to light , small particles in your vision . the injection may need to be stopped and the doctor or nurse will watch you closely during the injection . if the injection serious allergic reactions occur , the symptoms may last for up to 4
macugen will be given to you in a hospital or clinic under the supervision of a doctor experienced in the use of injections . your doctor will decide on the right dose for you based on your individual needs . the recommended dose is one injection ( 0 . 5 ml ) into your eye every 6 to 9 days . after the injection , the substance will be injected into the vitreous ( clear , clear ) part of your eye ( called the anterior ocular layer ). your doctor may decide that you can be treated with Macugen . you may also be given antibiotic eye drops to avoid it from getting into your eyes . if you are given some local anaesthetic ( numbing medicine ) to reduce or prevent any pain you might have with the injection ( see " instructions for use " at the end of this leaflet ). you may be allergic to antibiotic
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction ) with angioedema of which symptoms include : breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting ( rapid pulse ), stomach cramps , nausea , vomiting and diarrhoea . the frequency of these side effects is not known ( frequency cannot be estimated from the available data ). an infection in the internal portion of the eye has been reported in patients receiving macugen treatment . these symptoms are described in section 2 . if you get any of these symptoms , tell your doctor or pharmacist .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . the medicine should be used immediately after dilution .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 ml solution for injection , corresponding to 90 mg / millilitre .  the other ingredients ( excipients ) are sodium chloride , monobasic sodium phosphate monohydrate ( e339 ), dibasic salt ( a type of salt called sodium hydroxide ), hydrochloric acid ( for ph adjustment ) and water for injections ( see section 2 . what Macugen looks like and contents of the pack macarugen solution is a clear , colourless to pale yellow solution , supplied in a single dose pack or a pouch . it is supplied as a multidose pack containing one dose : - a powder vial containing a
kepivance contains the active substance palifermin ( produced by recombinant dna technology in escherichia coli ). it belongs to a group of medicines called epithelial cells , which are found in the mouth and digestive tract ( tissues of the skin ). they work by attaching themselves to the receptors in the blood called epidermal cells and are then released into the blood stream . when you have this reaction , it can be removed by your doctor . it can also be used if other treatments have not worked or are not suitable for you . oral mucositis ( soreness , dryness and inflammation of the mouth ) has been reported as a side effect in patients receiving treatments for your blood cancer . if you have or have had a lot of blood cancer ( for example , chemotherapy , radiotherapy or autologous
do not take kepivance - if you are allergic to palifermin or escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . children and adolescents do not give this medicine to children or adolescents under 18 years of age as it has not yet been studied in these patients . other medicines and kepeivance tell your doctor or pharmacist if using , have recently used or might use any other medicines . in particular , you should inform your doctor of any medicine you are taking , or have recently taken , heparin . your doctor may decide to keep you under closer observation or change your dose . pregnancy and breast - feeding it is not recommended to start breast feeding when you are pregnant , think you may be pregnant or are planning
kepivance will be given to you in a hospital or clinic under the supervision of a doctor experienced in cancer treatment . your doctor will calculate the dose you need based on : your body surface area ( m2 ) in square meter ( 0 . 5 ml ). the recommended dose is 60 mg / kilogram body weight given once a week as an intravenous injection into a vein . if you have any questions , ask your doctor , pharmacist or nurse . how often you will receive kepeivance it is very important that you have it all in the three days before chemotherapy and radiotherapy , and for at least three days after chemotherapy and radiation . chemotherapy andradiotherapy are usually given at the same time each day . it is usually given for 24 to 48 hours after the chemotherapy has finished . you should usually receive radiotherapy at least one week after the
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ) side effects reported with kepivance include : skin rash , itching and redness ( pruritus ) and erythaema ( an increase in the thickness in the mouth or tongue , change in colour of the mouth and tongue ) generalised swelling ( oedema ) including swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ), altered taste , lipase , and amylase levels ( seen commonly in patients taking this medicine ). not known ( frequency cannot be estimated from the available data ): dizziness , headache , diarrhoea , vomiting , nausea , constipation ,
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 milligrams ( 8 . 0 millilitres ) ( equivalent to 12 . 1 milliliters ).  the other ingredients are mannitol ( e421 ), sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid ( see end of section 2 for further information about some of the ingredients ). what you need to know before you have been given kepeivance ? what the pack contains one vial of powder for solution for injection . it is available in packs containing 6 vials .
the active ingredient cinacalcet accordpharma works by reducing the levels of parathyroid hormone ( pth ), calcium and phosphorous in the blood . it is used to treat problems with organs called parathyroid glands . the four small glands in the neck are near the thyroid gland , where they are used : to treat secondary hyperparathyroidism in patients with serious kidney disease who may need dialysis to clear their blood of waste products . to reduce the amount of calcium inthe blood ( hypercalcaemia ) in some patients with atathyroid cancer , there is also a possibility of a build - up of some of the excess , resulting in a high level of calcium to be removed in some cases ( e . g . in primary and secondary hyperparathyroidisme ) when removal of the gland is not feasible . use of cina
do not take cinacalcet accordpharma - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking any medicine . - you have low levels of calcium in your blood . your doctor may need to increase your blood calcium levels . you should not be treated with any other medicines or supplements . take special care with the tablets . do not swallow the tablets whole , as they may have an effect on their ability to resist the impulse , drive or temptation to carry out certain activities that could harm yourself or others . these activities are called convulsions . in some cases , seizures ( fits ), seizures may be life threatening and even fatal outcomes . low calcium levels in the blood may be associated with hypocalcaemia . therefore , you should tell your doctor or pharmacist
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of cinacalcet accordpharma is one tablet a day . your doctor will tell you the dose to take . you should swallow your tablet whole with a drink of water . do not chew or break the tablet before swallowing . if necessary your doctor may ask you to take the tablets for a short time before you start treatment . for patients with secondary hyperparathyroidism the usual starting dose for the first three months of treatment is 30 mg . this dose will be increased to one tablet every three weeks . children and adolescents ( 3 to 18 years of age ) the usual dose is 0 . 20 mg / m2 body surface area , which will be added to the tablet and will be diluted with another tablet ( s ) once a
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience numbness or tingling around the mouth , muscle aches or cramps and / or seizures ( these may be signs that your calcium levels are too low ( hypocalcaemia ). swelling of the face , lips ,mouth , tongue or throat that may cause difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ) nausea and vomiting . these side effects are very common . common : may affect up to 1 in10 people dizziness , headache , hiccups . not known ( frequency cannot be estimated from the available data ). you may experience more diarrhoea , vomiting , nausea , constipation , flatulence ( wind ),
what cinacalcet accordpharma contains - the active substance in each film - coated tablet is a colourless to light yellow - yellow , oval shaped tablet of approximately 9 . 65 mm x 6 . 00 mm in diameter , biconvex . tablet coating : - cellulose , microcrystalline - crspovidone - magnesium stearate , hypromellose , titanium dioxide ( e171 ), triacetin , indigo carmine aluminium lake , iron oxide yellow and engraved with ' cbc ' on one side of the tablet and plain on the other side , with a blue imprint of ' 30 mg '. the tablet can be divided into equal doses . it is available in bottles of 30 tablets . each bottle contains a white to light green colored ,
jentadueto contains two different medicines called linagliptin and metformin in one tablet : one is called dpp - 4 inhibitors and the other is called dipeptidyl peptidase - 4- inhibitors . one of these belongs to a class of medicines called biguanides . they work together to control blood sugar levels in adult patients with a form of diabetes called ' type 2 diabetes mellitus '. this medicine can be used alone or together with insulin . your doctor may prescribe this medicine alone or in combination with certain other medicines for diabetes ( such as sulphonylureas , empagliflozin ) which are also used together to treat a certain type of diabetes ( e . g . insulin ). it is important that you continue to follow the advice on diet and exercise given to you
do not take jentadueto if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). you have severely reduced kidney function . you have uncontrolled diabetes , with , for example , severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss , lactic acidosis . if this is the case , you must contact your doctor as soon as possible , as it may be a more serious , possibly life - threatening problem , and if there is a risk of lactic acidsis ( see section 4 ). if ketoacidosis is the condition , which occurs when substances called ' ketone bodies ' accumulate in the blood and which can lead to diabetic pre
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of jentadueto is one tablet a day . you currently take metformin in the form of individual tablets . your doctor will tell you how many tablets of linagliptin to take in the morning and evening , based on how well your body is converting insulin ( see section 2 ). your doctor may adjust your dose of this medicine if necessary . taking this medicine to lower your chance of an upset stomach . take one tablet each day with food , and one tablet at a time . this will help you to remember to take your tablet ( s ) as soon as you wake up . the tablet can be taken with or without food . if your doctor prescribes you : - take 5 mg 
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms need immediate medical attention you should stop taking jentadueto and see a doctor immediately if you experience any of the following symptoms of low blood sugar ( hypoglycaemia ), which are usually mild : trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change or confusion ( see section " warnings and precautions " for information on some of the side effects in section 2 ). the frequency of this side effect is common ( may affect up to 1 in 10 people ). a side effect has been reported in patients treated with jerkin - to - mix with sulphonylurea . this is more likely to occur in patients who are not able to take tablets and who are unable to take the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , blister or bottle after " exp ". this medicine does not require any special temperature storage conditions . blister : store in the original package in order to protect from moisture . tampering : do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . - each japanese 2 . 5 mg / 850 mg film - coated tablet ( tablet ) contains 2 : 5 milligrams ( 3 millilitres ) of lilly nealadsorbed on a bed or a chair with a tachometer . this quantity corresponds to a volume equivalent to two doses , corresponding to four doses per tablet , which is equal to one third of one milliliter ( 10 micrograms / kg ). the other ingredients are : - in the core of one tablet ( a desiccant ) - arginine , copovidone , magnesium stearate - maize star
edurant contains the active substance rilpivirine . it is used to treat human immunodeficiency virus ( hiv ) infection in adults , adolescents and children of all ages who are also taking hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). it works by reducing the amount of hiv in your body . this means that it can be passed on hiv to other people who are already infected with hiv and it is not known how it will become resistant to hiv or if you have already taken hiv medicine ( or a combination of medicines that have been prescribed for you ).
do not take edurant : - if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before taking the following medicines : carbamazepine ( esomeprazole ), oxcarbazepine , phenobarbital and phenytoin ( medicines used to treat epilepsy and prevent seizures ) rifampicin ( a medicine used to suppress the immune system and to treat some bacterial infections such as tuberculosis ). omeprazoline ( i . e ., opportunistic drug of the class iii ) and st john ' s wort ( bitter stomatitis ) ( medicines
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults ( 18 years of age and over ) the recommended doses of edurant are : 1 . rifabutin , a medicine used to treat some bacterial infections , have been shown to be less effective in some patients when they were younger than before . your doctor may decide to change your dose , but your doctor will tell you if it is suitable for you or your child . do not change the dose unless your doctor tells you to . 2 . make sure your doctor gives you an antacid ( a drug used to prevent diseases caused by the acid in the stomach ) such as aluminium / magnesium hydroxide or calcium carbonate . you must take the anteacid at least 2 hours before or 4 hours after meals .
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience headache , nausea , difficulty falling asleep , insomnia and dizziness when getting up from a lying or sitting position . your usual liver tests may also show an increase in transaminase , increase in cholesterol and pancreatic amylase in your blood , abnormal dreams , rash and stomach pain ( signs of depression , tiredness , vomiting ), drowsiness , decreased appetite , sleep disorders , stomach discomfort , depressed mood , feeling unwell . if you notice any of these signs , tell your doctor straight away . side effects reported with edurant may include : very common ( may affect more than 1 in 10 people ): diarrhoea , constipation , weight gain , increased sweating 
what edurant contains - the active substance is rilpivirine . each film - coated tablet contains rillirine hydrochloride of 25 mg / ml . the other ingredients are : in the tablet core : lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose , magnesium stearate in the core of the tablet . in addition , there is a further inactive ingredient called ' sodium - free ' ( see section 2 ). in addition to the above - listed ingredients : - particulate matter ( e463 ), hypromellose 2910 ( 6 mpa . s ) titanium dioxide , macrogol 3000 ( 3000 ) triacetin .
avandamet tablets are a combination of two different medicines called rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes in adults . people with type2 diabetes either don ' t make enough insulin ( a hormone that controls blood sugar levels ), or do not respond normally to the medicine when they are low . when this happens , it helps to increase the levels of insulin made by the body , which helps them to stay on the diet and exercise plan that your body makes when it is time for the insulin to be made . both of these medicines help to lower your blood sugar , and help to control the level of sugar in your blood when you have a sulphonylurea ( another medicine for diabetes ).
follow all your doctor ' s instructions carefully . they may differ from the general information contained in this leaflet . do not take avandamet if any of the following apply to you or the child you are caring for . if you are not sure , talk to your doctor or pharmacist before taking the tablets . warnings and precautions your doctor will tell you what to do if : you are allergic ( hypersensitive ) to rosiglitazone , metformin , or any other medicine of the group of medicines listed in section 6 you have had a heart attack or severe angina you have heart failure or have had heart failure in the past you have severe breathing difficulties you have liver disease you have diabetic ketoacidosis ( a complication of diabetes with rapid weight loss , nausea or vomiting ) you have kidney disease 107 you are very dehydrated ( alcohol )
always take avandamet tablets exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is 2 tablets of rosiglitazone and 1000 mg of metformin taken once a day . this dose is taken 1 to 8 hours apart . the maximum dose should not exceed 4 tablets . your doctor will tell you how many tablets to take . when to take your first dose : take one tablet in the morning and one in the evening , at about the same time each day , for at least 2 hours before you take your second dose . swallow the tablets whole with a glass of water . do not crush , chew or break the tablets as they may break apart and you may need to take them over a different time period . if this happens , your doctor may reduce your dose to one tablet of 
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions may occur with the use of this medicine . signs include : raised and itchy rash ( hives ) swelling , sometimes of the face or mouth ( angioedema ) and difficulty in breathing collapse . contact a doctor immediately if you experience any of these symptoms . your doctor may lower your dose , stop the treatment temporarily or permanently . lactic acidosis : a build - up of a molecule in the blood , which is a common side effect of metformin in patients with severe kidney disease . symptoms of lacticacidosis may include rapid breathing , cold or hot weather , rapid breathing and / or cold sweats . these may be due to the underlying disease and may be life - threatening . other
keep out of the sight and reach of children . do not use avandamet after the expiry date which is stated on the carton and the blister after exp . this medicine does not require any special storage conditions . if you have any unwanted tablets , don ' t put them in waste water or household rubbish . ask your pharmacist how to throw away tablets you no longer use . these measures will help protect the environment .
what avandamet contains - the active substances are rosiglitazone and metformin . each of the two active substances in each tablet contains a total of two different active substances : - two different strengths . - one of the three strengths is : one , followed by one another , in the form of a tablet called " riocigus " and one " non - crystalline cellulose , one of which is present as a powder for solution for injection ( see section 2 ). - three different strengths each , consisting of one or two tablets , each containing one tablet with one or three tablets with the other containing four tablets with two or three separate tablets . the other ingredients are : sodium starch glycollate ( type a ), hypromellose ( e464 ), microcrystalline ( cellulose ( 
clopidogrel mylan contains the active substance pretomanid , which belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , forming during blood clotting . by preventing this clumping , antiplatelets medicinal products cut off the blood supply completely ( a process called thrombosis ). if at any time you are not able to clot ( thrombi ), it can be hardened blood vessels ( arteries ) which can be severely damaged ( atherothrombosesis ), a condition that can lead to atherathrombotic events ( such as stroke , heart attack , or death ). you have been prescribed crombotis mylan to help reduce the number of blood coagulants and reduce the risk of them forming in adult patients .
you must not be given clopidogrel mylan 31 - if you are allergic to the active substance , or any of the other ingredients of this medicine ( listed in section 6 ). you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . you have severe liver disease . if this applies to you , your doctor may need to adjust your dose . do not take clopizide mylan . warnings and precautions talk to your doctor or nurse before you are given the medicine if : you are at an increased risk of bleeding ( for example , if your doctor determines that you need to be treated for a while ) or have been in close contact with someone who is known or suspected to have it , such as someone else . children and adolescents do not give this medicine to children under 18 years of age because there is
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food and drink , and at the same time each day . in case of severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg , once at the start of treatment , or up to 75 mg / 10 mg twice a day , unless your doctor tells you to stop . you should swallow the tablet whole with water and do not chew , crush or split the tablet before you take it . do not open or crush the tablet as this may affect its activity . for patients who take more clo
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and the whites of the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters ofthe skin . this may be the signs of an allergic reaction , particularly if taken with clopidogrel mylan . common side effects ( may affect up to 1 in 10 people ): diarrhoea , vomiting , nausea ,
what clopidogrel mylan contains - the active substance in each film - coated tablet is 75 mg / 0 . 25 milligram ( iu ) in each millilitre ( ml ) ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide , red iron oxide , yellow iron oxide ( e172 ), talc , macrogol 3000 . see section 2 ' important information about some of the ingredients of this medicine ' for further information on the contents of the tablet ( containing water for injections ) are : - tablet core : pregelatinised ( maize starch ) 
doptelet belongs to a group of medicines called thrombopoietin receptor agonists that are used to treat adults with chronic liver disease that results in low platelet count ( thrombocytepenia ). it is given to you by your doctor in a medical procedure that reduces the risk of bleeding by reducing the number of platelets in the blood . platelets are blood cells that help the blood to clot and so prevent bleeding .
do not take doptelet : - if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions blood clots may form in the veins or arteries , and this medicine may increase the risk of blood clumps . tell your doctor if any of these apply to you . your doctor may decide to reduce your dose , stop your treatment and tell you to stop . talk to your doctor or pharmacist before you start to take it if : you have cancer . you are taking the contraceptive birth control pill or hormone replacement therapy you have recently had surgery or you have been injured 23 you are overweight you have advanced chronic liver disease you are under 18 years old . this medicine is not recommended for use in this age group . other medicines and do not give this medicine to children or adolescents .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will calculate the dose according to your body surface area in square meters ( m2 ) and will determine the dose you should take during your procedure . the usual dose is 5 to 8 tablets of doptelet per day to be taken orally with or without food . swallow the tablets with a glass of water . do not crush , split or chew the tablets . you should not take dopetelet more than 20 mg , 40 mg or 60 mg tablets per day , for at least 5 days . depending on your platelet counts , your doctor may increase or decrease the dose of this medicine to 10 to 13 tablets in a day . this will make sure that your doctor knows exactly how many tablets you have to take , and how often to take them . if
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with doptelet : common ( may affect up to 1 in 10 people ): feeling tired 100 common : low red blood cell count ( anaemia ) blood clot in the portal vein ( a blood vessel that transports blood from the liver to the intestines ) upper abdominal pain , swelling bone pain muscle aches , fever tell your doctor or nurse straight away if you notice any of the side effects listed above , including any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what doptelet contains - the active substance in each film - coated tablet is avatrombopag maleate . - each tablet contains 20 milligrams / 0 . 5 millilitre ( ml ) version b ( equivalent to 20 mg / 10 milliliter ). -- the other ingredients are : lactose monohydrate ( see end of section 2 ), microcrystalline cellulose , crospovidone type b [ e1201 ], silica , colloidal anhydrous , magnesium stearate ( e470b ), vinyl alcohol ( partially hydrolysed ), talc , macrogol 3350 , titanium dioxide , iron oxide yellow and / or red ( for further information on the contents of the pack dopelet 20 mg tablets are pale yellow , round and rounded 
rapiscan belongs to a group of medicines called ' coronary vasodilators '. they work by helping to narrow the heart arteries and heart rate . they also help to relax the muscles in your heart , which is important for the function of the heart to be fully effective . if you have any questions about how this medicine works or why this medicine has been prescribed for you , ask your doctor . your doctor will do a scan of your chest for signs of ' myocardial perfusion imaging ', before it is given to you . the scan will be performed by using a radioactive substance called a ' radiopharmaceutical ' ( rms ). these images will help your doctor to see how well your muscles work . this can help your heart work better . it can also be done with a treadmill to help you get a closer look
do not use rapiscan - if you have slow heart rate , or high degree heart block ( e . g . due to sinus node disease ), or if your doctor has told you that you need a pacemaker to treat chest pain ( unstable angina ). warnings and precautions talk to your doctor or pharmacist before using this type of treatment if : you have low blood pressure ( hypotension ) or heart failure you are allergic to regadenoson or any of the other ingredients of the medicine ( listed in section 6 of this leaflet ). if any of these apply to you , tell your doctor straight away . your doctor may need to change your dose or stop your treatment temporarily or permanently . you have had a recent serious heart problem such as a heart attack you have abnormal heart rhythms you have been told by your doctor that your heart beat is very fast or uneven
rapiscan will be administered to you by a doctor or nurse who is experienced in the use of this type of medicine . the doctor will calculate your heart rate and blood pressure . it will be injected into a vein using 400 micrograms of a 5 ml solution the injection will take about 5 to 10 minutes . your weight will be calculated using the following formula : - an injection of sodium chloride 9 mg / kg ( 0 . 9 %) solution the dose you receive will be given over a period of 5 hours . - a radioactive substance ( radiopharmaceutical ) will be added to the injection before it is given to you . you will be asked to drink a sufficient amount of water for injections to help you breathe . this will be done in a hospital or clinic and will be monitored by the health care professional while you are being treated with rap
like all medicines , rapiscan can cause side effects , although not everybody gets them . some of the side effects may be serious and may occur shortly after the rapican injection . they usually occur within 30 minutes after you have received any treatment . tell your doctor straight away if you notice any of the following side effects as these may be signs of sudden stopping of the heart , damage to the heart or heart block . this may be a disorder ofthe heart ' s electrical signal . rapid heart beat low blood pressure , fainting , mini strokes , weakness of the face or inability to speak . your doctor may decide to temporarily or permanently stop your injection if he / she has had a stroke or cerebrovascular accident . an allergic reaction may be recognised as rash , wheals / weals or hives . the most frequently reported side effects
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , allowing blood to flow into the penis when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated . what viagra is used for viagra is a treatment for adult men with erectile dysfunction , sometimes known as impotence . this is when a man cannot get , or keep a hard - to - suitable penis suitable for sexual activity .
do not take viagra if : you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). you are taking medicines called nitrates , as the combination may lead to a dangerous fall in your blood pressure . tell your doctor if any of these medicines have been prescribed for you or you have ever had angina pectoris ( or " chest pain "). if you are not sure , talk to your doctor or pharmacist before taking the medicines . you may be given nitric oxide donors such as amyl nitsitrite (" poppers "), as the combined effect may also be used to cause a devastating fall in votre blood pressure ( see section 4 ). riociguat . this drug is used to treat pulmonary arterial hypertension ( i . e ., high blood pressure in the lungs
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is 50 mg . you should not take viagra more than once a day . your doctor may advise you to take viagra film - coated tablets or viagra orodispersible tablets with or without food . take viagra about one hour before you plan to have sex . swallow the tablet whole with a glass of water . viagra can help you to get an erection when you are sexually stimulated . it is very important that you do not have any effect with viagra unless you have discussed this with your partner , or your doctor tells you to stop taking it . do not stop taking viagra without your doctor ' s advice , as you may experience an increase in side effects . doses above 100 mg do not increase the efficacy .
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported in association with the use of viagra are usually mild to moderate and of a short duration . if you experience any of the following serious side effects stop taking viagra and seek medical help immediately : an allergic reaction - this occurs uncommonly ( may affect up to 1 in 100 people ). symptoms include sudden wheeziness , difficulty in breathing , or dizziness . swelling of the eyelids , face , lips or throat . chest pains : get in a semi - sitting position and try to relax . do not use nitrates to treat your chest pain . prolonged and sometimes painful erections have been reported in men . these are rare and affect less than 1 in 1 , 000 people . it may take longer than 4 hours for an er
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildinafil ( as the citrate salt ).  the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate , hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake . what viagra looks like and contents of the pack viagra film - coated tablets have a rounded - diamond shape and marked " gsi " on one side and " 25 " on the other . the tablets are provided in blister packs containing 2 , 4 , 8 or 12 tablets . not all pack sizes may be marketed .
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate receptors in the brain that are involved in the signalling and communication of nerve impulses . in adults , this signal is transmitted over a long period of time , leading to the development of the symptoms of primary parkinson ' s disease . it can be used alone or in combination with levodopa ( another medicine used in parkinsons ' disease ). it is used to relieve the symptoms in adults with moderate to severe primary restless legs syndrome that have been shown to improve physical function and coordination .
do not take sifrol : - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking sfrol . tell your doctor about any medical conditions or symptoms you may have . some of these may be serious . kidney disease . hallucinations ( seeing , hearing or feeling things that are not there ) are very common ( many people get them during the night in the morning and evening as they can be very dangerous as they may be harmful to others . the most commonly occurring effects of most halluzinations are visual . dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ). in patients with advanced parkinson ' s disease , levodopa may
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . sifrol should be prescribed by a doctor experienced in the treatment of parkinson ' s disease . use in children and adolescents the recommended dose is 3 tablets per day . during the first week , your doctor will start you on a 1 - day cycle . after this , the dose will be increased to a maximum of 0 . 088 mg / kg body weight . this will be given to you on day 1 . you will then start with a higher or lower dose . the usual dose is : adults : two tablets a day ( morning , evening , and evening ): one tablet each day , with or without food , in a glass of water . your doctor may tell you to increase your dose to 0
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very commonly ( may affect more than 1 in 10 people ) common : may affect up to 1 in every 10 people uncommon : will occur in between 1 in 100 and 1 in 1 , 000 people not known : frequency cannot be estimated from the available data very common in patients with parkinson ' s disease the following side effects have been reported in patients taking sifrol : dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ) dizziness nausea ( sickness ) a common urge to behave in an unusual way - hallucinations ( seeing , hearing or feeling things that are not there ) confusion , tiredness , disorientation , irritability
what sifrol contains - the active substance is pramipexole . - each tablet contains 0 . 088 mg ( equivalent to 18 mg ) - one liter ( liter ) of solution for injection , - another liter (0 . 35 mg tablet ) and a further insertion ( subcutaneous ) release ( corresponding to 7 . 7 mg / ml after reconstitution ). if you are not sure , talk to your doctor , pharmacist or nurse before you are given a tablet . the tablets are white to off - white , round , flat tablets , debossed with " pfizer " on one side and " nvr " on the other side . each tablet comes in a plastic bottle . it is available in different pack sizes containing : - bottles containing either 0
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye . it belongs to a group of medicines called ' allergens '. it is produced by recombinant technology without the use of any human - or animal - derived components in the eye that cause allergic conditions . the allergic reaction is usually mild to moderate and lasts for several days . in some cases it may be severe . for this reason , it is important that you and your doctor carefully monitor the condition of your eye and decide if you should continue to use it . your doctor will recommend the most appropriate treatment for you . you must follow carefully the instructions from your doctor , pharmacist or nurse so that it is clear what you have been given and how to throw away any medicines you no longer use . these measures will help protect the environment .
do not use emadine - if you are allergic to emedastine or any of the other ingredients of this medicine listed in section 6 . warnings and precautions children and adolescents do not give this medicine to children under the age of 3 years because the active substance is benzalkonium chloride . this product should not be used in this age group . in clinical trials and post - marketing experience , safety and efficacy have not been demonstrated . talk to your doctor if any of these apply to you . please read the section at the end of this leaflet . you must not use the product after the expiry date which is stated on the label and carton after " use ". children this medicine is not recommended for children younger than 6 years old because it has not been studied in these age groups . there is limited experience in these patients , however , clinical trials have been performed in
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one drop in each eye 3 times a day in the morning and evening . do not use more than your doctor tells you to use . this medicine should only be used in the eyes . use in children and adolescents do not give this medicine to children under the age of 3 years . for children aged 1 month to 2 years , use in adolescents aged 1 year and above . take the emadine bottle out of the refrigerator at the same time each day . wash your hands . hold the bottle . pull the cap off the bottle and pull back the cap . if snap collar is loose , the bottle can be taken out . bring the bottle close to your thumb and finger . tilt your head back and pull down your lower eyelid with a clean finger 
like all medicines , this medicine can cause side effects , although not everybody gets them . you should stop using the drops and see a doctor immediately if you notice any of the effects above . common side effects ( may affect up to 1 in 10 people ) effects in the eye : eye pain , itchy eye , eye redness . uncommon side effects that may affect more than 1 in 100 people effects at the site of application : damage to the front part of the eye ( corneal disorder ), abnormal eye sensation , increased tear production , tired eyes and eye irritation , blurred vision , corneal staining . not known ( frequency cannot be estimated from the available data ): allergic reactions ( e . g . swelling of the face , lips , mouth , tongue or throat ), runny nose , rash . side effects reported with emad
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the label and carton after exp . store below 25 . keep the container tightly closed in order to protect from moisture and light . your doctor or pharmacist is responsible for the correct storage of the medicine and for its correct disposal .
what emadine contains the active substance is difumarate . the other ingredients are benzalkonium chloride , trometamol , sodium chloride ( see section 2 ), hypromellose , purified water , hydrochloric acid , and sodium hydroxide ( to adjust acidity levels in the blood and ph levels ) to keep acidity within the normal range ( see ' important information about some of the ingredients in this medicine '), chlorine dioxide ( e171 ) and / or phosphate ( a type of sugar ) in the tablet core and the solvent in the vial is a clear , colourless to yellow solution . it is supplied in a pack containing : one vial of 5 ml and one plastic ( drop - container ) bottle with a screw cap . not all pack
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetistetam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epileptic , or a condition in which the patients have repeated fits ( seizures ) over a period of time . in this type of epilpsy , fits first affect the brain , but could thereafter extend to larger areas on both sides of the brain ( partial onset seizure with or without secondary generalisation ) and gradually replaces the original diagnosis of myoclonic seizures ( fits ) for adults , adolescents and children from 6 months of age .
do not take levetiracetam actavis : - if you are allergic to levetiractam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before and during your treatment with levetiratetam amgen . patients with kidney problems should be monitored carefully for signs of any slow down in the growth or unexpected puberty development of their child . a small number of people being treated with anti - epileptics such as levetistetam actingavis have had thoughts of harming or killing themselves , or any symptoms of depression and / or suicidal ideation . tell your doctor immediately if side effects occur , including abnormal thoughts , feeling irritable or reacting more aggressively than usually , to any change in mood or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . take the number of tablets following your doctor ' s instructions . levetiracetam actavis should be taken twice a day , once in the morning and twice in the evening , at about the same time each day . monotherapy dose in adults and adolescents ( from 16 years of age ) - the usual dose is 1 , 000 mg twice daily . your doctor will prescribe you the lowest dose based on your individual needs . - when you reach the dose that is right for you , your doctor may prescribe you a lower dose ( such as 2 tablespoons of 1 litres ) or a higher dose ( 4 tablespoons ). - if your daily dose has been increased , you may have to take the higher dose again . in children ( from
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately , or go to your nearest emergency department , if you experience weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction . swelling of the face , lips , tongue and throat ( quincke ' s oedema ). flu - like symptoms and a rash on the face followed by an extended rash with a high temperature , increased levels of liver enzymes seen in blood tests and an increase in a type of white blood cell ( 56 ) eosinophilia ) and enlarged lymph nodes ( drug reaction with fever ) common side effects ( may affect up to 1 in 10 people ): dizziness , headache 
the active substance in levetiracetam actavis is called ' lisinopril '. each tablet of levetiractam actsavis 250 mg contains 250 mg levetiretam . each levetiacetam actionavis 500 mg contains 500 mg levietam the other ingredients are : the tablet core is made of titanium dioxide ( e171 ) and the tablet is inserted into a sterile water for injections . the tablet also contains a desiccant to reduce moisture in the gut , which will help to keep the tablets moist , and to help protect the tablets from moisture . after dilution , the tablet may be taken out of the refrigerator and should be kept at room temperature ( not above 25oc ) for up to a maximum of 750 days . this will be followed by a further 750 mg
the active substance umeclidinium bromide belongs to a group of medicines called bronchodilators . incruse ellipta is used to treat chronic obstructive pulmonary disease ( copd ). copd is a long - term condition in which the airways and air - sacs in the lungs slowly tighten . this results in breathing difficulties that slowly get worse . as a result , difficulties in breathing are made worse by tightening of the muscles in your lungs . by doing so , this medicine blocks this tightener of these muscles and so restricts the flow of air , allowing your airways to open more easily and improving your breathing difficulties in the long term , and reduce the effects of copd on your everyday life . you don ' t need to exercise regularly , either every day or only from time to time
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : - you have asthma , as this medicine should not be used in asthma controlled conditions . if this applies to you , tell your doctor or nurse immediately . this medicine is not recommended for the treatment of asthma in the following conditions : heart problems or an eye problem called narrow - angle glaucoma ; an enlarged prostate , difficulty passing urine or a blockage in your bladder ; severe liver problems . immediate breathing difficulties such as tightness of the chest , coughing , wheezing or breathlessness immediately after inhalation of the inhaler , stop using it and use it
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . use incruse ellipta every day , even when you have symptoms that do not improve over time . this medicine should not be used to relieve a sudden attack of breathlessness or wheezing . in order to relieve this attack you must use a quick - acting reliever inhaler ( such as salbutamol ). you must follow the instructions for use at the end of this leaflet to ensure that you have the best chance of getting the best results for your health . if
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are uncommon ( may affect up to 1 in 100 people ). if you get any of the following symptoms while using incruse ellipta , stop using this medicine and tell your doctor straight away : itching skin rash ( hives ) or redness 29 other side effects may include : common : may affect more than 1 in 10 people faster heart beat painful and frequent urination ( may be signs of a urinary tract infection ) common cold infection of nose or throat cough feeling of pressure or pain in the cheeks and forehead ( signs of inflammation of the lining of the mouth and throat ) if any of these side effects causes you problems , talk to your doctor , pharmacist , or nurse . common reported side effects are shown in 1 to 10 users in 100
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label of the inhaler and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the sealed tray tightly closed in order to protect from light . after first use or if carried as a spare you can inhale incruse ellipta for up to 6 weeks without being able to use it . once you have taken the first dose , write down the date on the carton including day / week / month / year . write the date of the first use on the seal on the blister on the outer carton when you first open it , and on the back of the container after removing it from the refrigerator . you do not need to store in the original package , but you should store it in its sealed tray in
what incruse ellipta contains - the active substance is umeclidinium bromide . - each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms ( 0 . 5 ml ) umeklidinium , corresponding to a concentration of 65 microgram ( 10 microgram ) inhaled at the same time . the other ingredients ( excipients ) are lactose monohydrate ( see section 2 for further information on the ingredients of the inhaler ) and magnesium stearate ( e470b ) ( see end of section 2 under ' important information about the content of the pack '). what you need to know before your first dose : your doctor or pharmacist will help you to remember your dose . your doctor , pharmacist or nurse will show you how to
nucala contains the active substance mepolizumab . this is a monoclonal antibody , a type of protein that recognises and attaches to a specific target in the body . it is used to treat adults with severe asthma in adults , adolescents and children aged 6 years and older . severe asthma affects many eosinophils - a kind of white blood cell that circulates in the lungs . in people with eopenia , these cells can help to control asthma attacks . you may be given medicines called high dose inhalers to help control your asthma . these medicines may be medicines taken at the same time as medicines called oral corticosteroids . your doctor will discuss with you which medicine to use next , when to use and how often to use them . if you do not respond well enough or if someone else or a
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you have worsening asthma 58 you have asthma - related side effects as your doctor has told you . your doctor will monitor your asthma while you are being treated for your asthma . if any of these apply to you , or if they are not sure , ask your doctor for advice . you are not supposed to be treated at home , but your doctor may want to monitor you more closely , especially if your asthma is not getting better after Nucala treatment you have been using for a long time . allergic - injection site reactions medicines of this type ( monoclonal antibodies ) can cause severe allergic reactions when they are injected into the
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . nucala is given by injection under the skin ( subcutaneous injection ). the recommended dose for adults and adolescents 12 years of age and older is 100 mg / kg administered once a week for 1 week . use the pre - filled pen at the same time each day . your doctor will decide on the dose that is right for you and will tell you how many injections you need to receive . you will be monitored by your doctor while you are being treated . it is very important that you follow your doctor , nurse or doctor ' s instructions on how to give yourself the injection and how long you should continue treatment . read the " instructions for use " provided in the box at the end of this leaflet . if your doctor decides that you can use nucalala at any time
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions may occur ( very common , may affect more than 1 in 10 people ) where the injection is given . sometimes symptoms include symptoms such as chest tightness , cough , difficulty breathing fainting , dizziness or feeling lightheaded ( due to a drop in blood pressure ) swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you have had a reaction or a similar reaction after receiving the injection . your doctor may decide to keep you under closer observation or change the dose . if any of these side effects causes you problems , you should contact your doctor or nurse immediately . you may also experience a reduction in the number of white blood cells
keep out of the sight and reach of children . do not use nucala after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light and moisture . before first use , the nucale pre - filled pen can be removed from the refrigerator and left at room temperature ( not above 30 ) for a single period of up to 7 days ( but not beyond 7 days ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nucala contains - the active substance is mepolizumab . each vial contains 1 ml of solution ( 100 mg /ml ). the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate ( e330 ), polysorbate 80 , edta disodium dihydrate and water for injections ( see section 2 ). what nukala looks like and contents of the pack nucale is presented as a solution for injection in a glass vial . it is available in packs containing 1 vial or a pack containing 3 vials . not all pack sizes may be marketed . your physician will prescribe the pack which is best for you .
what ninlaro is this medicine is a cancer medicine that contains two active substances called ixazomib , known as a ' proteasome inhibitor '. what the active substance in this medicine belongs to a group of medicines called ' cytokines ' used for the treatment of adult patients with multiple myeloma . one of the active substances in the medicine works by blocking a protein in the cell called yew - globin ( pg ) that is involved in cell survival . in myelama cells , a lot of proteins called proteasoms play an important role in dividing and dividing cells . this leads to the formation of proteins that are involved in the growth and development of cell divisions . what are the benefits and risks of using the product ? if you have the impression that the effect of 
do not take ninlaro : - if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before taking any of these medicines . if this applies to you , tell your doctor immediately . before you start taking the medicine , make sure that you have the correct dose . you should not be given the cheapest and most effective medicine in the world . your doctor will tell you how long you should be treated before starting and during treatment . in some cases , you may experience bleeding , persistent nausea , vomiting , diarrhoea , nerve problems such as tingling , numbness , swelling or a persistent rash , liver or kidney problems . patients will be carefully checked by their doctor before starting
ninlaro should only be prescribed to you by a doctor with experience in treating multiple myeloma . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will tell you what dose to take . the recommended dose is one tablet a day . lenalidomide is a medicine that is taken in combination with dexamethasone , an anti - inflammatory medicine . your doctor may decide to keep your tablet on a different day , depending on how you respond to the treatment . you will usually start by taking one tablet each day and then gradually increase your dose over the next 4 - week period . if your doctor decides that you should take one tablet on the same day of the week . for the first 3 weeks of the first 4 weeks , your
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ) low platelet counts ( thrombocytopenia ) nose bleeds easily bruise nausea , vomiting or diarrhoea numbness , tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet , ( peripheral oedema ) skin rash , itchy , affects most of the body . rare side effects these may affect up to 1 in 1 , 000 people ninlaro may cause a combination of a rare but serious allergic reaction ( anaphylactic shock ). if any of these side effects causes you problems , or if you notice any side effects not listed in this leaflet , please tell your doctor or pharmacist
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister or the carton after " exp ". store below 30 . store in the original package in order to protect from light and moisture . the capsule should not be used if it is damaged or shows signs of tampering . this medicine does not require any special temperature storage conditions . any unused medicine should be disposed of in accordance with local requirements for medicine packaging .
what ninlaro contains - the active substance is ixazomib . each capsule contains 2 . 3 mg / 0 . 5 mg of xazomimb , corresponding to a concentration of 3 . 9 mg pfu / 1 , 000 international units ( iu ). the other ingredients ( excipients ) are microcrystalline cellulose , magnesium stearate and talc . the capsule shell contains gelatin , titanium dioxide ( e171 ), red iron oxide and , shellac , propylene glycol , potassium hydroxide , black iron oxide , all in the hard capsules , in black ink , which is printed with ' n1 ' on one side and plain on the other side . if you have any further questions on the use of this
do not use palforzia : - if you are allergic to peanuts , or to arachis hypogoea . warnings and precautions talk to your doctor or pharmacist before you have the medicine , and during treatment , if any of the following applies to you : children and adolescents ( 4 months to 17 years of age ) the safety and efficacy of treatment of peanut allergy has not been demonstrated in patients with peanut ( desensitisation ) to peanut ( e . g . in children ) and adolescents . your doctor will monitor you closely during and after your treatment . you must tell your doctor if : you have had allergic reactions after you have been treated with pal forzia and food allergies have not been investigated in patients receiving palfor zia , as there is no information on the use of this product in these patients .
do not take palforzia - if you are allergic to severe asthma . warnings and precautions talk to your doctor if your asthma is not well controlled . you may have a problem swallowing , or you have long term problems with your digestive system such as a severe mast cell disorder or severe or life - leading anaphylaxis . the first dose should be given within 60 days after your last dose of treatment . if this happens , your doctor may decide to stop your palforzaa and start taking it as soon as possible . it is very important that you follow this advice carefully so that you do not have the symptoms of peanut allergy . your doctor will discuss this with you before starting and during treatment , even if it does not seem to be too strong or too weak . peanut allergy is not allowed to enter into the food you eat . before you start taking palfor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . allergy or allergic reactions ( anaphylaxis ) may occur at least up to 3 months after you start treatment with palforzia . initial dose escalation should be started at the beginning of each of these treatment phases . during the initial dose elevation and up - dosing phases , your doctor will monitor you more closely during and after the dose adjustment period . it is very important that you follow the instructions from the doctor , pharmacist , or nurse so that you are able to follow your doctor ' s instructions exactly how to respond to the dose and how to prevent it from being taken into consideration by your doctor and should continue to follow them until your doctor tells you otherwise . if your doctor determines that you may need to be taken into account in this situation ,
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with palforzia : - severe allergic reactions . tell your doctor straight away if you get any of the following symptoms while you are taking palforzaa . depending on the severity of the reaction , you may have trouble breathing , throat tightness , a feeling of fulness , trouble swallowing or speaking - changes in voice , dizziness or fainting , severe stomach cramps , pain , vomiting , or diarrhoea ; severe flushing or itching of the skin pafzia can also cause problems with the stomach and digestive system . it is important that you drink plenty of fluids to help you sleep and / or eat properly . this is particularly important in patients who are unable to swallow the tablets .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . store below 25 . this medicine must not be used if any hard lumps of powder remain in the vial or if the solution is discoloured .
what palforzia contains the active substance is : 0 . 5 mg / 1 ml oral powder in sachets containing 10 mg or 20 mg . the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , magnesium stearate paul forzia 100 mg powder in powder in capsules , with printing ink indicating the product ' s colour ( see section 2 ). sealant : lactose , titanium dioxide ( e171 ) and beige oral powder , which is a white to off - white , capsule - shaped , biconvex tablet , debossed with " gsi " on one side and " nvr " on the other side . for single - dose blisters : the usual dose is 3 to 13 capsules per day
zerene belongs to the class of substances called benzodiazepine - related medicinal products . it contains hypnotic actions and is used to relieve sleeping problems in adults . treatment should be started at the earliest after a short period of time . if you still have problems sleeping after you have finished your capsules , you should contact your doctor .
do not take zerene - if you have hypersensitivity ( an allergy ) to the active substance , zaleplon or any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before taking zeene sleep apnoea syndrome . you may experience short periods without sleep , have severe kidney or liver problems or myasthenia gravis ( very weak or tired muscles ), have severe breathing or chest problems . children and adolescents do not give this medicine to children or adolescents under 18 years of age because it has not been studied in these age groups . the safety and efficacy have not been established in this age group . there have been no reports of undesirable effects with any medicine taken orally or with any medicines taken to treat physical dependence . during treatment , withdrawal symptoms may include headaches
always take zerene exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is 10 mg once a day , with no possibility of difficulty falling asleep . do not take more than the recommended dose for people aged 65 years and older , who have mild to moderate liver problems . take the 65 mg capsule about 5 hours before you go to bed , unless your doctor tells you otherwise . if your doctor advises you to take the capsule with food , you may find that the contents of the capsule become cloudy or you may have an overdose , becoming increasingly drowsy , leading to a coma . your doctor will tell you how long you should continue to take zeene . stopping treatment may stop your original sleeplessness and you may experience symptoms such as mood changes , anxiety or restlessness 
like all medicines , zerene can cause side effects , although not everybody gets them . if you notice any other changes in your health , tell your doctor or pharmacist straight away . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) unusually high levels of blood in the blood ( 1 , 000 iu / ml , see above under " warnings and precautions "). very common : may affect up to 1 in 10 people 100 not known : frequency cannot be estimated from the available data . very common reported side effects in children and adolescents ( 1 to 10 users in 100 ) very common reporting of side effects 36 if any of the side effects gets serious or are not related to your doctor , pharmacist or nurse . you can also report side effects directly via the national reporting system listed in append
what zerene contains the active substance is zaleplon 5 mg . the other ingredients are microcrystalline cellulose , pregelatinised starch , silicon dioxide , sodium lauryl sulphate , magnesium stearate , lactose monohydrate ( see end of section 2 ), indigo carmine ( e132 ), titanium dioxide . printing ink : shellac , red iron oxide , yellow iron oxide [ e172 ], black iron oxide ( fcf [ nvr / s - 1350 ), sodium lecithin , simethicone , white iron oxide in black ink that appears in red ink on the cap and the imprint " z5 ". the ink is composed of a white to off - white film - coated tablet , imprinted with "
